# Patent

## Title
Aspergillus containing beta-glucosidase, beta-glucosidases and nucleic acids encoding the same

## Abstract

A novel microorganism is provided named Aspergillus saccharolyticus. Further, beta-glucosidase enzymes encoded by said microorganism are provided, and the use thereof in the degradation of lignocellulosic material. Also, host organisms comprising the polypeptides of the invention and/or polynucleotides encoding these are provided. In addition, methods, compositions, and kit-of-parts are provided which comprise any component of the invention, and optionally any additional components.

## Background
CROSS-REFERENCE TO RELATED APPLICATIONS
The present application is a divisional application of U.S. patent application Ser. No. 13/813,031, filed Apr. 19, 2013 and titled “ASPERGILLUS CONTAINING BETA-GLUCOSIDASE, BETA-GLUCOSIDASES AND NUCLEIC ACIDS ENCODING THE SAME” (“the '031 Application”) The '031 Application is a national stage application of Patent Application Number PCT/DK2011/050296, filed Aug. 1, 2011 and titled “ASPERGILLUS CONTAINING BETA-GLUCOSIDASE, BETA-GLUCOSIDASES AND NUCLEIC ACIDS ENCODING THE SAME” (“the PCT Application”). The PCT Application claims priority to Danish Patent Application Number PA201070347, filed Jul. 30, 2010 (“the Danish Application”). The '031 Application, the PCT Application, and the Danish Application are hereby fully incorporated by reference.


FIELD OF INVENTION
The present invention relates to an Aspergillus strain AP, Aspergillus saccharolyticus, producing a superior novel beta-glucosidase enzyme for efficient saccharification of lignocellulosic biomasses.
BACKGROUND OF INVENTION
Exploitation of lignocellulosic biomasses for production of biofuels, biochemicals, and pharmaceuticals is alternative to the world's limited fossil resources. Bio refineries should replace oil refineries, producing the same products, but using renewable resources: lignocellulosic biomasses. Lignocellulosic biomasses mainly consist of cellulose, hemicelluloses, and lignin, with different distribution of each component depending on the specific plant species, from which it is derived. Cellulose is of great interest in terms of creating a sugar platform for biofuels and chemicals as its hydrolysis product, glucose, can readily be fermented into ethanol or converted into high value chemicals. Cellulose is a polymer of the simple sugar glucose covalently bonded by beta-1,4-glycosidic linkages. Many microorganisms produce enzymes that hydrolyze beta-linked glucans. These enzymes include endoglucanases, cellobiohydrolases, and beta-glucosidases. The complete hydrolysis of cellulose involves the synergistic action of cellobiohydrolases (EC 3.2.1.91), endoglucanases (EC 3.2.1.4), and beta-glucosidases (EC 3.2.1.21). The cellobiohydrolases are capable of degrading the crystalline parts of cellulose by cleaving off cellobiose molecules from the ends of the cellulose chains. The endoglucanases digest the cellulose polymer at random locations, hydrolyzing glucosidic bonds of the more amorphous regions of the cellulose, decreasing the degree of polymerization and opening it to attack by cellobiohydrolases by creating more free ends for attack by cellobiohydrolases. Finally, the beta-glucosidases act in the liquid phase hydrolyzing mainly cellobiose (a water-soluble beta-1,4-linked dimer of glucose) to glucose, but also to some extent cellodextrins, sugars with a low degree of polymerization.
Historically, enzymes from Trichoderma reesei and Aspergillus niger are known as a good match for the hydrolysis of cellulose; T. reesei enzymes mainly contributing with cellobiohydrolase and endoglucanase activity and A. niger enzymes with beta-glucosidase activity (Sternberg D et al. Can J Microbiol 1977; 2:139-47). Beta-glucosidases are of key importance as they are needed to supplement the cellobiohydrolase and endoglucanase activities for final glucose release and at the same time decreasing the accumulation of cellobiose and shorter cellooligmers that are known as product inhibitors for the cellobiohydrolases (Zhang Y-P et al. Biotechnol Adv 2006; 5:452-81). Especially efficient beta-glucosidases, that are not themselves easily inhibited by their substrate, glucose, are of great interest. Currently, most commercial cellulase preparations are produced by T. reesei, e.g. Celluclast 1.5 L (Novozymes A/S), which has to be supplemented with extra beta-glucosidase activity from another source, e.g. Novozym 188 (Novozymes A/S), in order to improve cellulose hydrolysis. However, the commercial available beta-glucosidases have relatively low long-term temperature stability. Robustness, thermostability and substrate specificity are very important characteristics for enzymes to be applied in industrial processes.
The conversion of cellulosic feedstocks into bioethanol has the advantages of the ready availability of large amounts of feedstock, the desirability of avoiding burning or land filling the materials, and the cleanliness of the ethanol fuel. Wood, agricultural residues, herbaceous crops, and municipal solid wastes have been considered as feedstocks for ethanol production. These materials primarily consist of cellulose, hemicellulose, and lignin. Once the cellulose is converted to glucose, the glucose is easily processed, for example fermented by yeast into ethanol. Since glucose is readily fermented to ethanol by a variety of yeasts while cellobiose is not, any cellobiose remaining at the end of the hydrolysis represents a loss of yield of ethanol. More importantly, cellobiose is a potent inhibitor of endoglucanases and cellobiohydrolases. The accumulation of cellobiose during hydrolysis is extremely undesirable for ethanol production. Other than biofuels, the monomeric sugars (including glucose) produced by enzymatic hydrolysis in the biorefinery will be used as a platform for biochemicals, plastics, pharmaceuticals, etc.
Cellobiose accumulation has been a major problem in enzymatic hydrolysis because cellulase-producing microorganisms produce little beta-glucosidase. The low amount of beta-glucosidase results in a shortage of capacity to hydrolyze the cellobiose to glucose. Several approaches have been used to increase the amount of beta-glucosidase in cellulose conversion to glucose.
Thus it would be an advantage in the art to provide beta-glucosidases with improved properties for converting cellulosic materials to polysaccharides, cellodextrins, disaccharides and monosaccharides. Improved properties include altered temperature-dependent activity profiles, thermostability, pH activity, pH stability, and substrate specificity.
SUMMARY OF INVENTION
The present invention relates to the identification of a novel and improved beta-glucosidase producing strain of the fungus Aspergillus, namely Aspergillus saccharolyticus, which is efficient in the degradation of lignocellulosic biomasses into glucose for production of biofuels, biochemical and pharmaceuticals. Several enzymes of the newly identified strain are efficient in degradation of lignocellulosic biomasses. In particular one enzyme has been identified and characterised as having improved beta-glucosidase activity. The identified beta-glucosidase has improved thermal stability, while maintaining its activity at a high level for a prolonged period of time compared to other fungal beta-glucosidases. This makes it a superior choice for degradation of lignocellulosic material.
In one aspect, the present invention relates to an isolated polypeptide comprising

    
    
        a. an amino acids consisting of the SEQ NO: 3, 4, 7, 10, or 13,
        b. a biologically active sequence variant of SEQ NO: 3, 4, 7, 10, or 13, wherein the variant has at least 92% sequence identity to said SEQ NO: 3, 4, 7, 10, or 13, or
        c. a biologically active fragment of at least 30 consecutive amino acids of any of a) through b), wherein said fragment is a fragment of SEQ ID NO: 3, 4, 7, 10, or 13.
    
    


In a preferred embodiment the polypeptide is purified from Aspergillus saccharolyticus, such as deposit no.: CBS 127449. The polypeptide is capable of degrading or converting lignocellulosic material that may be obtained from various sources. In a preferred embodiment the polypeptide of the present invention is capable of hydrolyzing a β1-4 bond linking two glucose or glucose-substituted molecules. A second aspect of the invention relates to an isolated polynucleotide comprising a nucleic acid or its complementary sequence being selected from the group consisting of

    
    
        a. a polynucleotide sequence encoding a polypeptide consisting of an amino acid sequence SEQ ID NO: 3, 4, 7, 10, or 13,
        b. a polynucleotide sequence encoding a biologically active sequence variant of the amino acid sequence, wherein the variant has at least 92% sequence identity to said SEQ ID NO 3, 4, 7, 10, or 13, and
        c. a polynucleotide sequence encoding a biologically active fragment of at least 30 contiguous consecutive amino acids of any of a) through b), wherein said fragment is a fragment of SEQ ID NO 3, 4, 7, 10, or 13 or
        d. SEQ ID NO.: 1, 2, 5, 6, 8, 9, 11, 12, or 29, or fragments of at least 90 contiguous nucleotides thereof, or
        e. a polynucleotide comprising a nucleic acid sequence having at least 88% identity to SEQ ID NO: 1, 2, 5, 6, 8, 9, 11, 12 or 29, or fragments of at least 90 contiguous nucleotides thereof or
        f. a polynucleotide hybridising to SEQ ID NO: 1, 2, 5, 6, 8, 9, 11, 12, or 29, or fragments of at least 30 contiguous nucleotides thereof, and
        g. a polynucleotide complementary to any of a) to f).
    
    


The polynucleotide may be used for cloning purposes and for production of the polypeptide of the invention. Thus, in a third aspect, the present invention also relates to a recombinant nucleic acid vector comprising a polynucleotide of the invention.
It is appreciated that the polynucleotide and/or the recombinant nucleic acid vector of the present invention may be introduced into host cells. Accordingly, the invention in a fourth aspect pertains to a recombinant host cell comprising a polynucleotide of the present invention and/or a nucleic acid vector of the invention.
A fifth aspect of the invention relates to an isolated microorganism comprising a polypeptide of the invention, a polynucleotide of the invention and/or a recombinant nucleic acid vector of the invention. The isolated microorganism is in one preferred embodiment the newly discovered strain Aspergillus saccharolyticcus of the invention or progeny thereof.
A sixth aspect relates to a method of producing a polypeptide as disclosed in the present invention comprising

    
    
        a. cultivating a microorganism, where said microorganism produces said polypeptide,
        b. recovering the polypeptide from said microorganism.
    
    


The microorganism may thus comprise a polynucleotide of the invention and/or a recombinant nucleic acid vector of the invention. The microorganism may be any microorganism suitable for the purpose. In a preferred embodiment, wherein microorganism is Aspergillus, and particularly Aspergillus saccharolyticcus or progeny thereof.
According to the invention the polypeptide, recombinant host cell and/or microorganism may be used in a composition. Thus, a seventh aspect related to a composition comprising at least one polypeptide of the invention, at least one recombinant host cell of the invention and/or at least one microorganism of the invention.
It is further appreciated that the polypeptide, recombinant nucleic acid vector, recombinant host cell, microorganism and/or composition of the present invention may be combined with other components. Thus, a further aspect pertains to a kit-of parts comprising at least one polypeptide of the invention, at least one recombinant nucleic acid vector of the invention, at least one recombinant host cell of the invention, at least one isolated microorganism of the invention and/or at least one composition of the invention, and at least one additional component. An additional component is typically enzymes that aid in the degradation or conversion of biomass for example cellulases, endogluconase, cellobiohydrolase, beta-glucosidase, hemicellulase, esterase, laccase, protease and/or peroxidise.
The invention in yet a further aspect relates to a method for degrading or converting a lignocellulosic material, said method comprising a) incubating said lignocellulosic material with at least one polypeptide of the invention, at least one microorganism of the invention, at least one recombinant host of the invention, at least one composition of the invention and/or at least one kit-of parts of the invention and b) recovering the degraded lignocellolosic material.
In a further aspect the invention pertains to a method for fermenting a cellulosic material, said method comprising

    
    
        a. treating the cellulosic material with at least one polypeptide of the invention, at least one recombinant host cell of the invention, at least one microorganism of the invention, at least one composition of the invention, at least one kit-of parts of the invention, and
        b. incubating the treated cellulosic material with one or more fermenting microorganisms.
        c. obtaining at least one fermentation product.
    
    


In addition to the aspects mentioned above, the present invention also pertains to the following related aspects. In one related aspect, the invention relates to an isolated microorganism of the species Aspergillus saccharolyticus, in particular the microorganism as deposited in the Centraalbereau voor Schimmelcultures (CBS) and having accession number CBS 127449, or a descendant or a functional mutant thereof.
In another aspect, the present invention relates to an isolated polypeptide identified as a beta-glucosidase comprising

    
    
        a. an amino acid sequence selected from SEQ NO: 3, 4, 7, 10, or 13
        b. a biologically active sequence variant of any of SEQ NO: 3, 4, 7, 10, or 13, wherein said variant has at least 92% sequence identity to said SEQ NO: 3, 4, 7, 10, or 13, or
        c. a biologically active fragment of at least 30 consecutive amino acids of any of the amino acid sequences of a) through b.
    
    


The polypeptide is for example purified from Aspergillus saccharolyticus, such as deposit no.: CBS 127449, but it may also be heterologously expressed from a recombinant host cell and purified therefrom. The polypeptide is capable of hydrolyzing cellobiose and/or cellodextrins, by hydrolyzing a 131-4 glucose-glucose linkage.
The invention also pertains to an isolated polynucleotide comprising a nucleic acid or its complementary sequence being selected from the group consisting of

    
    
        a. a polynucleotide sequence encoding a polypeptide consisting of an amino acid sequence SEQ ID NO: 3, 4, 7, 10, or 13
        b. a polynucleotide sequence encoding a biologically active sequence variant of the amino acid sequence, wherein the variant has at least 92% sequence identity to said SEQ ID NO: 3, 4, 7, 10, or 13 and
        c. a polynucleotide sequence encoding a biologically active fragment of at least 30 consecutive amino acids of any of the amino acid sequences of a) through b), or
        d. SEQ ID NO.: 1, 2, 5, 6, 8, 9, 11, 12, 29, or fragments of at least 90 contiguous nucleotides thereof. or
        e. a polynucleotide comprising a nucleic acid sequence having at least 89% identity to SEQ ID NO: 1, 2, 5, 6, 8, 9, 11, 12, 14, 15, 16, 17, 29 or fragments of at least 30 contiguous nucleotides thereof, or
        f. a polynucleotide hybridising to SEQ ID NO.: 1, 2, 5, 6, 8, 9, 11, 12, 14, 15, 16, 17, 29, or fragments of at least 30 contiguous nucleotides thereof, and
        g. a polynucleotide complementary to any of a) to f).
    
    


The invention also relates to a recombinant nucleic acid vector comprising a polynucleotide of the present invention.
Moreover, the invention relates to a host cell and/or an Aspergillus saccharolyticus microorganism or a descendant or functional mutant thereof, which comprises a polypeptide, a polynucleotide and/or a recombinant nucleic acid vector according to the invention.
The invention also pertains to a method of producing a polypeptide, said method comprising

    
    
        a. cultivating a host cell and/or a microorganism of the invention, and b. recovering said polypeptide from said microorganism.
    
    


Furthermore, the invention encompass a composition comprising a polypeptide, a host cell and/or a microorganism of the invention, and the invention also pertains to a kit-of parts comprising such a composition and at least one additional component. The additional component is for example selected from the group consisting of cellulases, endogluconase, cellobiohydrolase, beta-glucosidase, hemicellulase, esterase, laccase, protease and peroxidise.
In one important aspect, the invention relates to a method of degrading or converting a lignocellulosic material, said method comprising incubating said lignocellulosic material with a composition or a kit-of parts of the invention.



DESCRIPTION OF DRAWINGS
FIG. 1. Extracellular beta-glucosidase activity of screened fungi grown in simple submerged fermentation. pNPG was used as substrate in the assays, with one unit (U) of enzyme activity defined as the amount of enzyme needed to hydrolyze 1 umol pNPG in 1 minute.
FIG. 2. Neighbor-joining phylogenetic tree based on ITS1 region sequence data of black Aspergillus, including strain AP/Aspergillus saccharolyticus, and using A. flavus as out group. Numbers above the branches are bootstrap values. Bar, 0.02 substitutions per nucleotide.
FIG. 3. Beta-glucosidase activity of extracts from selected Aspergilli grown in simple submerged fermentation (*=type strain). One unit (U) of enzyme activity is defined as the amount of enzyme needed to hydrolyze 1 umol pNPG in 1 minute.
FIG. 4. pH profile. Beta-glucosidase activity of Strain AP/Aspergillus saccharolyticus and Novoym 188 at different pH measured on pNPG. Endoglucanase activity of Celluclast 1.5 L at different pH measured on AZO-CMC.
FIG. 5. Product inhibition; remaining beta-glucosidase activity at different inhibitor (glucose) concentrations relative to activity measured without inhibitor. A: pNPG as substrate, activity measured by release of pNP. B: cellobiose as substrate, activity measured by decrease in cellobiose concentration.
FIG. 6. Time course of thermal inactivation of the beta-glucosidases of (A) strain AP/Aspergillus saccharolyticus, (B) Novozym 188, and (C) Cellic CTec. Thermostability is evaluated based on the remaining activity after 0-4 hours of incubation at different temperatures relative to the activity without incubation.
FIG. 7. Hydrolysis of cellohexaose by Strain AP/Aspergillus saccharolyticus extract, Novozym 188, Celluclast 1.5 L, and Cellic CTec showing a clear difference in the mode of action.
FIG. 8. Hydrolysis of bagasse using different enzyme ratios of Strain AP/Aspergillus saccharolyticus or Novozym 188 relative to Celluclast 1.5 L.
FIG. 9. Neighbor-joining phylogenetic tree based on partial calmodulin gene sequence data for Aspergillus section Nigri. Numbers above the branches are bootstrap values. Only values above 70% are indicated. Bar, 0.02 substitutions per nucleotide.
FIG. 10. Neighbor-joining phylogenetic tree based on ITS sequence data for Aspergillus section Nigri. Numbers above the branches are bootstrap values. Only values above 70% are indicated. Bar, 0.02 substitutions per nucleotide.
FIG. 11. Neighbor-joining phylogenetic tree based on partial beta-tubulin gene sequence data for Aspergillus section Nigri. Numbers above the branches are bootstrap values. Only values above 70% are indicated. Bar, 0.02 substitutions per nucleotide.
FIG. 12. Universally Primed-PCR analysis using each of the two UP primers, L45 and L15/AS19. Loaded in lanes: 1&2) A. saccharolyticus sp. nov. CBS 127449T, 3) A. aculeatinus CBS 121060T, 4) A. ellipticus CBS 707.79T, 5) A. homomorphus CBS 101889T, 6) A. niger CBS 554.65T, 7) A. uvarum CBS 121591T, 8) A. auleatus CBS 172.66T, 9) A. japonicus CBS 114.51T 
FIG. 13. Extrolite profile from YES agar (14 days 25° C.) of A. saccharolyticus sp. nov. CBS 127449T. Above is the ESI+ trace (m/z 100-900) and below the UV trace (200-700 nm, 0.05 min ahead of ESI+). Mono isotopic masses (Mm) of major peaks are inserted. The UV spectrum of two related compounds, ACU-1 and ACU-2, with identical UV spectra is also inserted.
FIG. 14. A. saccharolyticus sp. nov. CBS 127449T. A) conidia, B-C) conidial heads, D-H) Three-point inoculation on CREA, CYA, CYA 37° C., MEA, and CYAS, respectively, incubated 7 days
FIG. 15. A. saccharolyticus sp. nov. CBS 127449T three point inoculation on CYA, incubation at different temperatures, growth observation day 7.
FIG. 16. Sketch of the cloning vector, pAN7-1 modified with a cassette of RP27 promoter, beta-glucosidase gene bgl1, his-tail, and beta-tubulin terminator inserted at the PciI restriction site.
FIG. 17. Beta-glucosidase activity and protein content of the different fractions from ion exchange, and SDS-page 4-12% of fractions 14-23 with high beta-glucosidase activity. Fractions 2-6 are flow through from the load, fractions 7-8 are wash prior to gradient elution, fractions 9-38 are gradient elution, and fractions 39-45 are final column stripping.
FIG. 18. SDS-page 12-20%, lane 1) A. cellulolyticus raw extract, lane 2) fraction #15 from the ion exchange fractionation, lane 3) His-tag purified BGL1
FIG. 19. Alignment of proposed active site region (boxed) of different aspergilli GH3 beta-glucosidases, the GenBank accession number is given in parenthesis
FIG. 20. A) Substrate saturation plot where enzyme activity is related to substrate concentration with the two substrates, pNPG and cellobiose. B) Relative beta-glucosidase activity at different inhibitor concentrations with a substrate concentration of 5 mM pNPG.
FIG. 21. A) Thermostability of BGL 1 incubated at different temperatures for different time period followed by assaying at 50° C., pH 4.8, 10 min reactions. TR1/2=half-life, calculated for temperatures above 60° C. B) pH profile of BGL1 assayed at 50° C., varying pH, 10 min reactions.
FIG. 22. Snap shot at different time points of the hydrolysis of cellohexaose for analysis of the degradation pattern. G1=glucose, G2=cellobiose, G3=cellotriose, G4=cellotetraose, G5=cellopentaose, G6=cellohexaose.
FIG. 23. Homology model of the catalytic module of beta-glucosidase from Aspergillus saccharolyticus. A. Ribbon cartoon representation of the catalytic module showing the important residues for catalysis (in royal-blue) and substrate/product binding (in spring-green). Glucose (in gray) is modeled into the catalytic site. The part of the loop marked ‘Y’ is not modeled. B. Stereo diagram illustrating the comparison of beta-glucosidase homology model of A. saccharolyticus (in steel-blue) with the template structure from T. neapolitana (PDB entry 2X41) (in orange-red). The catalytic nucleophile (D261) and the acid/base (E490) are shown in gold.
FIG. 24. NCBI blastn of BGL1 gDNA, closest identity 74%
FIG. 25. NCBI blastn of BGL1 cDNA without signal sequence, closest identity 84%
FIG. 26. NCBI blastx of BGL1 gDNA, closest identity 96%
FIG. 27. NCBI blastx of BGL1 cDNA, without signal sequence, closest identity 91%
FIG. 28. NCBI blastp of BGL1 polypeptide, without signal sequence, closest identity 91%
FIG. 29. NCBI blastn of BGL2 gDNA, closest identity 78%
FIG. 30. NCBI blastn of BGL2 cDNA, without signal sequence, closest identity 78%
FIG. 31. NCBI blastx of BGL2 gDNA, closest identity 87%
FIG. 32. NCBI blastx of BGL2 cDNA, closest identity 87%
FIG. 33. NCBI blastp of BGL2 polypeptide, without signal sequence, closest identity 73%
FIG. 34. NCBI blastn of BGL3 gDNA, closest identity 88%
FIG. 35. NCBI blastn of BGL3 cDNA, without signal sequence, closest identity 84%
FIG. 36. NCBI blastx of BGL3 gDNA, closest identity 92%
FIG. 37. NCBI blastx of BGL3 cDNA, without signal sequence, closest identity 75%
FIG. 38. NCBI blastp of BGL3 polypeptide, without signal sequence, closest identity 75%
FIG. 39. NCBI blastn of BGL4 gDNA, closest identity 77%
FIG. 40. NCBI blastn of BGL4 cDNA, without signal sequence, closest identity 71%
FIG. 41. NCBI blastx of BGL4 gDNA, closest identity 86%
FIG. 42. NCBI blastx of BGL4 cDNA, without signal sequence, closest identity 78%
FIG. 43. NCBI blastn of beta-tubulin partial coding sequence, SEQ ID NO: 14, closest identity 87%
FIG. 44. NCBI blastn of calmodulin partial coding sequence, SEQ ID NO: 15, closest identity 89% and
FIG. 45. NCBI blastn of ITS partial coding sequence, SEQ ID NO: 16, closest identity 89%.



DETAILED DESCRIPTION OF THE INVENTION
Definitions
Unless otherwise stated, the following terms used in this application, including the specification and claims, have the definitions given below. It must be noted that, as used in the specification and the appended claims, the singular forms “a,” “an” and “the” include plural referents unless the context clearly dictates otherwise. Definition of standard chemistry terms may be found in reference works, including Carey and Sundberg (1992) “Advanced Organic Chemistry 3rd Ed.” Vols. A and B, Plenum Press, New York. The practice of the present invention will employ, unless otherwise indicated, conventional methods of mass spectroscopy, protein chemistry, biochemistry, and recombinant DNA techniques, within the skill of the art. The term AP, Aspergillus AP as found herein is meant to refer to Aspergillus saccharolyticus. 
Amino Acids and Nucleic Acids
Throughout the description and claims the three letter code for natural amino acids are used. Where the L or D form has not been specified it is to be understood that the amino acid in question has the natural L form, cf. Pure & Appl. Chem. Vol. (56(5) pp 595-624 (1984) or the D form, so that the peptides formed may be constituted of amino acids of L form, D form, or a sequence of mixed L forms and D forms.
Where nothing is specified it is to be understood that the C-terminal amino acid of a polypeptide of the invention exists as the free carboxylic acid, this may also be specified as “—OH”. The N-terminal amino acid of a polypeptide comprise a free amino-group, this may also be specified as “H—”.
Where nothing else is specified amino acid can be selected from any amino acid, whether naturally occurring or not, such as alfa amino acids, beta amino acids, and/or gamma amino acids. Accordingly, the group comprises but are not limited to: Ala, Val, Leu, Ile, Pro, Phe, Trp, Met, Gly, Ser, Thr, Cys, Tyr, Asn, Gln, Asp. Glu, Lys, Arg, His, Aib, Nal, Sar, Orn, Lysine analogues DAP and DAPA.
Nucleic acid is meant to encompass DNA and RNA as well as derivatives thereof such as peptide nucleic acids (PNA) or locked nucleic acids (LNA) throughout the description.
Gene product refers to any transcriptional or translational product of a gene. A transcriptional product comprises any RNA-species, which is transcribed from the specific gene, such as pre-RNA, mRNA, tRNA, miRNA, spliced and nonspliced RNA. Thus, a transcriptional gene product of the present invention comprises any RNA-species encoded by or comprising a sequence selected from any β-glucosidase gene. For example, a transcriptional gene product of the present invention comprises any RNA-species encoded by or comprising a sequence selected from any of SEQ ID NO: 1, 2, 5, 6, 8, 9, 11, or 12. The transcript may be bound by RNA-binding proteins and, thus, packaged into a ribonucleoprotein (RNP), for example an mRNP molecule.
A translational gene product of the present invention comprises any peptide or polypeptide encoded by the gene or a fragment thereof. Thus, a “polypeptide encoded by a gene of the present invention” is comprised in the terms “gene product”, or “translational gene product”. A translational gene product of the present invention comprises any polypeptide-species encoded by a sequence selected from any β-glucosidase. For example, a gene product or translational gene product of the present invention comprises any polypeptide-species encoded by a sequence selected from any of SEQ ID NO: 1, 2, 5, 6, 8, 9, 11, 12, or the complement thereof or part thereof or any sequence which is at least 70%, such as at least 80%, for example at least 90% identical to any of said sequences or part thereof.
Fragments or parts of a polypeptide or polynucleotide refers to a fragment, piece, or sub-region of a nucleic acid or protein molecule whose sequence is disclosed herein, such that the fragment comprising 5, 10, 15, 20 or more amino acids, or 5, 10, 15, 30, 45, 60 or more nucleotides that are contiguous in the parent protein or nucleic acid compound. When referring to a nucleic acid sequence, “fragment thereof” or “part thereof” refers to 5, 10, 15, 30, 45, 60 or more contiguous nucleotides, derived from the parent nucleic acid sequence, and also, owing to the genetic code, to the complementary sequence. For example, if the fragment entails the sequence 5′-AGCTAG-3′, then “fragment thereof” would also include the complementary sequence, 3′-TCGATC-5′. Thus, the terms “fragment thereof” or “part thereof” as used herein in relation to an amino acid sequence refers to any portion of the given amino acid sequence which has the same activity as the complete amino acid sequence. Fragments will suitably comprise at least 30 and preferably at least 35 consecutive amino acids from the basic sequence. Fragments or parts of the polypeptide include deletion mutants and polypeptides where small regions of the polypeptides are joined together. The fragments should contain an epitope, and preferably contain at least one antigenic region.
The terms “fragment thereof” or “part thereof” as used herein in relation to a nucleic acid or polynucleotide sequence refers to any portion of the given polynucleotide sequence which serves a relevant purpose. In an oligonucleotide primer or probe comprising a fragment or part of a given basic sequence, the fragment or part should comprise enough nucleotides to support specific binding of the oligonucleotide primer or probe to its target. Such fragments typically comprise or consist of at least 5 nucleotides, such as at least 10, 15, or at least 20 consecutive nucleotides. With respect to a nucleic acid sequence encoding a polypeptide, wherein the nucleic acid sequence comprises or consists of a fragment or part of a basic nucleic acid, the fragment or part should comprise or consist of a nucleic acid sequence, which encodes a polypeptide with an activity which corresponds to the activity of the basic protein. Such fragments or parts will typically comprise at least 15, preferably at least 30 and more preferably at least 60 consecutive bases from the basic sequence.
Cellulosic ethanol is a biofuel produced from wood, grasses, or the non-edible parts of plants. It is a type of biofuel produced from lignocellulose, a structural material that comprises much of the mass of plants. Lignocellulose is composed mainly of cellulose, hemicellulose and lignin.
Beta-glucosidase is defined herein as a beta-D-glucoside glycohydrolase (E.C. 3.2.1.21) which catalyses the hydrolysis of terminal non-reducing beta-D-glucose residues with release of beta-D-glucose.
Extract is used herein for any extraction of a microorganism and/or host cell of the present invention. The extract preferably comprise a polypeptide and/or polynucleotide of the present invention. The extract may be prepared by opening the cells by lysis or chemical shear, and extracting the desired components in a suitable buffer.
Broth is used herein to describe a medium, which has been used for the culturing of a microorganism and/or host cell of the present invention. The broth is preferably a liquid culture broth, and the broth preferably comprise metabolites and/or other secreted components of the cultured microorganism and/or host cell, for example polypeptides of the present invention.
Lignocellulosic Material
The present invention refers to a newly identified strain of Aspergillus, strain AP, Aspergillus saccharolyticus, and the polypeptide of the present invention harbouring polypeptides that have improved qualities in the conversion or degradation of lignocellulosic material. Thus, the invention relates to the newly discovered strain, extracts, broths and polypeptides isolated from the strain, such as BGL1-4, that can be used in the conversion or degradation of lignocellulosic material. The invention also provides methods for degradation and/or conversion of lignocellulosic material. The origin of the lignocellulosic material of the present invention is preferably biomass in the form of low-cost by-products from gardening, agriculture, forestry, the timber industry and the like; thus, for example, materials such as straw, maize stems, forestry waste (log slash, bark, small branches, twigs and the like), sawdust and wood-chips are all materials which can be degraded or converted to lower order sugars, such as monosaccharide sugars according to the present invention. Thus, according to the present invention the lignocellulosic material may be obtained from agricultural residues such as straw, maize stems, corn fibers and husk, forestry waste such as sawdust and/or wood-chips, and/or from energy crops such as willow, yellow poplar and/or switch grass. Thus, the lignocellulosic material may be obtained from for example, but not limited to, straw, maize stems, corn fibers, husk, sawdust, wood-chips, willow, yellow poplar and/or switch grass. A cellulosic material to be used in accordance with the present invention is any available carbon source such as for example biomass, including plant biomass and complex plant biomass, such as e.g. plant cell wall constituents. The polypeptide, recombinant host cells, and/or microorganisms (Aspergillus saccharolyticus) of the present invention is preferably capable of degrading one or more plant cell wall constituents selected from the group consisting of cellulose, hemicellulose, pectin, and lignin. Accordingly, the carbon source preferably comprises at least one of, preferably at least two of, more preferably at least three of, yet more preferably all of the plant cell wall constituents selected from the group consisting of cellulose, hemicellulose, pectin, and lignin. Thus, the microorganism is preferably capable of degrading at least one or more selected from the group consisting of cellulose, hemicellulose, cellobiose, cellodextrin and pectin, more preferably from the group consisting of cellobiose and cellodextrin, More preferably, the microorganism of the present invention, extracts thereof, and/or the polypeptide of the present invention is at least capable of degrading icellobiose. In another preferred embodiment, the microorganism of the present invention, extracts thereof, and/or the polypeptide of the present invention is capable of degrading cellodextrin.
Cellulose is the structural component of the primary cell wall of green plants, many forms of algae and the oomycetes. Some species of bacteria secrete it to form biofilms. Cellulose is the most common organic compound on Earth. About 33 percent of all plant matter is cellulose (the cellulose content of cotton is 90 percent and that of wood is 40-50 percent). Cellulose is a polysaccharide consisting essentially of polymerized glucose monomer units, in general cellulose is a linear chain of D-glucose monomer units linked by β-(1→4) bonds. The cellulose polysaccharide preferably consists of in the range of 300 to 15,000, for example in the range of 500 to 10,000 glucose monomer units. The enzymes utilized to cleave the glycosidic linkage in cellulose are glycoside hydrolases including endo-acting cellulases (glucanases) and exo-acting glucosidases. Such enzymes are usually secreted as part of multienzyme complexes that may include dockerins and cellulose binding modules.
Cellobiose is a disaccharide with the formula [HOCH2CHO(CHOH)3]2O. The molecule is derived from the condensation of two glucose molecules linked in a β(1→4) bond.
Cellodextrin is classified by its degree of polymerization (DP) which indicates the number of linked glucose monomers it contains. Each glucose monomer is linked via a beta-1,4 glycosidic bond. The most common cellodextrins are
cellobiose (DP=2)
cellotriose (DP=3)
cellotetrose (DP=4)
cellopentose (DP=5)
cellohexose (DP=6)
Thus, in a preferred embodiment the beta-glucosidase of the present invention is capable of degrading or converting a lignocellulosic material, preferably cellobiose and/or cellodextrin, recovering degraded lignocellulosic material in the form of glucose monomers.
Hemicellulose is the term used to denote non-cellulosic polysaccharides associated with cellulose in plant tissues. Hemicellulose frequently constitutes about 20-35% w/w of lignocellulosic materials, and the majority of hemicelluloses consists predominantly of polymers based on pentose (five-carbon) sugar units, such as D-xylose and D-arabinose units, although more minor proportions of hexose (six-carbon) sugar units, such as D-glucose and D-mannose units, are generally also present.
Lignin, which is a complex, cross-linked polymer based on variously substituted p-hydroxyphenylpropane units, generally constitutes about 10-30% w/w of lignocellulosic materials. It is believed that lignin functions as a physical barrier to the direct bioconversion (e.g. by fermenting microorganisms) of cellulose and hemicellulose in lignocellulosic materials which have not been subjected to some kind of pre-treatment process (which may very suitably be a wet-oxidative process as described in relation to the present invention) to disrupt the structure of lignocellulose.
To minimise the production cost of generating a sugar platform in the biorefinery for biofuel and chemicals produced from biomass it is important to use biomass in the form of low-cost by-products from gardening such as garden refuse, waste materials from agriculture, forestry, the timber industry and the like. Thus, processes of the invention are applicable to any kind of cellulose-containing lignocellulosic materials, Relevant materials thus include wooden or non-wooden plant material in the form of stem, stalk, shrub, foliage, bark, root, shell, pod, nut, husk, fibre, vine, straw, hay, grass, bamboo or reed, singularly or in a mixture.
Preferred lignocellulosic materials in the context of the invention include but are not limited to wood (both softwood and hardwood), straw, corn stovers and so-called hulls. Wood employed in the context of the invention is generally heartwood (duramen) and/or outer wood (secondary xylem) derived from trunks, stems and/or branches of deciduous or evergreen trees or shrubs, Wood from the roots of such trees or shrubs may also be of value.
Useful sources of wood include numerous species of various genera of coniferous and broad-leaved trees/shrubs. Among conifers may be mentioned the following: Pinaceae, including pines (Pinus spp., such as Pinus sylvestris), silver firs (Abies spp., such as Abies alba), spruces (Picea spp., such as Picea abies), larches (Larix and Pseudolarix spp., such as Larix decidua and L. kaempfen) and Douglas fir (Pseudotsuga menziesii). Among broadleaves may be mentioned the following: Betulaceae, including birches (Betula spp., such as Betula pendufa); and Fagaceae, including beeches (Fagus spp., such as Fagus sylvatica) and oaks (Quercus spp., such as Quercus robur).
Useful sources of straw include in particular cereals (cereal grasses), i.e. gramineous plants which yield edible grain or seed. Straw from, for example, oat (Avena spp., such as A. saliva), barley (Hordeum spp., such as H. vulgare), wheat (Triticum spp., including T. durum), rye (Secal cereale), rice (Oryza spp.), millet (e.g. species of Digitaria, Panicum, Paspalum, Pennisetum or Setana), sorghum (Sorghum spp., including S. bicolor var. durra (also referred to as “durra”) and milo), buckwheat (Fagopyrum spp., such as F. esculentum) and maize (also referred to as corn (Zea mays), including sweetcorn) is well suited for treatment according to the process of the invention.
As employed herein, the term “hull” generally denotes the outer covering, rind, shell, pod or husk of any fruit or seed, but the term as employed herein also embraces, for example, the outer covering of an ear of maize. Relevant hulls include hulls selected among the following: hulls from oat (Avena spp., such as A. saliva), barley (Hordeum spp., such as H. vulgare), wheat (Triticum spp., including T. durum), rye (Secal cereale), rice (Oryza spp.), millet (e.g. species of Digiftaa, Panicum, Paspalum, Pennisetum or Setaria), sorghum (Sorghum spp., including S. bicolor var. durra and milo), buckwheat (Fagopyrum spp., such as F. esculentum), maize [also known as corn (Zea mays), including sweetcorn], corn cob, rape-seed (from Brassica spp., such as B. napus, B. napus subsp. rapifera or B. napus subsp. oleifera), cotton-seed (from Gossypium spp., such as G. heraceum), almond (Prunus dulcis, including both sweet and bitter almond) and sunflower seed (Helianthus spp., such as H. annuus).
Hulls of cereals, including not only those mentioned among the above, but also hulls of cereals other than those mentioned among the above, are generally of interest in the context of the invention, and preferred hulls, such as oat hulls and barley hulls, belong to this category. In this connection it may be mentioned by way of example that oat hulls are often available in large quantities at low cost as a by-product of oat-processing procedures for the production of oatmeal, porridge oats, rolled oats and the like; thus, a total of around 75,000 tons of oat hulls is produced per year as a by-product of oat-processing in Denmark, Norway and Sweden together with northern Germany.
Other types of hulls of relevance in relation to processes of the invention include, for example, palm shells, peanut shells, coconut shells, other types of nut shells, and coconut husk.
It should be noted that the native physical form, bulk and/or dimensions of lignocellulosic materials such as wood, straw, hay and the like will generally necessitate, or at least make it desirable, to carry out comminution of the material (e.g. by milling, abrading, grinding, crushing, chopping, chipping or the like) to some extent in order to obtain particles, pieces, fibres, strands, wafers, flakes or the like of material of sufficiently small size and/or sufficiently high surface area to mass ratio to enable degradation of the material to be performed satisfactorily. In the case of wood, material of suitable dimensions will often be available as a waste product in the form of sawdust, wood chips, wood flakes, twigs and the like from sawmills, forestry and other commercial sources.
In contrast, numerous types of hulls, e.g. cereal grain or seed hulls in general, including oat hulls as employed in the working examples reported herein, have in their native form sufficiently small dimensions and a sufficiently high surface area to mass ratio to enable them to be used directly, without prior comminution, as lignocellulosic materials in a process according to the present invention.
According to the present invention, a microorganism, an extract or broth from the microorganism, or a polypeptide is considered capable of degrading cellulose and/or cellodextrins, such as cellobiose, when it is capable of degrading at least 50%, preferably at least 60%, more preferably at least 70%, yet more preferably at least 80%, yet more preferably at least 90% of provided cellulose and/or cellodextrins, such as cellobiose to monomers or oligomers of glucose, wherein oligomers of glucose consists of in the range of 2 to 8 glucosidic monomers. The microorganism may be capable of further degrading glucose or oligomers of glucose and for example use said glucose as carbon source for growth and/or acid or acid derivative synthesis.
Hemicellulose may comprise monosaccharide units selected from the group consisting of glucose, xylose, mannose, galactose, rhamnose and arabinose, more preferably hemicellulose comprises at least glucose and xylose. In general the hemicellulose polysaccharide consists of in the range of 100 to 300, such as 150 to 250 monosaccharide monomer units.
According to the present invention, a microorganism, an extract or broth from the microorganism, or a polypeptide is considered capable of degrading hemicellulose, when it is capable of degrading at least 50%, preferably at least 60%, more preferably at least 70%, yet more preferably at least 80%, yet more preferably at least 90% of provided hemicellulose to monosaccharide monomers or oligosaccharides, wherein oligosaccharides consists of in the range of 2 to 8 monosaccharide monomers. The nature of said monosaccharide monomers depend on the particular hemicellulose, but may in general be selected from the group consisting of glucose, xylose, mannose, galactose, rhamnose and arabinose. The microorganism may be capable of further degrading said monosaccharides or oligosaccharides and for example use said monosaccharides or oligosaccharides as carbon source for growth and/or acid or acid derivative synthesis. Thus, it is preferred that in addition to the capability of degrading hemicellulose, the genetically modified microorganisms of the present invention also are capable of degrading one or more selected from the group consisting of glucose, xylose, mannose, galactose, rhamnose and arabinose, in particular it is preferred that the genetically modified microorganisms of the present invention at least are capable of further degrading glucose and xylose and for example use said monosaccharide as carbon source for growth and/or acid or acid derivative synthesis.
Pectin is a polysaccharide consisting of different monosaccharide monomer units, wherein at least some the monosaccharides may be sugar acids. Thus, pectin may be considered a heteropolysaccharide. Preferably, pectin according to the present invention may comprise monosaccharide units selected from the group consisting of galacturonic acid, rhamnose, xylose, galactose and arabinose, more preferably pectin comprises at least galacturonic acid and rhamnose. The galacturonic acid may be esterified, for example with a short alkyl-, preferably methyl-group. The galacturonic acid may also be present in the form of a salt, with any useful cation, for example sodium, potassium or calcium. In general pectin has a size of in the range of 60 to 130,000 g/mol.
According to the present invention, a microorganism, an extract from the microorganism, or a polypeptide is considered capable of degrading pectin, when it is capable of degrading at least 50%, preferably at least 60%, more preferably at least 70%, yet more preferably at least 80%, yet more preferably at least 90% of provided pectin to monosaccharides or oligosaccharides, wherein oligosaccharides consists of in the range of 2 to 8 monosaccharides. The monosaccharides may for example be sugars, sugar acids or esters or salts thereof. Thus, the monosaccharides may for example be selected from the group consisting of galacturonic acid, rhamnose, xylose, galactose and arabinose. The microorganism may be capable of further degrading the monosaccharides and/or oligosaccharides and for example use said monosaccharides and/or oligosaccharides as carbon source for growth and/or acid or acid derivative synthesis.
Lignin is a large polymer which is abundant in plant biomass and it is an integral part of the cell walls of plants. Lignins are very diverse in structure and according to the present invention lignin may be any naturally occurring lignin. Preferably, lignin comprises one or more different monomer units (also referred to as monolignol) selected from the group consisting of p-coumaryl alcohol, coniferyl alcohol, sinapyl alcohol and any of the aforementioned substituted with one or more lower alkoxy, preferably methoxy. Preferably, said monomer units are incorporated into the lignin polymer in the form of phenylpropanoid p-hydroxyphenyl, guaiacyl, syringal and any of the aforementioned substituted with one or more lower alkoxy, preferably methoxy, respectively. In addition to the aforementioned monomer units, lignin may comprise other monolignols. Lignin may be covalently linked to hemicellulose and/or cellulose. In particular, lignin may be covalently bonded to hemicellulose via infrequent linkages to the hemicellulose chains. Alternatively, lignin may be associated with hemicellulose and/or cellulose for example through hydrogen bonding. A complex (covalently bound and/or associated by means of hydrogen bonding) of lignin, hemicellulose and cellulose is also referred to as lignocellulosic complexes herein.
According to the present invention, a microorganism or a polypeptide is considered capable of degrading lignin, when it is capable of degrading at least 40%, preferably at least 50%, more preferably at least 60%, yet more preferably at least 65%, for example at least 70%, such as at least 80% of provided lignin to mono components derived from lignins or to oligomers of in the range of 2 to 8 monolignols. The microorganism may be capable of further degrading said monolignols or said oligomers and for example use said monolignols as carbon source for growth and/or acid or acid derivative synthesis.
The carbon source preferably comprises at least one, preferably at least two, more preferably at least three, even more preferably at least four, for example all of the plant cell wall constituents selected from the group consisting of cellulose, hemicellulose, cellobiose, cellodextrin and pectin. Thus, the microorganism is preferably capable of degrading at least one or more selected from the group consisting of cellulose, hemicellulose, cellobiose, cellodextrin and pectin, more preferably from the group consisting of cellobiose and cellodextrin. More preferably, the microorganism of the present invention, extracts thereof, polypeptide of the present invention is at least capable of degrading cellobiose. In another preferred embodiment, the microorganism of the present invention, extracts thereof, polypeptide of the present invention is capable of degrading cellodextrin. Aforementioned plant cell wall constituents may be provided in a purified form or a partly purified form, however, frequently they will be provided in the form of plant biomass (see below).
In addition to the plant cell wall constituents the carbon source may comprise other components, in particular it is comprised within the scope of the present invention that the carbon source may comprise additional polysaccharides, such as e.g. starch. The carbon source may also comprise chitin. Starch is a polysaccharide consisting essentially of polymerized glucose monomer units. Starch is in general made up by a mixture of amylose and amylopectin. Amylose is a polymer of glucose linked mainly by α(1→4) bonds and amylopectin is a branched polymer of glucose linked in a linear way with α(1→4) bonds and with branching taking place with α(1→6) bonds occurring approximately at every 24 to 30 glucose units.
In one embodiment of the invention where the carbon source further comprises a polysaccharide as e.g. starch, the microorganism is capable of degrading at least 50%, preferably at least 60%, more preferably at least 70%, yet more preferably at least 80%, yet more preferably at least 90% of provided polysaccharide as e.g. starch to monomers or oligomers of glucose, wherein oligomers of glucose consists of in the range of 2 to 8 glucosidic monomers. The microorganism may be capable of further degrading glucose or oligomers of glucose and for example use said glucose as carbon source for growth and/or acid or acid derivative synthesis.
In a very preferred embodiment of the invention the carbon source is a complex carbon source, such as a carbon source comprising complex plant material, wherein said complex plant material may be plant biomass. In particular crude plant biomass is considered a complex plant material according to the present invention. In particular for industrial scale production of microbial oil for example for preparing bioethanol it is preferred that the carbon source is plant biomass. In this way, the methods of the present invention may serve to substitute conventional oil refineries by producing similar or identical products on the basis of plant biomass in stead of oil. Said plant biomass is readily available in the form of agricultural or forestry wastes. In general agricultural or forestry wastes comprise or more preferably even consist mainly of lignocellulosic complexes and starch. Thus, the carbon source may be plant biomass for example wood residues, paper waste, agricultural residues or energy crops, which all comprises one or more plant cell wall constituents. Wood residues may for example be forestry waste, saw mill waste and/or paper mill waste. Paper waste may be any discarded paper, such as discarded paper collected from households and/or businesses, such as industry. Agricultural residues may be any plant material obtained as a product of agriculture, and thus agricultural residues may for example be any cultivated plant or parts thereof. Preferably, agricultural residues is agricultural waste, such as waste from cereal crops, for example stalks, straw and/or leaves from cereal crops, wherein cereal crops for example may be selected from the group consisting of barley, wheat, millet, maize, rice, sorghum, oats, rye, triticale, buckwheat, fonio and quinoa. Agricultural waste may also be bagasse, for example bagasse from sugar production, such as sugar cane bagasse. Agricultural waste may also be waste from the production of vegetable oils, such as soybean oil, palm oil, peanut oil, rape seed oil, olive oil, grape seed oil or sunflower oil, preferably waste from production of palm oil, Waste from oil production, such as palm oil production may include fibers, kernel shells and/or oil mill effluent. Energy crops includes any plant grown for exploitation of its energy content and are thus typically densely planted, high yielding crop species. Non-limiting examples include miscanthus, salix, populus, maize, sudangrass, millet, or white sweet-clover. The carbon source may also be other organic waste, for example organic waste collected from house holds and/or industry. The carbon source may also be a mixture of one or more of the aforementioned.
In one embodiment it is preferred that the carbon source is not a plant product, which may be used for food or feed production. Preferably, the carbon source is not a plant product which may be used for food production.
The degradation of lignocellulosic complexes has been described for example in Kirk, T. K. and Cullen, D. in: Environmentally Friendly Technologies for the Pulp and Paper Industry; Young, R. A. and Akthar, M. eds. (1998) John Wiley & Sons ISBN 0-471-15770-8. Plant cell walls are a composite material having constituent parts for example cellulose, hemicellulose, lignin and pectin. With the exception of lignin these materials are polymerized carbohydrates with either C6 or C5-sugars or sugar acids as monomeric units. The long chains are branched at specific positions of the chains of the polymer.
The entire structure is rendered compact and semi-crystalline by crosslinking of the different polymer structures and by hydrogen-bonds giving the plant cell not only a turgor-resistant cell wall but also a barrier of defense against plant pathogens.
For any given process, such as an industrial process which uses a heterogeneous plant biomass as carbon source for the growth of the microorganism it is preferred that the enzymatic profile of the organism permits the degradation of a maximum of the available energy sources present in the given biomass. Thus, the preferred microorganism to be employed with the methods according to the present invention preferably are able to grow equally well on all major plant biomass constituents such as cellulose, hemi-cellulose, pectin, and lignin
In one embodiment the carbon source is pretreated. This is in particular relevant when the carbon source is a complex plant material, such as any of the complex plant materials described herein above.
The carbon source, such as the complex plant material can be pretreated. Such pretreatments could be treatment with cellular extracts. It could be treatment with chemicals for example acids, alkali or oxygen, such as acid or alkali treatment of wood for wood saccharification. The pretreatment may also be a heat treatment. Said heat treatment may be performed alone (e.g. as in wood distillation) or in combination with acid, alkali and oxygen treatment. Such methods are for example used in the paper industry to separate cellulose from other wood constituents.
In one embodiment of the invention the carbon source is pretreated with enzymes capable of degrading lignocellulosic material extracted or purified from microorganisms, for example microorganisms like Chrysosporium, Trichoderma, Aspergillus, Fusarium and Pencillium. Preferably a complex carbon source containing one or more of cellulose, cellobiose, cellodextrin and/or pectin is pretreated with a multi-enzyme product comprising enzymes e.g. selected from hemicellulases and cellulases, prepared as described by Magnuson et al in WO 2008/008793, which is hereby incorporated by reference.
Polypeptide
The present invention relates to polypeptides with beta-glucosidase activity. Thus, the polypeptides provided herein are capable of hydrolyzing a glycosidic linkage in a polysaccharide. In specific embodiment, the polypeptide or a biologically active fragment thereof is encoded by a gene selected from the group consisting of SEQ ID NO: 1, 2, 5, 6, 8, 9, 11 and 12.
Thus the present invention relates in one aspect to an isolated polypeptide comprising

    
    
        a. an amino acid sequence consisting of SEQ NO: 3, 4, 7, 10, or 13,
        b. a biologically active sequence variant of SEQ NO: 3, 4, 7, 10, or 13, wherein the variant has at least 92% sequence identity to said SEQ NO: 3, 4, 7, 10, or 13, or
        c. a biologically active fragment of at least 30 consecutive amino acids of any of a) through b), wherein said fragment is a fragment of SEQ ID NO: 3, 4, 7, 10, or 13.
    
    


In a preferred embodiment the polypeptide originates from or is purified from Aspergillus saccharolyticus, characterised as deposit no.: CBS 127449T.
The polypeptide of the invention has beta-glucosidase activity, and thus, the polypeptide of the invention is capable of hydrolyzing a β1-4 glucose-glucose linkage. Accordingly, the isolated polypeptide is capable of hydrolyzing cellobiose and/or other cellodextrins, such as cellotriose (DP=3), cellotetrose (DP=4), cellopentose (DP=5), or cellohexose (DP=6). The cellobiose and/or cellodextrins is preferably obtained from a lignocellulosic material originating from agricultural residues such as straw, maize stems, corn fibers and husk, forestry waste such as sawdust and/or wood-chips, and/or from energy crops such as willow, yellow poplar and/or switch grass.
The catalytic activity of the betaglucosidase (BGL) polypeptides of the present invention is higher, and more robost in terms of thermostability, pH activity, and pH stability than conventional BGL enzymes. For example, in one embodiment, a BGL polypeptide of the invention, such as the BGL1 polypeptide, has a specific activity, Vmax, of at least 20, such as at least 30, for example at least 40, for example at least 50, such as at least 60 U/mg with cellobiose as substrate in hydrolysis. Preferably, the BGL polypeptide has a specific activity, Vmax, of at least 40, such as at least 45 U/mg with cellobiose as substrate in hydrolysis.
The half-life of the beta-glucosidase activity at 60° C. of a BGL polypeptide of the invention, such as the BGL1 polypeptide, is preferably at least 100 minutes, such as at least 150, such as at least 180, or at least 190, such as at least 200 minutes. In a preferred embodiment, the half-life of the beta-glucosidase activity at 60° C. is at least 200 minutes, such as at least 300 minutes, for example at least 400 minutes, such as at least 430, 440, or at least 450 minutes.
In one embodiment, at least 30%, such as at least 40, 50, 60, such as at least 70% of the beta-glucosidase activity of said polypeptide remains after 4 hours of incubation at 60° C. In a more preferred embodiment, at least 60%, such as at least 65% of the beta-glucosidase activity of said polypeptide remains after 4 hours of incubation at 60° C.
The polypeptide of the present invention may be a fragment of SEQ ID NO: 3, 7, 10, 13, wherein the polypeptide fragment is devoid of the signal peptide, wherein said polypeptide for example for BGL1 is SEQ ID NO: 4. The position of the signal peptides for BGL1-4 are indicated in the sequences herein below.
Biologically Active Variant of Polypeptides
A biologically active variant of a polypeptide of a given sequence within the present invention is a polypeptide sharing at least some sequence identity with the given sequence and which shares at least one function. For enzymes, that function is preferably the capability to catalyse the reaction catalysed by the particular enzyme.
Evolutionary conservation between polypeptides of different closely related species, e.g. assessed by sequence alignment, can also be used to pinpoint the degree of evolutionary pressure on individual residues. Preferably, polypeptide sequences from at least 2, preferably at least 3, more preferably at least four different species where the function of the polypeptide is conserved are compared, for example from different species of fungi. Conserved residues are more likely to represent essential amino acids that cannot easily be substituted than residues that change between species. For example, such an alignment may be performed using ClustalW from EMBL-EBI. It is evident from the above that a reasonable number of modifications or alterations of a polypeptide sequence does not interfere with the activity of a given polypeptide. Thus, preferably, functional homologues of a given polypeptide comprise all residues, which are conserved between at least 4, such as at least 3, for example at least 2 different species. Functional homologues may thus comprise one or more amino acid substitutions at residues, which are not conserved between at least 4, such as at least 3, for example at least 2 different species.
Functional homologues may also be identified by DNA shuffling such as for example described in WO 95/22625, Stemmer, W. and Crameri: A DNA Mutagenesis by Random Fragmentation and Reassembly, and be prepared by conventional molecular biology techniques.
Biologically active as described herein means that the polypeptide, variant or fragment thereof is able to degrade or convert lignocellulosic material, preferably cellobiose, into monomeric glucose units. The ability to degrade or convert lignocellulosic material is determined in a beta-glucosidase assay. In this work specific activity is defined as units per amount of total protein.
Biologically active variants may also be defined with reference to the biological assays described in the examples. A preferred biological activity is the ability of the polypeptide to act as a beta-glucosidase, being capable of hydrolysing a glycosidic linkage in a polysaccharide, see elsewhere herein.
As used herein “variant” refers to polypeptides or proteins which are homologous to a polypeptide, for example beta-glucosidase/BGL-genes (such as BGL1, SEQ ID NO.: 3, BGL2: SEQ ID NO: 7, BGL3, SEQ ID NO: 10, and BGL4, SEQ ID NO: 13), but which differs from the base sequence from which they are derived in that one or more amino acids within the sequence are substituted for other amino acids. Amino acid substitutions may be regarded as “conservative” where an amino acid is replaced with a different amino acid with broadly similar properties. Non-conservative substitutions are where amino acids are replaced with amino acids of a different type. Broadly speaking, fewer non-conservative substitutions will be possible without altering the biological activity of the polypeptide.
A person skilled in the art will know how to make and assess ‘conservative’ amino acid substitutions, by which one amino acid is substituted for another with one or more shared chemical and/or physical characteristics. Conservative amino acid substitutions are less likely to affect the functionality of the protein. Amino acids may be grouped according to shared characteristics. A conservative amino acid substitution is a substitution of one amino acid within a predetermined group of amino acids for another amino acid within the same group, wherein the amino acids within a predetermined groups exhibit similar or substantially similar characteristics.
Conservative amino acid substitutions refer to the interchangeability of residues having similar side chains. For example, a group of amino acids having aliphatic side chains is glycine, alanine, valine, leucine, and isoleucine; a group of amino acids having aliphatic-hydroxyl side chains is serine and threonine, a group of amino acids having amide-containing side chains is asparagine and glutamine; a group of amino acids having aromatic side chains is phenylalanine, tyrosine, and tryptophan; a group of amino acids having basic side chains is lysine, arginine, and histidine; and a group of amino acids having sulfur-containing side chains is cysteine and methionine. Preferred conservative amino acids substitution groups are: valine-leucine-isoleucine, phenylalanine-tyrosine, lysine-arginine, alanine-valine, and asparagine-glutamine.
Within the meaning of the term “conservative amino acid substitution” as applied herein, one amino acid may be substituted for another within the groups of amino acids indicated herein below:
Lower Levels of Similarity:
Polarity:


    i) Amino acids having polar side chains (Asp, Glu, Lys, Arg, His, Asn, Gln, Ser, Thr, Tyr, and Cys)
    ii) Amino acids having non-polar side chains (Gly, Ala, Val, Leu, Ile, Phe, Trp, Pro, and Met)

Hydrophilic or Hydrophobic:

    iii) Hydrophobic amino acids (Ala, Cys, Gly, Ile, Leu, Met, Phe, Pro, Trp, Tyr, Val)
    iv) Hydrophilic amino acids (Arg, Ser, Thr, Asn. Asp, Gln, Glu, His, Lys)

Charges:

    v) Neutral amino acids (Ala, Asn. Cys, Gln, Gly, Ile, Leu, Met, Phe, Pro, Ser, Thr, Trp, Tyr, Val)
    vi) Basic amino acids (Arg. His, Lys)
    vii) Acidic amino acids (Asp, Glu)

High Level of Similarity:

    viii) Acidic amino acids and their amides (Gln, Asn, Glu, Asp)
    ix) Amino acids having aliphatic side chains (Gly, Ala Val, Leu, Ile)
    x) Amino acids having aromatic side chains (Phe, Tyr, Trp)
    xi) Amino acids having basic side chains (Lys, Arg, His)
    xii) Amino acids having hydroxy side chains (Ser. Thr)
    xiii) Amino acids having sulphor-containing side chains (Cys. Met).


Substitutions within the following groups (‘strong’ conservation group) are to be regarded as conservative substitutions within the meaning of the present invention

    
    
        -STA, NEQK, NHQK, NDEQ, QHRK, MILV, MILF, HY, FYW.
    
    


Substitutions within the following groups (‘weak’ conservation group) are to be regarded as semi-conservative substitutions within the meaning of the present invention

    
    
        -CSA, ATV, SAG, STNK, STPA, SGND, SNDEQK, NDEQHK, NEQHRK, VLIM, HFY.
    
    


Accordingly, a variant or a fragment thereof according to the invention may comprise, within the same variant of the sequence or fragments thereof, or among different variants of the sequence or fragments thereof, at least one substitution, such as a plurality of substitutions introduced independently of one another.
It is clear from the above outline that the same variant or fragment thereof may comprise more than one conservative amino acid substitution from more than one group of conservative amino acids as defined herein above.
Both standard and non standard amino acid residues described herein can be in the “D” or or “L” isomeric form.
It is contemplated that a functional equivalent according to the invention may comprise any amino acid including non-standard amino acids. In preferred embodiments a functional equivalent comprises only standard amino acids.
The standard and/or non-standard amino acids may be linked by peptide bonds or by non-peptide bonds. The term peptide also embraces post-translational modifications introduced by chemical or enzyme-catalyzed reactions, as are known in the art. Such post-translational modifications can be introduced prior to partitioning, if desired. Amino acids as specified herein will preferentially be in the L-stereoisomeric form. Amino acid analogs can be employed instead of the 20 naturally-occurring amino acids. Several such analogs are known, including fluorophenylalanine, norleucine, azetidine-2-carboxylic acid, S-aminoethyl cysteine, 4-methyl tryptophan and the like.
Suitably variants of SEQ ID NO: 3, 4, 7, 10, and 13 are variants having at least 73%, such as at least 74%, for example at least 75%, such as at least 76%, such as at least 77%, for example at least 78%, such as at least 79%, such as at least 80%, for example at least 81%, such as at least 82%, such as at least 83%, for example at least 84%, such as at least 85%, such as at least 86%, for example at least 87%, such as at least 88%, such as at least 89%, for example at least 90%, such as at least 91%, such as at least 92% sequence identity, such as at least 93% sequence identity, more preferably e.g. at least 94% sequence identity, more preferably such as at least 95% sequence identity, more preferably e.g. at least 96% sequence identity, more preferably such as at least 97% sequence identity, more preferably e.g. at least 98% sequence identity, more preferably such as at least 99% sequence identity, more preferably e.g. at least 99.5% sequence identity with any one of SEQ ID No: 3, 4, 7, 10, and 13 or fragments thereof, such as fragments of at least 30 amino acids, for example any fragments of 30-300 amino acids or 300-600, or 600-850 amino acids.
Suitably variants are variant(s) of SEQ ID NO: 4, which is a preferred fragment of SEQ ID NO: 3 are variants having at least 92% sequence identity, such as at least 93% sequence identity, more preferably e.g. at least 94% sequence identity, more preferably such as at least 95% sequence identity, more preferably e.g. at least 96% sequence identity, more preferably such as at least 97% sequence identity, more preferably e.g. at least 98% sequence identity, more preferably such as at least 99% sequence identity, more preferably e.g. at least 99.5% sequence identity with SEQ ID No: 4, or fragments thereof, such as fragments of at least 30 amino acids, for example any fragments of 30-300 amino acids or 300-600, or 600-850 amino acids.
Suitably variants are variant(s) of BGL1 are variants having at least 91%, such as preferably at least 92% sequence identity, such as at least 93% sequence identity, more preferably e.g. at least 94% sequence identity, more preferably such as at least 95% sequence identity, more preferably e.g. at least 96% sequence identity, more preferably such as at least 97% sequence identity, more preferably e.g. at least 98% sequence identity, more preferably such as at least 99% sequence identity, more preferably e.g. at least 99.5% sequence identity with SEQ ID No: 3 or fragments thereof, such as fragments of at least 30 amino acids, for example any fragments of 30-300 amino acids or 300-600, or 600-850 amino acids. One suitable variant of BGL1 is a variant devoid of the signal peptide. Thus in one embodiment, the polypeptide of the present invention has at least 91%, such as preferably at least 92% sequence identity, such as at least 93% sequence identity, more preferably e.g. at least 94% sequence identity, more preferably such as at least 95% sequence identity, more preferably e.g. at least 96% sequence identity, more preferably such as at least 97% sequence identity, more preferably e.g. at least 98% sequence identity, more preferably such as at least 99% sequence identity, more preferably e.g. at least 99.5% sequence identity with amino acids 20-860 of SEQ ID No: 3, which corresponds to SEQ ID NO: 4, or fragments thereof, such as fragments of at least 30 amino acids, for example any fragments of 30-300 amino acids or 300-600, or 600-850 amino acids.
Suitably variants are variant(s) of BGL2 are variants having at least 73%, such as preferably at least 74%, for example at least 75%, such as at least 76%, such as at least 77%, for example at least 78%, such as at least 79%, such as at least 80%, for example at least 81%, such as at least 82%, such as at least 83%, for example at least 84%, such as at least 85%, such as at least 86%, for example at least 87%, such as at least 88%, such as at least 89%, for example at least 90%, such as at least 91%, such as at least 92% sequence identity, such as at least 93% sequence identity, more preferably e.g. at least 94% sequence identity, more preferably such as at least 95% sequence identity, more preferably e.g. at least 96% sequence identity, more preferably such as at least 97% sequence identity, more preferably e.g. at least 98% sequence identity, more preferably such as at least 99% sequence identity, more preferably e.g. at least 99.5% sequence identity with SEQ ID No: 7, or fragments thereof, such as fragments of at least 30 amino acids, for example any fragments of 30-300 amino acids or 300-600, or 600-850 amino acids. One suitable variant of BGL2 is a variant devoid of the signal peptide. Thus in one embodiment, the polypeptide of the present invention has at least 73%, such as preferably at least 74%, for example at least 75%, such as at least 76%, such as at least 77%, for example at least 78%, such as at least 79%, such as at least 80%, for example at least 81%, such as at least 82%, such as at least 83%, for example at least 84%, such as at least 85%, such as at least 86%, for example at least 87%, such as at least 88%, such as at least 89%, for example at least 90%, such as at least 91%, such as at least 92% sequence identity, such as at least 93% sequence identity, more preferably e.g. at least 94% sequence identity, more preferably such as at least 95% sequence identity, more preferably e.g. at least 96% sequence identity, more preferably such as at least 97% sequence identity, more preferably e.g. at least 98% sequence identity, more preferably such as at least 99% sequence identity, more preferably e.g. at least 99.5% sequence identity with amino acids 21-866 of SEQ ID No: 7, or fragments thereof, such as fragments of at least 30 amino acids, for example any fragments of 30-300 amino acids or 300-600, or 600-850 amino acids.
Suitably variants are variant(s) of BGL3 are variants having at least 75%, such as preferably at least 76%, such as at least 77%, for example at least 78%, such as at least 79%, such as at least 80%, for example at least 81%, such as at least 82%, such as at least 83%, for example at least 84%, such as at least 85%, such as at least 86%, for example at least 87%, such as at least 88%, such as at least 89%, for example at least 90%, such as at least 91%, such as at least 92% sequence identity, such as at least 93% sequence identity, more preferably e.g. at least 94% sequence identity, more preferably such as at least 95% sequence identity, more preferably e.g. at least 96% sequence identity, more preferably such as at least 97% sequence identity, more preferably e.g. at least 98% sequence identity, more preferably such as at least 99% sequence identity, more preferably e.g. at least 99.5% sequence identity with SEQ ID No: 10 or fragments thereof, such as fragments of at least 30 amino acids, for example any fragments of 30-300 amino acids or 300-600, or 600-850 amino acids. One suitable variant of BGL3 is a variant devoid of the signal peptide. Thus in one embodiment, the polypeptide of the present invention has at least at least 75%, such as preferably at least 76%, such as at least 77%, for example at least 78%, such as at least 79%, such as at least 80%, for example at least 81%, such as at least 82%, such as at least 83%, for example at least 84%, such as at least 85%, such as at least 86%, for example at least 87%, such as at least 88%, such as at least 89%, for example at least 90%, such as at least 91%, such as at least 92% sequence identity, such as at least 93% sequence identity, more preferably e.g. at least 94% sequence identity, more preferably such as at least 95% sequence identity, more preferably e.g. at least 96% sequence identity, more preferably such as at least 97% sequence identity, more preferably e.g. at least 98% sequence identity, more preferably such as at least 99% sequence identity, more preferably e.g. at least 99.5% sequence identity with amino acids 21-722 of SEQ ID No: 10 or fragments thereof, such as fragments of at least 30 amino acids, for example any fragments of 30-300 amino acids or 300-600, or 600-850 amino acids.
Suitably variants are variant(s) of BGL4 are variants having at least 78%, such as preferably at least 79%, such as at least 80%, for example at least 81%, such as at least 82%, such as at least 83%, for example at least 84%, such as at least 85%, such as at least 86%, for example at least 87%, such as at least 88%, such as at least 89%, for example at least 90%, such as at least 91%, such as at least 92% sequence identity, such as at least 93% sequence identity, more preferably e.g. at least 94% sequence identity, more preferably such as at least 95% sequence identity, more preferably e.g. at least 96% sequence identity, more preferably such as at least 97% sequence identity, more preferably e.g. at least 98% sequence identity, more preferably such as at least 99% sequence identity, more preferably e.g. at least 99.5% sequence identity with SEQ ID No: 13 or fragments thereof, such as fragments of at least 30 amino acids, for example any fragments of 30-300 amino acids or 300-600, or 600-850 amino acids. One suitable variant of BGL4 is a variant devoid of the signal peptide. Thus in one embodiment, the polypeptide of the present invention has at least at least 78%, such as preferably at least 79%, such as at least 80%, for example at least 81%, such as at least 82%, such as at least 83%, for example at least 84%, such as at least 85%, such as at least 86%, for example at least 87%, such as at least 88%, such as at least 89%, for example at least 90%, such as at least 91%, such as at least 92% sequence identity, such as at least 93% sequence identity, more preferably e.g. at least 94% sequence identity, more preferably such as at least 95% sequence identity, more preferably e.g. at least 96% sequence identity, more preferably such as at least 97% sequence identity, more preferably e.g. at least 98% sequence identity, more preferably such as at least 99% sequence identity, more preferably e.g. at least 99.5% sequence identity with amino acids 20-766 of SEQ ID No: 13 or fragments thereof, such as fragments of at least 30 amino acids, for example any fragments of 30-300 amino acids or 300-600, or 600-850 amino acids.
The polypeptide fragment according to the invention is a fragment, wherein the fragment has a stretch of at least 30 consecutive amino acids and contains less than 860 amino acids residues of SEQ ID NO: 3, or at least 30 consecutive amino acids and less than 866 amino acids residues of SEQ ID NO: 7, or at least 30 consecutive amino acids and less than 722 amino acids residues of SEQ ID NO: 10, or at least 30 consecutive amino acids and less than 766 amino acids residues of SEQ ID NO: 13. So in general, a polypeptide fragment according to the invention is a fragment, wherein the fragment has a stretch of at least 30 consecutive amino acids and contains less than 800 consecutive amino acid residues of any one of SEQ ID NO: 3, 4, 7, 10, and 13, such as less than 800 consecutive amino acid residues, such as less than 795 consecutive amino acid residues, e.g. less than 790 consecutive amino acid residues, such as less than 785 consecutive amino acid residues, e.g. less than 780 consecutive amino acid residues, such as less than 770 consecutive amino acid residues, e.g. less than 760 consecutive amino acid residues, such as less than 750 consecutive amino acid residues, e.g. less than 745 consecutive amino acid residues, such as less than 740 consecutive amino acid residues, e.g. less than 735 consecutive amino acid residues, such as less than 730 consecutive amino acid residues, e.g. less than 725 consecutive amino acid residues, such as less than 720 consecutive amino acid residues, such as less than 715 consecutive amino acid residues, e.g. less than 390 consecutive amino acid residues, such as less than 710 consecutive amino acid residues, e.g. less than 705 consecutive amino acid residues, such as less than 700 consecutive amino acid residues. e.g. less than 690 consecutive amino acid residues, such as less than 685 consecutive amino acid residues, e.g. less than 680 consecutive amino acid residues, such as less than 675 consecutive amino acid residues, e.g. less than 670 consecutive amino acid residues, such as less than 650 consecutive amino acid residues, e.g. less than 645 consecutive amino acid residues, such as less than 640 consecutive amino acid residues, e.g. less than 635 consecutive amino acid residues, such as less than 630 consecutive amino acid residues, e.g. less than 625 consecutive amino acid residues, such as less than 620 consecutive amino acid residues, such as less than 615 consecutive amino acid residues, such as less than 610 consecutive amino acid residues, e.g. less than 605 consecutive amino acid residues, such as less than 600 consecutive amino acid residues, e.g. less than 590 consecutive amino acid residues, such as less than 585 consecutive amino acid residues. e.g. less than 580 consecutive amino acid residues, such as less than 575 consecutive amino acid residues, e.g. less than 570 consecutive amino acid residues, such as less than 565 consecutive amino acid residues, such as less than 560 consecutive amino acid residues, e.g. less than 555 consecutive amino acid residues, such as less than 550 consecutive amino acid residues, e.g. less than 545 consecutive amino acid residues, such as less than 540 consecutive amino acid residues, e.g. less than 535 consecutive amino acid residues, such as less than 530 consecutive amino acid residues, e.g. less than 525 consecutive amino acid residues, such as less than 520 consecutive amino acid residues, such as less than 515 consecutive amino acid residues, e.g. less than 490 consecutive amino acid residues, such as less than 485 consecutive amino acid residues, e.g. less than 480 consecutive amino acid residues, such as less than 475 consecutive amino acid residues, e.g. less than 470 consecutive amino acid residues, such as less than 465 consecutive amino acid residues, such as less than 460 consecutive amino acid residues, e.g. less than 455 consecutive amino acid residues, such as less than 450 consecutive amino acid residues, e.g. less than 445 consecutive amino acid residues, such as less than 440 consecutive amino acid residues, e.g. less than 435 consecutive amino acid residues, such as less than 430 consecutive amino acid residues, e.g. less than 425 consecutive amino acid residues, such as less than 420 consecutive amino acid residues, such as less than 415 consecutive amino acid residues, such as less than 410 consecutive amino acid residues, e.g. less than 405 consecutive amino acid residues, such as less than 400 consecutive amino acid residues, e.g. less than 410 consecutive amino acid residues of, such as less than 400 consecutive amino acid residues, such as less than 395 consecutive amino acid residues, e.g. less than 390 consecutive amino acid residues, such as less than 385 consecutive amino acid residues, e.g. less than 380 consecutive amino acid residues, such as less than 370 consecutive amino acid residues, e.g. less than 360 consecutive amino acid residues, such as less than 350 consecutive amino acid residues, e.g. less than 345 consecutive amino acid residues, such as less than 340 consecutive amino acid residues, e.g. less than 335 consecutive amino acid residues, such as less than 330 consecutive amino acid residues, e.g. less than 325 consecutive amino acid residues, such as less than 300 consecutive amino acid residues, e.g. less than 295 consecutive amino acid residues, such as less than 290 consecutive amino acid residues, e.g. less than 285 consecutive amino acid residues, such as less than 280 consecutive amino acid residues, e.g. less than 275 consecutive amino acid residues, such as less than 270 consecutive amino acid residues, e.g. less than 265 consecutive amino acid residues, such as less than 260 consecutive amino acid residues, such as less than 255 consecutive amino acid residues, e.g. less than 250 consecutive amino acid residues, such as less than 245 consecutive amino acid residues, e.g. less than 240 consecutive amino acid residues, such as less than 235 consecutive amino acid residues, e.g. less than 230 consecutive amino acid residues, such as less than 225 consecutive amino acid residues, such as less than 220 consecutive amino acid residues, such as less than 215 consecutive amino acid residues, e.g. less than 210 consecutive amino acid residues, such as less than 205 consecutive amino acid residues, e.g. less than 200 consecutive amino acid residues, such as less than 195 consecutive amino acid residues, e.g. less than 190 consecutive amino acid residues, such as less than 185 consecutive amino acid residues, e.g. less than 180 consecutive amino acid residues, such as less than 175 consecutive amino acid residues, e.g. less than 170 consecutive amino acid residues, such as less than 165 consecutive amino acid residues, e.g. less than 160 consecutive amino acid residues, such as less than 155 consecutive amino acid residues, e.g. less than 150 consecutive amino acid residues, such as less than 145 consecutive amino acid residues, e.g. less than 140 consecutive amino acid residues, such as less than 135 consecutive amino acid residues, e.g. less than 130 consecutive amino acid residues, such as less than 125 consecutive amino acid residues, e.g. less than 120 consecutive amino acid residues, such as less than 115 consecutive amino acid residues, e.g. less than 110 consecutive amino acid residues, such as less than 105 consecutive amino acid residues, e.g. less than 100 consecutive amino acid residues, such as less than 95 consecutive amino acid residues, e.g. less than 90 consecutive amino acid residues, such as less than 85 consecutive amino acid residues, e.g. less than 80 consecutive amino acid residues, such as less than 75, e.g. less than 60 consecutive amino acid residues, such as less than 50 consecutive amino acids, e.g. less than 40 consecutive amino acids of SEQ ID NO: 3, 4, 7, 10, and 13.
The polypeptide variant according to the present invention, is a variant of SEQ ID NO: 3, 4, 7, 10, and 13 having at least 73%, such as preferably at least 74%, for example at least 75%, such as at least 76%, such as at least 77%, for example at least 78%, such as at least 79%, such as at least 80%, for example at least 81%, such as at least 82%, such as at least 83%, for example at least 84%, such as at least 85%, such as at least 86%, for example at least 87%, such as at least 88%, such as at least 89%, for example at least 90%, such as at least 91%, such as preferably at least 92% sequence identity, such as at least 93% sequence identity, more preferably e.g. at least 94% sequence identity, more preferably such as at least 95% sequence identity, more preferably e.g. at least 96% sequence identity, more preferably such as at least 97% sequence identity, more preferably e.g. at least 98% sequence identity, more preferably such as at least 99% sequence identity, more preferably e.g. at least 99.5% sequence identity to any one of said SEQ ID NO: 3, 4, 7, 10 and 13, or a fragment thereof. The polypeptide according to the present invention is a variant, wherein the polypeptide variant fragment contains less than 99.5%, such as less than 98%, e.g. less than 97%, such as less than 96%, e.g. less than 95%, such as less than 94%, e.g. less than 93% of the amino acid residues of any one of SEQ ID NO: 3, 4, 7, 10 and 13, or a fragment thereof.
In one embodiment of the present invention the polypeptide variant fragment contains less than 810 consecutive amino acid residues of any one of SEQ ID NO: 3, 4, 7, 10 and 13, or a fragment thereof, such as less than 800 consecutive amino acid residues, such as less than 795 consecutive amino acid residues, e.g. less than 790 consecutive amino acid residues, such as less than 785 consecutive amino acid residues, e.g. less than 780 consecutive amino acid residues, such as less than 770 consecutive amino acid residues, e.g. less than 760 consecutive amino acid residues, such as less than 750 consecutive amino acid residues, e.g. less than 745 consecutive amino acid residues, such as less than 740 consecutive amino acid residues, e.g. less than 735 consecutive amino acid residues, such as less than 730 consecutive amino acid residues, e.g. less than 725 consecutive amino acid residues, such as less than 720 consecutive amino acid residues, such as less than 715 consecutive amino acid residues, e.g. less than 390 consecutive amino acid residues, such as less than 710 consecutive amino acid residues, e.g. less than 705 consecutive amino acid residues, such as less than 700 consecutive amino acid residues, e.g. less than 690 consecutive amino acid residues, such as less than 685 consecutive amino acid residues, e.g. less than 680 consecutive amino acid residues, such as less than 675 consecutive amino acid residues, e.g. less than 670 consecutive amino acid residues, such as less than 650 consecutive amino acid residues, e.g. less than 645 consecutive amino acid residues, such as less than 640 consecutive amino acid residues, e.g. less than 635 consecutive amino acid residues, such as less than 630 consecutive amino acid residues, e.g. less than 625 consecutive amino acid residues, such as less than 620 consecutive amino acid residues, such as less than 615 consecutive amino acid residues, such as less than 610 consecutive amino acid residues, e.g. less than 605 consecutive amino acid residues, such as less than 600 consecutive amino acid residues, e.g. less than 590 consecutive amino acid residues, such as less than 585 consecutive amino acid residues, e.g. less than 580 consecutive amino acid residues, such as less than 575 consecutive amino acid residues, e.g. less than 570 consecutive amino acid residues, such as less than 565 consecutive amino acid residues, such as less than 560 consecutive amino acid residues, e.g. less than 555 consecutive amino acid residues, such as less than 550 consecutive amino acid residues, e.g. less than 545 consecutive amino acid residues, such as less than 540 consecutive amino acid residues, e.g. less than 535 consecutive amino acid residues, such as less than 530 consecutive amino acid residues, e.g. less than 525 consecutive amino acid residues, such as less than 520 consecutive amino acid residues, such as less than 515 consecutive amino acid residues, e.g. less than 490 consecutive amino acid residues, such as less than 485 consecutive amino acid residues, e.g. less than 480 consecutive amino acid residues, such as less than 475 consecutive amino acid residues, e.g. less than 470 consecutive amino acid residues, such as less than 465 consecutive amino acid residues, such as less than 460 consecutive amino acid residues, e.g. less than 455 consecutive amino acid residues, such as less than 450 consecutive amino acid residues, e.g. less than 445 consecutive amino acid residues, such as less than 440 consecutive amino acid residues, e.g. less than 435 consecutive amino acid residues, such as less than 430 consecutive amino acid residues, e.g. less than 425 consecutive amino acid residues, such as less than 420 consecutive amino acid residues, such as less than 415 consecutive amino acid residues, such as less than 410 consecutive amino acid residues of any one of SEQ ID NO: 3, 4, 7, 10 and 13, or a fragment thereof, such as less than 400 consecutive amino acid residues, such as less than 395 consecutive amino acid residues, e.g. less than 390 consecutive amino acid residues, such as less than 385 consecutive amino acid residues, e.g. less than 380 consecutive amino acid residues, such as less than 370 consecutive amino acid residues, e.g. less than 360 consecutive amino acid residues, such as less than 350 consecutive amino acid residues, e.g. less than 345 consecutive amino acid residues, such as less than 340 consecutive amino acid residues, e.g. less than 335 consecutive amino acid residues, such as less than 330 consecutive amino acid residues, e.g. less than 325 consecutive amino acid residues, such as less than 300 consecutive amino acid residues, e.g. less than 295 consecutive amino acid residues, such as less than 290 consecutive amino acid residues, e.g. less than 285 consecutive amino acid residues, such as less than 280 consecutive amino acid residues, e.g. less than 275 consecutive amino acid residues, such as less than 270 consecutive amino acid residues, e.g. less than 265 consecutive amino acid residues, such as less than 260 consecutive amino acid residues, such as less than 255 consecutive amino acid residues, e.g. less than 250 consecutive amino acid residues, such as less than 245 consecutive amino acid residues, e.g. less than 240 consecutive amino acid residues, such as less than 235 consecutive amino acid residues, e.g. less than 230 consecutive amino acid residues, such as less than 225 consecutive amino acid residues, such as less than 220 consecutive amino acid residues, such as less than 215 consecutive amino acid residues, e.g. less than 210 consecutive amino acid residues, such as less than 205 consecutive amino acid residues, e.g. less than 200 consecutive amino acid residues, such as less than 195 consecutive amino acid residues, e.g. less than 190 consecutive amino acid residues, such as less than 185 consecutive amino acid residues, e.g. less than 180 consecutive amino acid residues, such as less than 175 consecutive amino acid residues, e.g. less than 170 consecutive amino acid residues, such as less than 165 consecutive amino acid residues. e.g. less than 160 consecutive amino acid residues, such as less than 155 consecutive amino acid residues, e.g. less than 150 consecutive amino acid residues, such as less than 145 consecutive amino acid residues, e.g. less than 140 consecutive amino acid residues, such as less than 135 consecutive amino acid residues, e.g. less than 130 consecutive amino acid residues, such as less than 125 consecutive amino acid residues, e.g. less than 120 consecutive amino acid residues, such as less than 115 consecutive amino acid residues, e.g. less than 110 consecutive amino acid residues, such as less than 105 consecutive amino acid residues, e.g. less than 100 consecutive amino acid residues, such as less than 95 consecutive amino acid residues, e.g. less than 90 consecutive amino acid residues, such as less than 85 consecutive amino acid residues, e.g. less than 80 consecutive amino acid residues, such as less than 75, e.g. less than 60 consecutive amino acid residues, such as less than 50 consecutive amino acids, e.g. less than 40 consecutive amino acids of any one of SEQ ID NO: 3, 4, 7, 10 and 13, or a fragment thereof.
The term “fragment thereof” may refer to any portion of the given amino acid sequence of any one of SEQ ID NO: 3, 4, 7, 10 and 13. Fragments may comprise more than one portion from within a full-length protein (such as SEQ ID NO: 3, 7, 10, or 13), joined together. Suitable fragments may be deletion or addition mutants. The addition of at least one amino acid may be an addition of from preferably 2 to 250 amino acids, such as from 10 to 20 amino acids, for example from 20 to 30 amino acids, such as from 40 to 50 amino acids. Fragments may include small regions from the protein or combinations of these. The deletion and/or the addition may—independently of one another—be a deletion and/or an addition within a sequence and/or at the end of a sequence.
A biologically active variant may be a deletion mutant of any one of SEQ ID NO: 3.4, 7, 10 and 13, sharing at least 92% sequence identity, for example at least 93% sequence identity, such as at least 94% sequence identity, for example at least 95% sequence identity, such as at least 96% sequence identity, for example at least 97% sequence identity, such as at least 98% sequence identity, for example 99% sequence identity to any one of SEQ ID NO: 3, 4, 7, 10 and 13.
Deletion mutants suitably comprise at least 20 or 40 consecutive amino acid and more preferably at least 80 or 100 consecutive amino acids in length. Accordingly such a fragment may be a shorter sequence of the sequence as identified by any one of SEQ ID NO: 3, 4, 7, 10 and 13, comprising at least 20 consecutive amino acids, for example at least 30 consecutive amino acids, such as at least 40 consecutive amino acids, for example at least 50 consecutive amino acids, such as at least 60 consecutive amino acids, for example at least 70 consecutive amino acids, such as at least 80 consecutive amino acids, for example at least 90 consecutive amino acids, such as at least 95 consecutive amino acids, such as at least 100 consecutive amino acids, such as at least 105 amino acids, for example at least 110 consecutive amino acids, such as at least 115 consecutive amino acids, for example at least 120 consecutive amino acids, wherein said deletion mutants preferably share at least 92% sequence identity, for example at least 93% sequence identity, such as at least 94% sequence identity, for example at least 95% sequence identity, such as at least 96% sequence identity, for example at least 97% sequence identity, such as at least 98% sequence identity, for example 99% sequence identity with full length any one of SEQ ID NO: 3, 4, 7, 10 and 13.
It is preferred that biological active variant of any one of SEQ ID NO: 3, 4, 7, 10 and 13 comprises at the most 860, preferably at the most 850, more preferably at the most 840, even more preferably at the most 820, yet more preferably at the most 810, such as at the most 800, for example at the most 790, more preferably at the most 780, even more preferably at the most 770, at the most 760, preferably at the most 750, more preferably at the most 740, even more preferably at the most 720, yet more preferably at the most 710, such as at the most 700, for example at the most 690, more preferably at the most 680, even more preferably at the most 670, at the most 660, preferably at the most 650, more preferably at the most 640, even more preferably at the most 620, yet more preferably at the most 610, such as at the most 600, for example at the most 590, more preferably at the most 580, even more preferably at the most 570, at the most 560, preferably at the most 550, more preferably at the most 540, even more preferably at the most 520, yet more preferably at the most 510, such as at the most 500, for example at the most 490, more preferably at the most 480, even more preferably at the most 470, at the most 460, preferably at the most 450, more preferably at the most 440, even more preferably at the most 420, yet more preferably at the most 410, such as at the most 400, even more preferably at the most 300, yet more preferably at the most 200, such as at the most 175, for example at the most 160, such as at the most 150 amino acids, for example at the most 140 amino acids.
It is appreciated that a person skilled in the art will know how to make and assess ‘conservative’ amino acid substitutions, by which one amino acid is substituted for another with one or more shared chemical and/or physical characteristics. Conservative amino acid substitutions are less likely to affect the functionality of the protein.
SEQ ID NO: 3 defines the BGL1 polypeptide of the present invention. The signal peptide is underlined.








SEQ ID NO: 3
















APTFGEIGNASDYLYPEGLDRITAFIYPWLNSTDLKESSGDPDYGVDTAKYIPAGATNS


 


SAQPVLPAGGGFGGNPRLYDELIRVSVTVKNTGRVTGDAVPQLYVSLGGPNEPKVVL


 


RQFDRITLRPSEETVWTTTLTRRDLSNWDVAAQDWVITSYPKKVHVGSSSRQLPLHA


 


ALPKVQ






SEQ ID NO: 4 is the amino acid sequence of the BGL1 polypeptide without signal peptide.







SEQ ID NO: 4














EIGNASDYLYPEGLDRITAFIYPWLNSTDLKESSGDPDYGVDTAKYIPA


 


GATNSSAQPVLPAGGGFGGNPRLYDELIRVSVTVKNTGRVTGDAVPQLY


 


VSLGGPNEPKVVLRQFDRITLRPSEETVWTTTLTRRDLSNWDVAAQDWV


 


ITSYPKKVHVGSSSRQLPLHAAPKVQ






For the sequence shown above, amino acid residues shown in bold are involved in substrate binding
Residues in italics are D (catalytic nucleophil) and E (catalytic acid residue). The amino acids that are underlined by ‘ . . . ’ constitute the catalytic domain of the beta-glucosidase polypeptide BGL1. Within this region of the catalytic domain it is preferred that the amino acids are not changed. In another embodiment the amino acids of the region of the catalytic domain if changed are only substituted with conservative amino acids as described herein. In a preferred embodiment variants are variants, wherein variation is occurs outside amino acids D261 and/or E490. In another preferred embodiment variants are variants, wherein variation occurs outside the catalytic domain. In a more preferred embodiment variants, are variants, wherein variation occurs outside amino acids selected from the group consisting of D73, R137, R181, H171, Y229, M226, L122, W262, W49 and V55. It is appreciated that any single of the amino acids of the group constitutes separate preferred embodiments. Thus, variants are variants, wherein variation occurs outside amino acids D73, R137, R181, H171, Y229, M226, L122, W262, W49 or V55.
Measuring Activity of the Polypeptide
Specific beta-glucosidase activity was measured using two different substrates, pNPG and cellobiose. The assay using 5 mM p-nitrophenyl-beta-D-glucopyranoside (pNPG) (Sigma) as substrate for measuring beta-glucosidase activity was in 50 mM Na-Citrate buffer pH 4.8, 15 μl sample and 150 μl substrate was incubated at 50° C. for 10 min in 200 μl PCR tubes in a thermocycler (Biorad); 30 μl of the reaction was transferred to a microtiter plate already containing 50 μl 1M Na2CO3 for termination of the reaction. Absorbance was read at 405 nm in a plate reader (Dynex technology revalation 4.25). pNP (Sigma) was used to prepare a standard curve. One unit (U) of enzyme activity was defined as the amount of enzyme needed to hydrolyze 1 μmol pNPG in 1 minute. Protein quantification was done using the Pierce BCA protein assay kit microplate procedure according to manufacturer's instructions (Pierce Biotechnology); enzyme samples were assayed at different concentrations in triple determination to ensure substrate saturation in the assay.
The assay using 6 mM cellobiose was in 50 mM NaCitrate buffer pH 4.8 and was performed as follows: 15 μl sample and 150 μl substrate was incubated at 50° C. for 10 min in PCR tubes in a thermocycler (Bioread); 50 μl of the reaction was transferred to a HPLC vial already containing 1 ml 100 mM NaOH for termination of the reaction. The glucose concentration was measured by ion exchange chromatography at Dionex ICS3000 chromatography system equipped with an amperometric detector using a gold working electrode and an Ag/AgCl pH reference electrode, acquiring and interpreting data with the Chromeleon software (Dionex). 10 μl samples were run on a CarboPac PA1 column with 100 mM NaOH as eluent A and 0.5 M NaAcetate in 100 mM NaOH as eluent B, run at a flow rate of 1 ml/min. Gradient elution was performed: 0-20% eluent B (0.5M NaAcetate in 100 mM NaOH) in 13 min followed by 2 min washing with 50% eluent B and 5 min re-equilibrating with 100% eluent A (100 mM NaOH). Samples were assayed at different concentrations in triple determination to ensure substrate saturation in the assay.
For beta-glucosidase activity screening, three 0.5×0.5 cm squares were cut from PDA plates with 7 days old single fungal strains and incubated in liquid culture of 20 g/l wheat bran (Finax), 20 g/l corn steep liquor (Sigma), 3 g/l NaNO3, 1 g/l K2HPO4, 0.5 g/l KCl, 0.5 g/l MgSO47H2O, 0.01 g/l FeSO47H2O in a Falcon tube set-up with 10 ml of media shaking (180 rpm) at room temperature for another 7 days. The samples were centrifuged at 10,000 rpm for 10 min and the supernatants assayed for beta-glucosidase activity and protein content.
Enzymatic Activity of the Polypeptide
The polypeptide of the present invention has good thermostability compared to known beta-glucosidases. This makes the polypeptide suitable for incubation at higher temperatures than normally employed for degrading or converting lignocellulosic material into glucose due to the intolerance of increased temperatures by other enzymes present in the degradation cocktail as a cocktail of enzymes may be employed in order to obtain a complete hydrolysis of lignocellulosic material. It is appreciated that the beta-glucosidase polypeptide of the present invention is hydrolyzing a β1-4 glucose-glucose linkage
In one embodiment the incubation temperature is in the range of 35° C. to 65° C., such as 40° C., preferably 41° C., more preferably 42° C., preferably 43° C., more preferably 44° C., preferably 45° C., more preferably 46° C., preferably 47° C., more preferably 48° C., preferably 49° C., more preferably 50° C. However, the incubation temperature may also be higher such as 51° C., for example 52° C., such as 53° C., for example 54° C., such as 55° C., for example 56° C., such as 58° C., for example 59° C., such as 60° C., for example 61° C., such as 62° C. for example 63° C., such as 64° C., for example 65° C., such as 66° C. for example 67° C.
The activity of the polypeptides of the present invention is maintained to a large extent even at elevated incubation temperatures. Thus, at 62° C. the activity of said polypeptide is 50% after 2 hours incubation.
The half life of the polypeptides of the present invention is preferably at least 1 hr at the selected temperature for incubation, preferably at least 1.5 hrs. more preferably at least 2 hrs, preferably at least 2.5 hrs, more preferably at least 3 hrs, preferably at least 3.5 hrs, more preferably at least 4 hrs, preferably at least 5.5 hrs, more preferably at least 6 hrs, preferably at least 6.5 hrs, more preferably at least 7 hrs, preferably at least 8 hrs, more preferably at least 9 hours, preferably at least 12 hours, more preferably at least 24 hours, preferably at least 2 days at 40° C.
The half life of the polypeptides of the present invention is preferably at least 1 hr at the selected temperature for incubation, preferably at least 1.5 hrs, more preferably at least 2 hrs, preferably at least 2.5 hrs, more preferably at least 3 hrs, preferably at least 3.5 hrs, more preferably at least 4 hrs, preferably at least 5.5 hrs, more preferably at least 6 hrs, preferably at least 6.5 hrs, more preferably at least 7 hrs, preferably at least 8 hrs, more preferably at least 9 hours, preferably at least 12 hours, more preferably at least 24 hours, preferably at least 2 days at 45° C.
The half life of the polypeptides of the present invention is preferably at least 1 hr at the selected temperature for incubation, preferably at least 1.5 hrs, more preferably at least 2 hrs, preferably at least 2.5 hrs, more preferably at least 3 hrs, preferably at least 3.5 hrs. more preferably at least 4 hrs. preferably at least 5.5 hrs, more preferably at least 6 hrs, preferably at least 6.5 hrs, more preferably at least 7 hrs, preferably at least 8 hrs, more preferably at least 9 hours, preferably at least 12 hours, more preferably at least 24 hours at 50° C.
The half life of the polypeptides of the present invention is preferably at least 1 hr at the selected temperature for incubation, preferably at least 1.5 hrs, more preferably at least 2 hrs, preferably at least 2.5 hrs, more preferably at least 3 hrs, preferably at least 3.5 hrs, more preferably at least 4 hrs, preferably at least 5.5 hrs, more preferably at least 6 hrs, preferably at least 6.5 hrs, more preferably at least 7 hrs, preferably at least 8 hrs, more preferably at least 9 hours, preferably at least 12 hours at 55° C.
The half life of the polypeptides of the present invention is preferably at least 1 hr at the selected temperature for incubation, preferably at least 1.5 hrs, more preferably at least 2 hrs, preferably at least 2.5 hrs, more preferably at least 3 hrs, preferably at least 3.5 hrs, more preferably at least 4 hrs, preferably at least 5.5 hrs, more preferably at least 6 hrs at 60° C.
The half life of the polypeptides of the present invention is preferably at least 1 hr at the selected temperature for incubation, preferably at least 1.5 hrs, more preferably at least 2 hrs, preferably at least 2.5 hrs at 62° C.
The half life of the polypeptides of the present invention is preferably at least 1 hr at the selected temperature for incubation at 65° C.
The half life of the polypeptides of the present invention is preferably at least 30 min, preferably at least 1 hr at the selected temperature for incubation at 66° C.
In particular, when the polypeptide of the invention is SEQ ID NO: 3, 4, or any functional fragment or variant thereof, as described elsewhere herein, the half-life of the beta-glucosidase activity at 60° C. is at least 200 minutes, for example 300 minutes, such as at least 360 minutes. Furthermore, when the polypeptide of the invention is SEQ ID NO: 3, 4, or any functional fragment or variant thereof, as described elsewhere herein, at least 50% of the beta-glucosidase activity of said polypeptide remains after 4 hours, such as 5 hours, for example after 6 hours of incubation at 60° C.
Also, when the polypeptide of the invention is SEQ ID NO: 3, 4, or any functional fragment or variant thereof, as described elsewhere herein, the specific activity, Vmax, of at least 40 U/mg with cellobiose as substrate in hydrolysis.
The activity of the enzyme in degrading or converting lignocellulosic material at temperatures as described herein incubating the enzyme with the cellulosic material for 2 hrs is at least 20%, preferably at least 30%, more preferably at least 40%, preferably at least 50%, more preferably at least 60%, preferably at least 70%, more preferably at least 80%, preferably at least 90%, more preferably at least 95% of the activity at the starting activity.
In another embodiment, the activity of the enzyme in degrading or converting lignocellulosic material at elevated temperatures incubating the enzyme with the cellulosic material for 3 hrs is at least 20%, preferably at least 30%, more preferably at least 40%, preferably at least 50%, more preferably at least 60%, preferably at least 70%, more preferably at least 80%, preferably at least 90%, more preferably at least 95% of the activity at the starting activity.
In a further embodiment, the activity of the enzyme in degrading or converting lignocellulosic material at elevated temperatures incubating the enzyme with the cellulosic material for 4 hrs is at least 20%, preferably at least 30%, more preferably at least 40%, preferably at least 50%, more preferably at least 60%, preferably at least 70%, more preferably at least 80%, preferably at least 90%, more preferably at least 95% of the activity at the starting activity.
In yet a further embodiment, the activity of the enzyme in degrading or converting lignocellulosic material at elevated temperatures incubating the enzyme with the cellulosic material for 5 hrs is at least 20%, preferably at least 30%, more preferably at least 40%, preferably at least 50%, more preferably at least 60%, preferably at least 70%, more preferably at least 80%, preferably at least 90%, more preferably at least 95% of the activity at the starting activity.
In another embodiment, the activity of the enzyme in degrading or converting lignocellulosic material at elevated temperatures incubating the enzyme with the cellulosic material for 6 hrs is at least 20%, preferably at least 30%, more preferably at least 40%, preferably at least 50%, more preferably at least 60%, preferably at least 70%, more preferably at least 80%, preferably at least 90%, more preferably at least 95% of the activity at the starting activity.
The polypeptides of the present invention is capable of degrading at least 20% lignocellulosic material, preferably at least 30%, more preferably at least 40%, preferably at least 50%, more preferably at least 60%, preferably at least 70%, more preferably at least 80%, preferably at least 90%, more preferably at least 95% of the lignocellulosic material over a time span of at the most 7 days.
The mentioned activities and incubation temperatures are performed at pH in the range of pH 3 to pH 6, preferably in the range of pH 3.5 to pH 5.5, more preferably in the range of pH 4 to pH 5, preferably in the range of pH 4.5 to pH 5.
In a preferred embodiment the pH used for incubation when degrading or converting a lignocellulosic material is at pH 4.8
It is appreciated that the lignocellulosic material is in one embodiment cellulose, in particular cellobiose, cellodextrins as defined elsewhere herein. The lignocellulosic material may be obtained from any plant biomass source, for example straw, maize stems, forestry waste, sawdust and/or wood-chips.
Polynucleotide
The present invention relates in one aspect to an isolated polynucleotide comprising a nucleic acid or its complementary sequence being selected from the group consisting of

    
    
        a. a polynucleotide sequence encoding a polypeptide consisting of an amino acid sequence SEQ ID NO: 3, 4, 7, 10, or 13.
        b. a polynucleotide sequence encoding a biologically active sequence variant of the amino acid sequence, wherein the variant has at least 92% sequence identity to said SEQ ID NO: 3, 4, 7, 10, or 13, and
        c. a polynucleotide sequence encoding a biologically active fragment of at least 30 consecutive amino acids of any of a) through b), wherein said fragment is a fragment of SEQ ID NO 3, 4, 7, 10, or 13 or
        d. SEQ ID NO.: 1, 2, 5, 6, 8.9, 11, 12, 29, or fragments of at least 30 contiguous nucleotides therefor
        e. a polynucleotide comprising a nucleic acid sequence having at least 70% identity to SEQ ID NO: 1, 2, 5, 6, 8, 9, 11, 12, 29 or fragments of at least 30 contiguous nucleotides thereof, or
        f. a polynucleotide hybridising to SEQ ID NO.: 1, 2, 5, 6, 8, 9, 11, 12, or 29, or fragments of at least 90 contiguous nucleotides thereof, and
        g. a polynucleotide complementary to any of a) to f).
    
    


In one embodiment, the polynucleotide of the present invention is selected from the group consisting of

    
    
        a. a polynucleotide encoding an amino acid sequence consisting of SEQ ID NO.: 3 or
        b. a polynucleotide sequence encoding a biologically active sequence variant of the amino acid sequence, wherein the variant has at least 92% sequence identity to said SEQ ID NO.: 3 and
        c. a polynucleotide sequence encoding a biologically active fragment of at least 30 consecutive amino acid of any of a) trough b), wherein said fragment is a fragment of SEQ ID NO.: 3.
    
    


In another preferred embodiment of the invention, the polynucleotide is SEQ ID NO.: 1 or 2.
In another preferred embodiment of the invention the polynucleotide is a polynucleotide comprising a nucleic acid having 70% sequence identity to SEQ ID NO.: 1 or 2.
In yet another preferred embodiment of the invention the polynucleotide is capable of hybridising to a polynucleotide having the sequence of SEQ ID NO.: 1 or 2.
In a further, preferred embodiment of the invention the polynucleotide is complementary to

    
    
        i) a polynucleotide encoding an amino acid sequence consisting of SEQ ID No. 3 or
        ii) a polynucleotide encoding a biologically active sequence variant of the amino acid sequence, wherein the variant has at least 70% sequence identity to said SEQ ID NO. 3, and
        iii) a polynucleotide encoding a biologically active fragment of at least 30 consecutive amino acids of any of a) through b), wherein said fragment is a fragment of SEQ ID NO 3.
    
    


Thus, in one embodiment the polynucleotide of the present invention is complementary to SEQ ID NO.:1 or 2. In another preferred embodiment the polynucleotide of the present invention is complementary to a polynucleotide encoding an amino acid sequence consisting of SEQ ID NO.: 3.
However, the polynucleotide of the invention is in another embodiment complementary to a polynucleotide comprising a nucleic acid having 70% sequence identity to SEQ ID NO.: 1 or 2.
The polynucleotide may comprise the nucleotide sequence of a naturally occurring allelic nucleic acid variant.
The polynucleotide of the invention may encode a variant polypeptide, wherein the variant polypeptide has the polypeptide sequence of a naturally occurring polypeptide variant.
The nucleic acid sequence of the polynucleotide may differ by a single nucleotide from a nucleic acid sequence selected from the group consisting of SEQ ID NO: 1, 2, 5, 6, 8, 9, 11, 12 or 29. However, the polynucleotide may also differ from a nucleic acid sequence selected from the group consisting of SEQ ID NO: 1, 2, 5, 6, 8, 9, 11, 12 or 29 by 2, 3, 4, 5, 6, 7, 8, 9, 10, or more nucleotides.
In one embodiment, the nucleic acid sequence of the polynucleotide has at least 70% sequence identity such as preferably at least 71% sequence identity, more preferably e.g. at least 72% sequence identity, such as more preferably at least 73% sequence identity, e.g. more preferably at least 74% sequence identity, more preferably such as at least 75% sequence identity, more preferably e.g. at least 76% sequence identity, more preferably such as at least 77% sequence identity, more preferably e.g. at least 78% sequence identity, more preferably such as at least 79% sequence identity, such as preferably 80% sequence identity, such as preferably at least 81% sequence identity, more preferably e.g. at least 82% sequence identity, such as more preferably at least 83% sequence identity, e.g. more preferably at least 84% sequence identity, more preferably such as at least 85% sequence identity, more preferably e.g. at least 86% sequence identity, more preferably such as at least 87% sequence identity, more preferably e.g. at least 88% sequence identity, more preferably such as at least 89% sequence identity, more preferably e.g. at least 90% sequence identity, more preferably such as at least 91% sequence identity, more preferably e.g. at least 92% sequence identity, such as at least 93% sequence identity, more preferably e.g. at least 94% sequence identity, more preferably such as at least 95% sequence identity, more preferably e.g. at least 96% sequence identity, more preferably such as at least 97% sequence identity, more preferably e.g. at least 98% sequence identity, more preferably such as at least 99% sequence identity, more preferably e.g. at least 99.5% sequence identity to a nucleotide sequence selected from the group consisting of SEQ ID No. 1, 2, 5, 6, 8, 9, 11, 12 and 29.
In a preferred embodiment the encoded polypeptide has at least 73%, such as preferably at least 74%, for example at least 75%, such as at least 76%, such as at least 77%, for example at least 78%, such as at least 79%, such as at least 80%, for example at least 81%, such as at least 82%, such as at least 83%, for example at least 84%, such as at least 85%, such as at least 86%, for example at least 87%, such as at least 88%, such as at least 89%, for example at least 90%, such as at least 91%, such as at least 92% sequence identity, such as at least 93% sequence identity, more preferably e.g. at least 94% sequence identity, more preferably such as at least 95% sequence identity, more preferably e.g. at least 96% sequence identity, more preferably such as at least 97% sequence identity, more preferably e.g. at least 98% sequence identity, more preferably such as at least 99% sequence identity, more preferably e.g. at least 99.5% sequence identity with SEQ ID No: 3, 4, 7, 10, or 13, more preferably at least 93%, more preferably at least 94%, more preferably at least 95%, more preferably at least 96% more preferably at least 96%, more preferably at least 97%, more preferably at least 98%, more preferably at least 99% sequence identity to SEQ ID No. 3, 4, 7, 10, or 13, more preferably wherein said polypeptide has the sequence of SEQ ID No. 3, 4, 7, 10, or 13.
In one embodiment, the isolated polynucleotide of the invention comprises a nucleic acid sequence having at least 70%, preferably at least 71%, more preferably at least 72%, preferably at least 73%, more preferred at least 74%, more preferred at least 75%, preferably at least 76%, more preferably at least 77%, preferably at least 78%, more preferred at least 79%, more preferred at least 80%, preferably at least 81%, more preferably at least 82%, preferably at least 83%, more preferred at least 84%, more preferred at least 85%, preferably at least 86%, more preferably at least 87%, preferably at least 88%, more preferred at least 89%, more preferred at least 90%, preferably at least 91%, more preferably at least 92%, preferably at least 93%, more preferred at least 94%, more preferred at least 95%, preferably at least 96%, more preferably at least 97%, preferably at least 98%, more preferred at least 99% sequence identity to the polynucleotide sequence presented as any one of SEQ ID NO: 1, 2, 5, 6, 8, 9, 11, 12 and 29.
In one embodiment, the isolated polynucleotide of the invention comprises a nucleic acid sequence having at least 70%, preferably at least 71%, more preferably at least 72%, preferably at least 73%, more preferred at least 74%, more preferred at least 75%, preferably at least 76%, more preferably at least 77%, preferably at least 78%, more preferred at least 79%, more preferred at least 80%, preferably at least 81%, more preferably at least 82%, preferably at least 83%, more preferred at least 84%, more preferred at least 85%, preferably at least 86%, more preferably at least 87%, preferably at least 88%, more preferred at least 89%, more preferred at least 90%, preferably at least 91%, more preferably at least 92%, preferably at least 93%, more preferred at least 94%, more preferred at least 95%, preferably at least 96%, more preferably at least 97%, preferably at least 98%, more preferred at least 99% sequence identity to the polynucleotide sequence presented as SEQ ID NO: 1 and/or 2. The polynucleotide is even more preferred at least 75%, such as at least 76%, for example at least 77, 78, 79 or at least 80% identical to SEQ ID NO: 1 or 29, or any fragment of at least 30 amino acids thereof, and/or at least 85%, such as at least 86%, for example at least 87, 88.89 or at least 90% identical to SEQ ID NO: 2, or any fragment of at least 30 nucleotides thereof.
In another preferred embodiment, the polynucleotide is even more preferred at least 79%, such as at least 80%, for example at least 81, 82, 82 or at least 85% identical to SEQ ID NO: 5, or any fragment of at least 30 nucleotides thereof, and/or at least 79%, such as at least 80%, for example at least 81, 82, 83 or at least 85% identical to SEQ ID NO: 6, or any fragment of at least 30 nucleotides thereof.
In another preferred embodiment, the polynucleotide is even more preferred at least 89%, such as at least 90%, for example at least 91, 92, 93 or at least 95% identical to SEQ ID NO: 8, or any fragment of at least 30 nucleotides thereof, and/or at least 85%, such as at least 86%, for example at least 87, 88, 89 or at least 90% identical to SEQ ID NO: 9, or any fragment of at least 30 nucleotides thereof.
In another preferred embodiment, the polynucleotide is even more preferred at least 78%, such as at least 79%, for example at least 79, 80, 81 or at least 82% identical to SEQ ID NO: 11, or any fragment of at least 30 nucleotides thereof, and/or at least 72%, such as at least 73%, for example at least 74, 75, 76, 77, 78, 79 or at least 80%, identical to SEQ ID NO: 12, or any fragment of at least 30 nucleotides thereof.
In yet another embodiment the polynucleotide is capable of hybridizing to the nucleic acid selected from the group consisting of SEQ ID NO: 1, 2, 5, 6, 8, 9, 11, 12 and 29, or a fragment hereof, under stringent conditions as described below.
A portion of the polynucleotide may hybridize under stringent conditions to a nucleotide probe corresponding to at least 10 consecutive nucleotides of a nucleotide sequence selected from the group consisting of SEQ ID NO: 1, 2, 5, 6, 8, 9, 11, 12 and 29, or a fragment hereof.
In yet another embodiment, the invention relates to polynucleotides having nucleic acid sequences (e. g., DNA, RNA) that hybridise to nucleic acids encoding a beta-glucosidase BGL polypeptide. In particular, nucleic acids which hybridize to SEQ ID NO: 1, 2, 5, 6, 8, 9, 11, 12 or 29 under high, moderate or reduced stringency conditions as described above.
In another embodiment, the invention relates to an RNA counterpart of the DNA nucleic acid encoding a beta-glucosidase BGL. In particular, it relates to RNA counterparts of SEQ ID NO: 1, 2, 5, 6, 8, 9, 11, 12 or 29.
It is appreciated that the polynucleotide of the present invention is DNA, RNA, LNA or PNA.
Heterologous Nucleic Acid Sequence
The microorganism and/or the host cell of the present invention may comprise one or more additional sequences, such as heterologous nucleic acid sequences, which are not native to the microorganism and/or host cell, but has for example been inserted by recombinant gene transfection technologies.
For example, a genetically modified host cell and/or microorganism according to the invention may comprise one or more additional heterologous nucleic acid sequences in addition to a polynucleotide encoding a beta-glucosidase polypeptide of the present invention. Such sequences may encode additional components as described herein below, including for example endoglucanase and/or cellobiohydrolase. However, the additional sequence may also be operably linked to the beta-glucosidase gene of the invention, and direct the expression thereof.
Accordingly, in the host cell and/or microorganism, a beta-glucosidase gene may be operably linked to an additional sequence directing the expression thereof. In this case, it is preferred that the additional sequence is capable of directing expression of the beta-glucosidase gene in the particular host cell and/or microorganism. If a heterologous nucleic acid sequence comprises more than one beta-glucosidase gene the expression of all of said beta-glucosidase genes may be directed by one second sequence, it is however preferred that each beta-glucosidase gene comprised within a genetically modified host microorganism is operably linked to one such additional sequence, which directs expression of said beta-glucosidase gene. It is preferred that the additional sequence comprises or even more preferably consists of a promoter sequence capable of directing expression in the particular host microorganism. The skilled person will in general be able to identify and provide promoter sequences useful in a particular host microorganism.
The additional sequence may thus be a constitutive promoter or an externally inducible promoter. In embodiments of the invention, wherein the host microorganism is a fungus, and in particular when the host microorganism is selected from species of Phanerochaete, such as P. chrysosporium; or Trichoderma, Fusarium or Aspergillus, then the additional sequence may for example be selected from the group consisting of GPD-1 (Glyceraldehyd-Dehydrogenase), CBH1-1 (Cellobiohydrolase), and G-6-P-DH (Glucose-6-phosphate Dehydrogenase) promoters (see specifics regarding these promoters in the Examples herein below).
The additional sequence may also be an externally inducible promoter, i.e. any promoter which may be controlled by external factors, such as temperature or concentration of solutes in the surroundings, or an internally inducible promoter, such as e.g. internally inducible by a metabolite reaching a threshold value. Preferred externally inducible promoters are such promoters which are responsive to the concentration of a solute in the surroundings, such as in the culture medium or in the provided substrate. Very preferred inducible promoters are such promoters, which are activated by low levels or more preferably absence of a nutrient, such as a nutrient selected from the group consisting of nitrogen, phosphate, potassium, magnesium, sulfur and iron. Yet more preferably, the inducible promoter is activated by low levels of and/or absence of nitrogen. A non-limiting example of such a promoter is LG2 (Ligninperoxidase H8 from P. chrysosporium) (see also examples herein below) The LG2 promoter is in particularly useful, when the host microorganism is a fungus, such as P. chrysosporium or Aspergillus. 
In some embodiments of the invention, the heterologous nucleic acid sequence inserted in a host cell or microorganism of the present invention, does not comprise a second sequence, as described herein above. In these embodiments it is preferred that expression of the heterologous gene, such as a beta-glucosidase gene or other additional component as described herein below, including for example endoglucanase and/or cellobiohydrolase is directed by a sequence endogenous to the host microorganism, such as an endogenous promoter. This may be achieved by inserting the heterologous gene, such as the beta-glucosidase gene, just downstream of an endogenous promoter, for example by replacement by recombination. For this purpose the heterologous nucleic acid sequence preferably comprises flanking sequences (see more details below).
In addition to said heterologous gene, such as beta-glucosidase gene and optionally said second sequence, the heterologous nucleic acid sequence may comprise flanking regions. This is in particularly the case when it is desired that the heterologous sequence is comprised in a specific position in the genome of the host cell and/or microorganism of the invention. Each flanking sequence preferably comprises a sequence of in the range of 200 to 2000, more preferably in the range of 200 to 1000 base pairs, wherein said flanking sequence is at least 70%, preferably at least 80%, more preferably at least 90%, yet more preferably at least 95%, even more preferably at least 98%, yet more preferably at least 100% identical to the sequence of the host cell or microorganism genome, where it is desirable that the heterologous nucleic acid sequence is inserted. In general the heterologous nucleic acid sequence comprises a 5′ and a 3′ flanking sequence, wherein the 5′ flanking sequence also is positioned 5′ to the 3′ flanking sequence within the genome of the host cell or microorganism. Preferably, a heterologous nucleic acid sequence comprising flanking regions will be inserted into the genome of the host cell or microorganism by recombination. Non-limiting examples of flanking sequences are given in the Examples herein below.
It is also comprised within the present invention that the heterologous nucleic acid sequence does not comprise flanking sequences, in which case the heterologous nucleic acid sequence may be inserted randomly into the genome of the host cell or microorganism.
In addition to gene encoded by the heterologous sequence, such as a beta-glucosidase gene and the optional additional sequence and/or flanking sequences, the heterologous nucleic acid may comprise one or more terminator sequences. In general the heterologous nucleic acid comprises at most one terminator sequence operably linked to each first sequence. The skilled person will be able to identify suitable terminator sequences useful in any given host cell or microorganism. In embodiments wherein the host cell is a fungus, the terminator sequence may for example be selected from the group consisting of trpC (Indole-3-glycerolphosphate synthase), GDP-(Glyceraldehyde phosphate dehydrogenase), CBH1-2 (Cellobiohydrolase)-terminator.
Further, in addition to gene encoded by the heterologous sequence, such as a beta-glucosidase gene of the present invention and the optional additional sequence and/or flanking sequences and/or terminator, the heterologous nucleic acid may comprise one or more selection markers, preferably one selection marker. When a genetically modified host cell or microorganism comprises more than one heterologous nucleic acid sequence, then it is preferred that each heterologous nucleic acid sequence comprises different selection markers. The skilled person will be able to identify suitable selection markers useful in any given host cell and/or microorganism. In embodiments wherein the host cell or microorganism is a fungus, such as Phanerochaete (such as P. chrysosporium), Trichoderma, Fusarium or Aspergillus (such as Aspergillus saccharolyticus) then the selection markers may for example be selected from the group consisting of Phleomycin binding protein (providing resistance to Phleomycin), Neomycin phosphotransferase (providing resistance to Kanamycin), Hygromycin resistance factor (providing resistance to hygromycin), NCBI Blast of icidine-aminase (providing resistance to NCBI Blast of icidine) and Bialaphois resistance factor (providing resistance to Bialaphos).
Recombinant Vector Construct
The present invention also relates to recombinant expression vectors comprising a nucleotide sequence encoding a polypeptide of the present invention, a promoter, and transcriptional and translational stop signals. The various nucleotide and control sequences described above may be joined together to produce a recombinant expression vector which may include one or more convenient restriction sites to allow for insertion or substitution of the nucleotide sequence encoding the variant at such sites. Alternatively, the nucleotide sequence may be expressed by inserting the nucleotide sequence or a nucleic acid construct comprising the sequence into an appropriate vector for expression. In creating the expression vector, the coding sequence is located in the vector so that the coding sequence is operably linked with the appropriate control sequences for expression.
The recombinant expression vector may be any vector (e.g., a plasmid or virus) which can be conveniently subjected to recombinant DNA procedures and can bring about the expression of the nucleotide sequence. The choice of the vector will typically depend on the compatibility of the vector with the host cell into which the vector is to be introduced. The vectors may be linear or closed circular plasmids.
The vectors of the present invention preferably contain one or more selectable markers which permit easy selection of transformed cells. A selectable marker is a gene the product of which provides for biocide or viral resistance, resistance to heavy metals, prototrophy to auxotrophs, and the like. Suitable markers for yeast host cells are ADE2, HISS, LEU2, LYS2, MET3, TRP1, and URA3. Selectable markers for use in a filamentous fungal host cell include, but are not limited to, amdS (acetamidase), argB (ornithine carbamoyltransferase), bar (phosphinothricin acetyltransferase), hph (hygromycin phosphotransferase), niaD (nitrate reductase), pyrg (orotidine-5′-phosphate decarboxylase), sC (sulfate adenyltransferase), and trpC (anthranilate synthase), as well as equivalents thereof. Preferred for use in an Aspergillus cell are the amdS and pyrG genes of Aspergillus nidulans or Aspergillus oryzae and the bar gene of Streptomyces hygroscopicus. 
The vector may be an autonomously replicating vector, i.e., a vector which exists as an extrachromosomal entity, the replication of which is distinct from chromosomal replication, e.g., a plasmid, an extrachromosomal element, a minichromosome, or an artificial chromosome. The vector may contain any means for assuring self-replication. Alternatively, the vector may be one which, when introduced into the host cell, is integrated into the genome and replicated together with the chromosome(s) into which it has been integrated. Furthermore, a single vector or plasmid or two or more vectors or plasmids which together contain the total DNA to be introduced into the genome of the host cell, or a transposon may be used.
The vectors of the present invention preferably contain an element(s) that permits integration of the vector into the host cell's genome or autonomous replication of the vector in the cell independent of the genome.
For integration into the host cell genome, the vector may rely on the nucleotide sequence encoding the variant or any other element of the vector for integration of the vector into the genome by homologous or random recombination. Alternatively, the vector may contain additional nucleic acid sequences for directing integration by homologous recombination into the genome of the host cell. The additional nucleic acid sequences enable the vector to be integrated into the host cell genome at a precise location(s) in the chromosome(s). To increase the likelihood of integration at a precise location, the integrational elements should preferably contain a sufficient number of nucleic acids, such as 100 to 10,000 base pairs, preferably 400 to 10,000 base pairs, and most preferably 800 to 10,000 base pairs, which are highly homologous with the corresponding target sequence to enhance the probability of homologous recombination. The integrational elements may be any sequence that is homologous with the target sequence in the genome of the host cell. Furthermore, the Integrational elements may be non-encoding or encoding nucleic acid sequences. On the other hand, the vector may be integrated into the genome of the host cell by non-homologous recombination.
For autonomous replication, the vector may further comprise an origin of replication enabling the vector to replicate autonomously in the host cell in question. Examples of origins of replication for use in a yeast host cell are the 2 micron origin of replication, ARS1, ARS4, the combination of ARS1 and CEN3, and the combination of ARS4 and CEN6. The origin of replication may be one having a mutation which makes functioning temperature sensitive in the host cell (see, e.g., Ehrlich, 1978, Proceedings of the National Academy of Sciences USA 75: 1433). Examples of a plasmid replicator useful in a filamentous fungal cell are AMA1 and ANSI (Gerns et al., 1991, Gene 98:61-67; Cullen et al., 1987, Nucleic Acids Research 15: 9163-9175; WO 00/24883). Isolation of the AMA1 gene and construction of plasmids or vectors comprising the gene can be accomplished according to the methods disclosed in WO 00/24883.
More than one copy of a nucleotide sequence of the present invention may be inserted into the host cell to increase production. An increase in the copy number of the nucleotide sequence can be obtained by integrating at least one additional copy of the sequence into the host cell genome or by including an amplifiable selectable marker gene with the nucleotide sequence where cells containing amplified copies of the selectable marker gene, and thereby additional copies of the nucleotide sequence, can be selected for by cultivating the cells in the presence of the appropriate selectable agent.
The procedures used to ligate the elements described above to construct the recombinant expression vectors of the present invention are well known to one skilled in the art (see Sambrook et al., 1989, supra).
In one aspect, the present invention relates to an isolated recombinant nucleic acid vector comprising at least one isolated polynucleotide comprising a nucleic acid or its complementary sequence being selected from the group consisting of

    a. a polynucleotide sequence encoding a polypeptide consisting of an amino acid sequence SEQ ID NO: 3, 4, 7, 10, and 13,
    b. a polynucleotide sequence encoding a biologically active sequence variant as defined herein above, for example a varian having at least 92% sequence identity to any one of said SEQ ID NO: 3, 4, 7, 10, and 13, and
    c. a polynucleotide sequence encoding a biologically active fragment of at least 30 consecutive amino acids of any of the amino acid sequences of a) through b), or
    d. SEQ ID NO.: 1, 2, 5, 6, 8, 9, 11, or 12, 29, or
    e. a polynucleotide comprising a nucleic acid sequence having at least 70% identity to SEQ ID NO: 1, 2, 5, 6, 8, 9, 11, 12, or 29, or
    f. a polynucleotide hybridising to SEQ ID NO.: 1, 2, 5, 6, 8, 9, 11, 12 or 29, and
    g. a polynucleotide complementary to any of a) to f).


In a preferred embodiment, the nucleic acid vector comprises at least one polynucleotide comprising a nucleic acid sequence selected from the group consisting of:

    a. a polynucleotide encoding an amino acid sequence consisting of SEQ ID NO.: 3 or
    b. a polynucleotide sequence encoding a biologically active sequence variant of the amino acid sequence, wherein the variant has at least 92% sequence identity to said SEQ ID NO.: 3 and
    c. a polynucleotide sequence encoding a biologically active fragment of at least 30 consecutive amino acid of any of the amino acid sequences of a) trough b)
    d. a polynucleotide comprising a nucleic acid sequence having at least 70% identity to SEQ ID NO: 1 or 2, or
    e. a polynucleotide hybridising to SEQ ID NO.: 1 or 2, and
    f. a polynucleotide complementary to any of a) to f).


The specific choice of a vector backbone of the present invention depends on the choice of the microorganism for expression of a polypeptide of the present invention. For example, the vector is a prokaryotic expression vector or a eukaryotic expression vector. Thus, in one embodiment, the present invention relates to an isolated eukaryotic expression vector comprising at least one nucleic acid sequence encoding at least one β-glucosidase polypeptide of the present invention, or a biologically active fragment thereof.
Numerous vectors are available and the skilled person will be able to select a useful vector for the specific purpose. The vector may, for example, be in the form of a plasmid, cosmid, viral particle, yeast vector or artificial chromosome. In a preferred embodiment, a vector for fungal expression of the polynucleotide in a fungal cell such as Aspergillus, for example the Aspergillus AP, Aspergillus saccharolyticus, or Trichoderma, Fusarium. 
The appropriate polynucleotide sequence may be inserted into the vector by a variety of procedures, for example, DNA may be inserted into an appropriate restriction endonuclease site(s) using techniques well known in the art. Apart from the polynucleotide according to the invention, the vector may furthermore comprise one or more of a signal sequence, an origin of replication, one or more marker genes, an enhancer element, a promoter, and a transcription termination sequence. The vector may also comprise additional sequences, such as enhancers, poly-A tails, linkers, polylinkers, operative linkers, multiple cloning sites (MCS), STOP codons, internal ribosomal entry sites (IRES) and host homologous sequences for integration or other defined elements. Methods for engineering nucleic acid constructs are well known in the art (see, e.g., Molecular Cloning: A Laboratory Manual, Sambrook et al., eds., Cold Spring Harbor Laboratory, 2nd Edition, Cold Spring Harbor, N.Y., 1989).
The plasmid or plasmids used for preparing the beta-glucosidase of the present invention, in particular for producing BGL (such as SEQ ID NO; 3, 4, 7, 10 or 13) may be any plasmid or vector that may be subjected to recombinant DNA procedures. The plasmid comprising a polynucleotide sequence encoding a beta-glucosidase may be prepared by ligating the nucleotide sequence into a suitable plasmid, or by any other suitable method. The plasmid preferably contains one or more selectable markers described herein which permit easy selection of transformed cells. The choice of plasmid will often depend on the host cell into which it is to be introduced.
In the present invention, the plasmid may be an autonomously replicating plasmid, i.e. a plasmid which exists as an extrachromosomal entity, the replication of which is distinct from chromosomal replication.
The plasmid is preferably an expression vector in which the nucleotide sequence in question is operably linked to additional segments required for transcription of the DNA. In general, the expression vector is derived from a plasmid, a cosmid or a bacteriophage, or may contain elements of any or all of these. For purposes of the present invention, the terms “plasmid” and “vector” are used interchangeably.
The present invention also relates to nucleic acid constructs comprising a polynucleotide sequence encoding the beta-glucosidase of the present invention operably linked to one or more control sequences which direct the expression of the coding sequence in a suitable host cell under conditions compatible with the control sequences. Expression will be understood to include any step involved in the production of the polypeptide including, but not limited to, transcription, post-transcriptional modification, translation, post-translational modification, and secretion.
“Nucleic acid construct” is defined herein as a nucleic acid molecule, either single- or double-stranded, which is isolated from a naturally occurring gene or which has been modified to contain segments of nucleic acid combined and juxtaposed in a manner that would not otherwise exist in nature. The term nucleic acid construct is synonymous with the term expression cassette when the nucleic acid construct contains all the control sequences required for expression of a coding sequence of a polypeptide of the present invention. The term “coding sequence” is defined herein as a nucleotide sequence which directly specifies the amino acid sequence of its protein product. The boundaries of a genomic coding sequence are generally determined by the ATG start codon (eukaryotes), or alternative start codons such as GTG and TTG, located just upstream of the open reading frame at the 5′-end of the mRNA and a transcription terminator sequence located just downstream of the open reading frame at the 3′-end of the mRNA. A coding sequence can include, but is not limited to, DNA, cDNA, and recombinant nucleotide sequences.
An isolated nucleotide sequence encoding the polypeptides of the present invention, preferably a beta-glucosidase polypeptide BGL may be manipulated in a variety of ways to provide for expression of the variant. Manipulation of the nucleotide sequence prior to its insertion into a vector may be desirable or necessary depending on the expression vector. The techniques for modifying nucleotide sequences utilizing recombinant DNA methods are well known in the art.
The term “control sequences” is defined herein to include all components which are necessary or advantageous for the expression of the polypeptides, in particular a beta-glucosidase polypeptide BGL of the present invention. Each control sequence may be native or foreign to the nucleotide sequence encoding BGL. Such control sequences include, but are not limited to, a leader, polyadenylation sequence, propeptide sequence, promoter, signal peptide sequence, and transcription terminator. At a minimum, the control sequences include a promoter, and transcriptional and translational stop signals. The control sequences may be provided with linkers for the purpose of introducing specific restriction sites facilitating ligation of the control sequences with the coding region of the nucleotide sequence encoding the polypeptides of the present invention, in preferred embodiment the beta-glucosidase BGL. The term “operably linked” is defined herein as a configuration in which a control sequence is appropriately placed at a position relative to the coding sequence of the nucleotide sequence such that the control sequence directs the expression of the polypeptides.
The control sequence may be an appropriate promoter sequence, which is recognized by a host cell for expression of the nucleotide sequence. The promoter sequence contains transcriptional control sequences which mediate the expression of polypeptides of the present invention, in particular the beta-glucosidase polypeptide BGL. The promoter may be any nucleic acid sequence which shows transcriptional activity in the host cell of choice including mutant, truncated, and hybrid promoters, and may be obtained from genes encoding extracellular or intracellular polypeptides either homologous or heterologous to the host cell.
In one embodiment, at least one control sequence obtained from Aspergillus is employed, and in a preferred embodiment, one or more control sequences are obtained from a microorganism of the present invention, in particular Aspergillus saccharolyticus. 
Promoters for directing the transcription of the polynucleotides of the present invention is for example obtained from Aspergillus, most preferred from a microorganism of the present invention, such as Aspergillus saccharolyticus. Other examples of suitable promoters for directing the transcription of the polynucleotides of the present invention in a filamentous fungal host cell are obtained from Aspergillus saccharolyticus, or promoters obtained from the genes for Aspergillus oryzae TAKA amylase. Rhizomucor miehei aspartic proteinase, Aspergillus niger neutral alpha-amylase, Aspergillus niger acid stable alpha-amylase, Aspergillus niger or Aspergillus awamori glucoamylase (glaA), Rhizomucor miehei lipase, Aspergillus oryzae alkaline protease, Aspergillus oryzae triose phosphate isomerase, Aspergillus nidulans acetamidase, Fusarium venenalum amyloglucosidase, Fusarium oxysporum trypsin-like protease (WO 96/00787), Trichoderma reesei beta-glucosidase, Trichoderma reesei cellobiohydrolase I, Trichoderma reesei endoglucanase I, Trichoderma reesei endoglucanase II, Trichoderma reesei endoglucanase III, Trichoderma reesei endoglucanase IV, Trichoderma reesei endoglucanase V, Trichoderma reesei xylanase I, Trichoderma reesei xylanase II, Trichoderma reesei beta-xylosidase, as well as the NA2-tpi promoter (a hybrid of the promoters from the genes for Aspergillus niger neutral alpha-amylase and Aspergillus oryzae triose phosphate isomerase); Magnaporta grisea ribosomal promoter or equivalents thereof; and also mutant, truncated, and hybrid promoters thereof.
In a yeast host, useful promoters are obtained from the genes for Saccharomyces cerevisiae enolase (ENO-1). Saccharomyces cerevisiae galactokinase (GAL1), Saccharomyces cerevisiae alcohol dehydrogenase/glyceraldehyde3-phosphate dehydrogenase (ADH1,ADH2/GAP), Saccharomyces cerevisiae triose phosphate isomerase (TPI), Saccharomyces cerevisiae metallothionine (CUP1), and Saccharomyces cerevisiae 3-phosphoglycerate kinase. Other useful promoters for yeast host cells are described by Romanos et al, 1992, Yeast 8: 423-488.
The control sequence may also be a suitable transcription terminator sequence, which is recognized by a host cell to terminate transcription. The terminator sequence is operably linked to the 3′-terminus of the nucleotide sequence encoding the polypeptide, in particular the beta-glucosidase polypeptide BGL. Any terminator which is functional in the host cell of choice may be used in the present invention.
Terminators are for example obtained from Aspergillus, most preferred from a microorganism of the present invention, such as Aspergillus saccharolyticus. For example, preferred terminators for filamentous fungal host cells are obtained from Aspergillus saccharolyticus, or the genes for Aspergillus oryzae TAKA amylase, Aspergillus niger glucoamylase, Aspergillus nidulans anthranilate synthase, Aspergillus niger alphaglucosidase, Fusarium oxysporum trypsin-like protease, or Neurospora crassa beta-tubulin terminator.
Preferred terminators for yeast host cells are obtained from the genes for Saccharomyces cerevisiae enolase, Saccharomyces cerevisiae cytochrome C (CYC1), and Saccharomyces cerevisiae glyceraldehyde-3-phosphate dehydrogenase. Other useful terminators for yeast host cells are described by Romanos et al., 1992, supra.
The control sequence may also be a suitable leader sequence, a nontranslated region of an mRNA which is important for translation by the host cell. The leader sequence is operably linked to the 5′-terminus of the nucleotide sequence encoding the beta-glucosidase polypeptide BGL. Any leader sequence that is functional in the host cell of choice may be used in the present invention.
Leaders are for example obtained from Aspergillus, most preferred from a microorganism of the present invention, such as Aspergillus saccharolyticus. Preferred leaders for filamentous fungal host cells are obtained from Aspergillus saccharolyticus, or the genes for Aspergillus oryzae TAKA amylase and Aspergillus nidulans triose phosphate isomerase. Suitable leaders for yeast host cells are obtained from the genes for Saccharomyces cerevisiae enolase (ENO1). Saccharomyces cerevisiae 3-phosphoglycerate kinase, Saccharomyces cerevisiae alpha-factor, and Saccharomyces cerevisiae alcohol dehydrogenase/glyceraldehyde-3-phosphate dehydrogenase (ADH2/GAP).
The control sequence may also be a polyadenylation sequence, a sequence operably linked to the 3′-terminus of the polypeptide-encoding sequence and which, when transcribed, is recognized by the host cell as a signal to add polyadenosine residues to transcribed mRNA. Any polyadenylation sequence which is functional in the host cell of choice may be used in the present invention.
Polyadenylation sequences are for example obtained from Aspergillus, most preferred from a microorganism of the present invention, such as Aspergillus saccharolyticus. Preferred polyadenylation sequences for filamentous fungal host cells are obtained from Aspergillus saccharolyticus, or from the genes for Aspergillus oryzae TAKA amylase, Aspergillus niger glucoamylase, Aspergillus nidulans anthranilate synthase, Fusarium oxysporum trypsin-like protease, and Aspergillus niger alpha-glucosidase. Useful polyadenylation sequences for yeast host cells are described by Guo and Sherman, 1995, Molecular Cellular Biology 15: 5983-5990.
The control sequence may also be a signal peptide coding region that codes for an amino acid sequence linked to the amino terminus of the polypeptides of the present invention, in particular the beta-glucosidase polypeptide BGL, where BGL is free of its signal peptide (e.g. SEQ ID NO 4 for BGL1) and directs the encoded polypeptide into the cell's secretory pathway. The 5′-end of the coding sequence of the nucleotide sequence may inherently contain a signal peptide coding region naturally linked in translation reading frame with the segment of the coding region which encodes the secreted beta-glucosidase polypeptide(s). Alternatively, the 5′-end of the coding sequence may contain a signal peptide coding region which is foreign to the coding sequence. The foreign signal peptide coding region may be required where the coding sequence does not naturally contain a signal peptide coding region. Alternatively, the foreign signal peptide coding region may simply replace the natural signal peptide coding region in order to enhance secretion of the beta-glucosidase polypeptides of the present invention. However, any signal peptide coding region which directs the expressed polypeptide into the secretory pathway of a host cell of choice may be used in the present invention.
Signal peptide sequences are for example obtained from Aspergillus, most preferred from a microorganism of the present invention, such as Aspergillus saccharolyticus. Effective signal peptide coding regions for filamentous fungal host cells are the signal peptide coding regions obtained from Aspergillus saccharolyticus (cf. SEQ ID NO: 3, 7, 10, 13, initial bold sequence), or from the genes for Aspergillus oryzae TAKA amylase. Aspergillus niger neutral amylase, Aspergillus niger glucoamylase, Rhizomucor miehei aspartic proteinase, Humicola insolens Cel45A cellulase, and Humicola lanuginosa lipase. Useful signal peptides for yeast host cells are obtained from the genes for Saccharomyces cerevisiae alpha-factor and Saccharomyces cerevisiae invertase. Other useful signal peptide coding regions are described by Romanos et al., 1992, supra.
The control sequence may also be a propeptide coding region that codes for an amino acid sequence positioned at the amino terminus of the polypeptides of the present invention. The resultant polypeptide is known as a proenzyme or propolypeptide (or a zymogen in some cases). A propolypeptide is generally inactive and can be converted to a mature active polypeptide by catalytic or autocatalytic cleavage of the propeptide from the propolypeptide. The propeptide coding region may be obtained from the genes for Saccharomyces cerevisiae alpha-factor, Rhizomucor miehei aspartic proteinase, and Myceliophthora thermophila laccase (WO 95/33836). Where both signal peptide and propeptide regions are present at the amino terminus of a polypeptide, the propeptide region is positioned next to the amino terminus of a polypeptide and the signal peptide region is positioned next to the amino terminus of the propeptide region.
It may also be desirable to add regulatory sequences which allow the regulation of the expression of the polypeptides of the present invention relative to the growth of the host cell. Examples of regulatory systems are those which cause the expression of the gene to be turned on or off in response to a chemical or physical stimulus, including the presence of a regulatory compound. In yeast, the ADH2 system or GAL1 system may be used. In filamentous fungi, the TAKA alpha-amylase promoter, Aspergillus niger glucoamylase promoter, and Aspergillus oryzae glucoamylase promoter may be used as regulatory sequences. Other examples of regulatory sequences are those which allow for gene amplification. In eukaryotic systems, these include the dihydrofolate reductase gene which is amplified in the presence of methotrexate, and the metallothionein genes which are amplified with heavy metals. In these cases, the nucleotide sequence encoding polypeptides of the present invention, in particular the beta-glucosidase polypeptide BGL, would be operably linked with the regulatory sequence.
By having the polynucleotide positioned in a vector the polynucleotide can easily be stored, amplified, modified and expressed.
Microorganism and Host Cell
The present invention also encompasses any microorganism, which comprises a polypeptide or nucleic acid sequence or vector of the present invention, in particular, the host organism is a microorganism, which comprise a beta-glucosidase of the invention, or at least one polynucleotide encoding same or a biological active part thereof. The host organism may be the natural host of the native beta-glucosidase polypeptide, such as Aspergillus AP (Aspergillus saccharolyticus), or the host microorganism may be a genetically modified microorganism, wherein a polypeptide of the present invention has been introduced by transgenesis. Thus, one aspect of the present invention relates to an isolated microorganism comprising a polypeptide as defined elsewhere herein, a polynucleotide as defined herein and/or a recombinant nucleic acid vector as defined herein.
Preferably the microorganism, host organism, and/or polypeptide of the present invention is capable of degrading one or more plant cell wall constituents such as lignocellolosic material. In a preferred embodiment the lignocellulosic material is selected from the group consisting of cellulose, hemicellulose, cellobiose, cellodextrin and pectin, more preferably, the host microorganism is capable of degrading at least two plant cell wall constituents selected from the group consisting of cellulose, hemicellulose, cellobiose, cellodextrin and pectin, yet more preferably the host organism is capable of degrading at least three plant cell wall constituents selected from the group consisting of cellulose, hemicellulose, cellobiose, cellodextrin and pectin, even more preferably the host microorganism is capable of degrading all of cellulose, hemicellulose, cellobiose, cellodextrin and pectin.
It is thus preferred that the microorganism, host organism and/or polypeptide of the present invention is capable of degrading at least one plant cell wall constituent selected from the group consisting of cellulose, hemicellulose, cellobiose, cellodextrin and pectin, more preferably the host microorganism is capable of degrading at least one plant cell wall constituent selected from the group consisting of cellobiose and cellodextrin, yet more preferably, the host organism is capable of degrading cellobiose.
Accordingly, it is very preferred that the microorganism, host organism and/or polypeptide of the present invention is capable of degrading lignocellulosic material as described herein. Preferably, the microorganism, host organism and/or polypeptide of the present invention is capable of degrading at least 40%, more preferably at least 50%, even more preferably at least 60%, yet more preferably at least 65%, and most preferably at least 90% of the lignocellulosic material content of any given carbon source (preferably wood residuals or agricultural residuals), within a time span of at the most 6 months, preferably at the most 5 months, yet more preferably at the most 4 month, yet more preferably at the most 3 months, even more preferably at the most 2 months, yet more preferably at the most 1 month, yet more preferably at the most 1 week, and most preferably at the most 3 days.
In addition, it is preferred that the host organism of the present invention is capable of degrading one or more additional components of plant biomass, such as for example polymerized carbon sources, structural or non-structural carbohydrates, in particular it is preferred that the host organism is capable of degrading polysaccharides, such as e.g. cellulose, in plant biomass. Preferably at least 50%, more preferably at least 60%, yet more preferably at least 70%, even more preferably at least 80%, further preferred at least 90% of the one or more additional components of plant biomass, such as all polysaccharides in plant biomass, preferably within a time span of at the most 6 months, preferably at the most 3 months, yet more preferably at the most 1 month, yet more preferably at the most 20 days, even more preferably at the most 3 days.
Thus, it is preferred that the microorganism, host organism and/or polypeptide of the present invention is capable of degrading at least 50%, more preferably at least 60%, yet more preferably at least 70%, even more preferably at least 80% of any given plant, more preferably at least 90% biomass comprising lignocellulosic material as determined in reference to dry weight, preferably within a time span of at the most 6 months, preferably at the most 3 months, yet more preferably at the most 1 month, yet more preferably at the most 20 days, even more preferably at the most 3 days.
In addition it is preferred that the microorganism, host organism and/or polypeptide of the present invention is capable of degrading and assimilating at least 50%, more preferably at least 60%, yet more preferably at least 70%, even more preferably at least 80% of any given plant biomass as determined by carbon content, preferably within a time span of at the most 6 months, preferably at the most 3 months, yet more preferably at the most 1 month, yet more preferably at the most 20 days, even more preferably at the most 10 days, and most preferred at the most 3 days.
When mentioned herein that the genetically modified microorganism, or the host organism, is capable of degrading one or more plant cell wall constituents it is furthermore preferred that the genetically modified microorganism, or the host organism, is capable of degrading and assimilating the breakdown products of one or more plant cell wall constituents selected from the group consisting of cellulose, hemicellulose, cellobiose, cellodextrin and pectin.
When used herein the term assimilating means capable of degrading and utilizing the breakdown products of a carbon source in the metabolisme, preferably anabolism, of biomolecules, such as e.g. acids and acid derivatives, and preferably in the anabolism of “microbial oil” or biochemicals and bioproducts produced through biorefinery for substitution of products produced by oil in oil refineries.
Thus, it is preferred that the host organism expresses and secretes as complete a set of enzymes as possible for the degradation of the biomass as defined above. Thus, a host organism capable of degrading lignocellulosic material in general expresses and secretes all enzymes required for degradation of lignin. Preferred host microorganisms are capable of degrading lignin in its entirety and it is preferred that such host microorganisms comprise one or more enzymes selected from the group consisting of lignin peroxidases (also referred to as ligninase), manganese peroxidase, and laccase. Particularly useful is the combined action of a set of enzymes from Phanerochaete crysosporium having as main constituents a lignin peroxidase, a manganese peroxidase and a laccase activity, or enzymes from Trichoderma, Aspergillus or Fusarium. 
The same applies for the other polysaccharide and/or other plant cell wall constituents mentioned herein above. Thus, more preferably, the host microorganism expresses and secretes all enzymes for the degradation of all of cellulose, hemicellulose, cellobiose, cellodextrin and/or pectin, and any other structural or non-structural carbohydrate, such as polysaccharides. The enzyme mixtures that may be involved in degradation of various polysaccharides and/or plant cell wall constituents are reviewed by Evans and Hedge (Evans, C. S. and Hedger J. N. in Gadd, G. M. ed.: in Fungi in Bioremediation; Cambridge University Press, (2001) p 1-24; ISBN 0-521-781191). Preferably, the host microorganism expresses and preferably secretes a set of carbohydrolases.
Aspergillus saccharolyticus 
In one important aspect, the present invention relates to a microorganism, such as an isolated microorganism, of the species Aspergillus saccharolyticus. The novel Aspergillus strain of the present invention has been named Aspergillus saccharolyticus A. Sørensen, P. Lübeck et Frisvad sp. nov.
Aspergillus saccharolyticus (sac.ca'ro.ly'ti.cus. N.L. masc. adj. saccharolyticus, being able to degrade cellobiose and cellodextins).
In particular, the invention relates to a microorganism as deposited in the Centraalbereau voor Schimmelcultures (CBS) and having accession number CBS 127449. The invention also relates to any descendant or a functional mutant of said microorganism. Thus, in any context of the present invention, any reference to the microorganism, also relates to any descendant or a functional mutant of said microorganism.
In particular, the microorganism, descendant or a functional mutant thereof is capable of hydrolyzing a β1-4 glucose-glucose linkage. Thus, the microorganism of the invention, including said descendant or functional mutant thereof, comprises at least one beta-glucosidase (BGL) polypeptide and/or a gene endoding said polypeptide. However, the microorganism may comprise at least two, such as at least three, for example at least four beta-glucosidase (BGL) polypeptides and/or a genes endoding these. In particular, the microorganism, descendant or a functional mutant thereof may also comprise multiple copies of each beta-glucosidase (BGL) polypeptide and/or a gene endoding said polypeptide. For example, the microorganism, descendant or a functional mutant thereof, in one embodiment comprise comprise at least 2 copies of said one or more genes encoding said BGL polypeptide, for example at least 5, or at least 10, such as more than 20, 30, 40, or more than 50 copies of said one or more genes.
For example, the microorganism, Aspergillus saccharolyticus, comprise at least one beta-glucosidase (BGL) polypeptide, which is selected from the group consisting of BGL1 (SEQ ID NO: 3 or 4), BGL2 (SEQ ID NO: 7), BGL3 (SEQ ID NO: 10) and BGL4 (SEQ ID NO: 13).
In another example, the microorganism, Aspergillus saccharolyticus, comprise at least one nucleotide sequence encoding a beta-glucosidase (BGL) polypeptide, which is selected from the group consisting of BGL1 (SEQ ID NO: 3 or 4), BGL2 (SEQ ID NO: 7). BGL3 (SEQ ID NO: 10) and BGL4 (SEQ ID NO: 13). For example, the microorganism, Aspergillus saccharolyticus, comprise at least one nucleotide sequence, which is selected from the group consisting of SEQ ID NO: 1, 2, 5, 6, 8, 9, 11, 12, 14, 15, 16, and/or 29, and/or any fragment of at least 30 nucleotides thereof.
In one embodiment, the microorganism, descendant or functional mutant thereof, comprise an ITS nucleic acid sequence, which is at least 89% identical to SEQ ID NO: 16 or any fragment thereof as defined elsewhere herein. However in a preferred embodiment, the microorganism, descendant or functional mutant thereof, comprise an ITS nucleic acid sequence, which is at least 90%, such as at least 91%, such as at least 92%, such as at least 93%, more preferably e.g. at least 94%, more preferably such as at least 95%, more preferably e.g. at least 96%, more preferably such as at least 97%, more preferably e.g. at least 98%, more preferably such as at least 99%, more preferably e.g. at least 99.5% with SEQ ID NO: 16, or any fragment thereof as defined elsewhere herein.
In one embodiment, the microorganism, descendant or functional mutant thereof, comprise a Calmodulin nucleic acid sequence, which is at least 89% identical to SEQ ID NO: 15 or any fragment thereof as defined elsewhere herein. However in a preferred embodiment, the microorganism, descendant or functional mutant thereof, comprise a Calmodulin nucleic acid sequence, which is at least 90%, such as at least 91%, such as at least 92%, such as at least 93%, more preferably e.g. at least 94%, more preferably such as at least 95%, more preferably e.g. at least 96%, more preferably such as at least 97%, more preferably e.g. at least 98%, more preferably such as at least 99%, more preferably e.g. at least 99.5% identical with SEQ ID NO: 15, or any fragment thereof as defined elsewhere herein.
In one embodiment, the microorganism, descendant or functional mutant thereof, comprise a beta-tubulin nucleic acid sequence, which is at least 87% identical to SEQ ID NO: 14, or any fragment thereof as defined elsewhere herein. However in a preferred embodiment, the microorganism, descendant or functional mutant thereof, comprise a beta-tubulin nucleic acid sequence, which is at least 88%, such as at least 89%, such as at least 90%, such as at least 91%, such as at least 92%, such as at least 93%, more preferably e.g. at least 94%, more preferably such as at least 95%, more preferably e.g. at least 96%, more preferably such as at least 97%, more preferably e.g. at least 98%, more preferably such as at least 99%, more preferably e.g. at least 99.5% identical with SEQ ID NO: 14, or any fragment thereof as defined elsewhere herein.
In a preferred embodiment, the the microorganism, descendant or functional mutant thereof, comprise a nucleic acid sequence at least 90% identical to SEQ ID NO: 16, a nucleic acid sequence at least 90% identical to SEQ ID NO: 15, and a nucleic acid sequence at least 88% identical to SEQ ID NO: 14.
Based on morphology, the microorganism of the invention (Aspergillus saccharolyticus) is related to A. japonicus or A. aculeatus. However, extrolite profiles and DNA sequencing data show that Aspergillus saccharolyticus is clearly different from all known species. A. saccharolyticus is not related to other black aspergilli based on comparing sequence data of parts of the beta-tubulin and calmodulin genes as well as the ITS region, using A. flavus as the out group.
Phylogeny
Based on the phylogenetic analysis of the ITS and calmodulin gene sequence data, A. saccharolyticus belongs to the clade with A. homomorphus, A. aculeatinus, A. uvarum, A. japonicus, and both A. aculeatus strains, while for the beta-tubulin gene sequence data A. saccharolyticus clusters with A. homomorphus, A. aculeatinus, A. uvarum, and A. aculeatus CBS 114.80. The separate grouping in the beta-tubulin tree of A. japonicus and A. aculeatus CBS 172.66T has consistently been shown in other publications that have used these exact strain sequences (Noonim et al., 2008, Samson et al., 2007, Varga et al., 2007, de Vries et al., 2005, Samson et al., 2004b). The separate grouping is due to the two aspergilli having one less intron in the beta-tubulin gene compared to the other Nigri species. For all three loci, A. saccharolyticus is placed on its own branch far from the other species in the clade supported by the majority-rule consensus analysis for all three loci and high bootstrap values for the beta-tubulin and calmodulin loci, but low bootstrap value (51%) for the ITS locus. Sequence alignment shows that amongst the species from series Aculeata and Homomorpha (Frisvad et al., 2007) that are phylogenetically closely related to A. saccharolyticus, interspecific sequence divergences are 50.7%, 7.1%, and 5.7% for the ITS, calmodulin, and beta-tubulin regions, respectively.
Meanwhile, the interspecific sequence divergences in the ITS, calmodulin, and beta-tubulin region between A. saccharolyticus and the other species in the clade are on average 12.9±0.6%, 20±0.5%, and 15.4±1.2%, respectively. The variation in sequence data between A. saccharolyticus and A. homomorphus is the same as the variation between A. homomorphus and the smaller clade(s) of A. aculeatinus, A. uvarum, A. japonicus, and both A. aculeatus strains. Searching the NCBI database does not give any closer genetic match with respect to A. saccharolyticus. 
UP-PCR Fingerprinting
The microorganism of the invention, A. saccharolyticus, may be distinguished from other black aspergilli by Universally Primed-PCR analysis using each of the two UP primers, L45 and L15/AS19. UP-PCR is a PCR fingerprinting method that has demonstrated its applicability in different aspects of mycology. These applications constitute analysis of genome structures. Identification of species, analysis of population and species diversity, revealing of genetic relatedness at infra- and inter-species level, and identification of UP-PCR markers at different taxonomic levels (strain, group and/or species) (Lübeck & Lübeck, 2005). Different Aspergilli: A. saccharolyticus. A. aculeatinus, A. ellipticus, A. homomorphus, A. niger, A. uvarum, A. aculeatus and A. japonicus, produced a unique banding profile, and do not share any bands.
Enzyme Activity
The microorganism of the invention preferably comprise a beta-glucosidase activity, and the betaglucosidase activity may be isolated or obtained from an extract of the microorganism or from the incubation broth of the microorganism, after letting the microorganism incubate in the broth for a certain period. In one embodiment, the microorganism of the invention is characterized in that an extract and/or incubation broth of said microorganism, descendant or functional mutant thereof, has a beta-glucosidase activity of at least 5 U/mg of total protein. For example, an extract and/or incubation broth of said microorganism, descendant or functional mutant thereof, has a beta-glucosidase activity, wherein the half-life of said beta-glucosidase activity at 60° C. is at least 200 minutes. Also, in one example, an extract and/or incubation broth of said microorganism, descendant or functional mutant thereof, has a betaglucosidase activity, wherein at least 50% of said beta-glucosidase activity remains after 4 hours of incubation at 60° C.
Morphology
Aspergillus saccharolyticus is characterised by the following features: Colony diameter at 7 days: CYA at 25° C.: 58-62 mm, at 37° C.: 7-14 mm; CYAS: 11.14 mm; YES: 75-80 mm; OA: 39-42 mm; CY20S: 42-54 mm; CY40S: 43-54 mm; MEA: 35-37 mm; CREA 30-34 mm, poor growth, good acid production, colony first white then dark brown to black. Exudates absent, reverse cream-coloured to light greyish olive brown on CYA and light brown on YES. Conidial heads globose; stipes 200-850×5-7 μm, walls thick, smooth; vesicles 25-40 μm diam, globose; uniseriate, phialides flask shaped with a short broad collulum, 5.5-7 μm; conidia mostly globose, but some are subglobose, 5-6.2 μm, distinctly echinulate, with long sharp discrete spines, the spines being 0.6-0.8 μm long. Sclerotia have not been observed.
The type strain CBS 127449T (=IBT 28509T) was isolated from under a toilet seat made of treated oak wood, Gentofte, Denmark.
Further characteristics of Aspergillus saccharolyticus are described in example 2.
Host Cells
The present invention also relates to a recombinant host cell, comprising a polynucleotide sequence encoding a beta-glucosidase polypeptide as described elsewhere herein and/or a recombinant nucleic acid vector as described herein. The recombinant host cell comprises a recombinant nucleic acid vector comprising a polynucleotide of the present invention is introduced into a host cell so that the vector is maintained as a chromosomal integrant or as a self-replicating extrachromosomal vector as described earlier. The term “host cell” encompasses any progeny of a parent cell that is not identical to the parent cell due to mutations that occur during replication. The choice of a host cell will to a large extent depend upon the gene encoding the polypeptide and its source.
The host cell may also be any suitable host microorganism. Accordingly, preferably the host cell may be selected from host microorganisms belonging to a phylum selected from the group consisting of yeasts, fungi, bacteria, algae or plants. However, the host cell may be any prokaryote or eukaryote, such as a mammalian, insect, plant, or fungal cell.
Host microorganisms capable of degrading cellulose preferably express and secrete one or more glycoside hydrolases, such as endo-acting or exo-acting cellulases. These enzymes may be part of a multienzyme complex, such as a cellulosome. Host microorganisms that are capable of degrading starch preferably comprise amylases. In a very preferred embodiment the host microorganism comprises a secretome, such as a cellulose-induced secretome, which preferably may be composed of glycosyl-hydrolases, such as a total of in the range of 15 to 50, such as around 32, for example 32 glycosyl-hydrolases. In addition, the host microorganism preferably contains endoglucanases and/or cellobiohydrolases for cellulose degradation. Additionally, the host microorganism preferably comprises endoxylanases, alpha-galactosidases and/or other enzymes involved in the degradation of hemicelluloses.
If the host microorganism does not endogenously comprise genes encoding some or all of the enzymes for degradation of desired polysaccharides and/or plant cell wall constituents, the enzyme(s) may be introduced into the host microorganism by genetic modification.
In one embodiment, the host microorganism is an organism with a yeast-like growth behavior, such as yeast, for example Saccharomyces cerevisiae. Preferably, said yeast is capable of degrading polysaccharides, such as starch, comprises the enzymatic apparatus to grow on carbon sources such as, for example, fruit juices or starch containing substrates. In another less preferred embodiment the host microorganism is a bacteria, such as a bacteria capable of degrading at least one, preferably at least two, more preferably at least three, even more preferably at least four, yet more preferably all of the plant cell wall constituents selected from the group consisting of cellulose, hemicellulose, pectin, and lignin.
In a very preferred embodiment of the invention the host microorganism is a fungus, more preferably a filamentous fungus. Filamentous fungi particularly useful as host microorganisms within the scope of the present invention are filamentous fungi capable of degrading and assimilating the breakdown products of the lignocellulosic matter from the plant biomass, preferably the natural habitat of said filamentous fungi is decaying plant material. Examples of useful host organisms having as natural habitat decaying plant material include white rot, red rot and soft rot fungi together with fungi like Penicillium, Aspergillus, Fusarium, Trichoderma and Neurospora. Preferred host microorganisms are fungi capable of hyphal growth that can penetrate into the lignocellulosic matter, usually with the help of secreted carbohydrolases.
Many fungi have specialized in the degradation of a fraction of the polysaccharides and/or plant cell wall constituents from plant biomass such as for example cellulose or hemicellulose. Thus, in one embodiment, the host microorganism is a fungus specialized in the degradation of a fraction of the polysaccharides and/or plant cell wall constituents from plant biomass such as for example cellulose or hemicellulose. However, more preferably the host microorganism is a fungus capable of degrading most of the polysaccharides and plant cell wall constituents present in plant biomass.
Thus, the host microorganism may be any fungus having the ability to degrade any plant cell wall constituents, in particular lignocellosic material e.g. any structural or non-structural polysaccharide as described herein above, in particular the host microorganism may be any fungus capable of growing on one or more constituents of plant biomass such as starch, pectin, cellulose, hemicellulose, cellobiose, cellodextrin or lignin. Accordingly, the host organism may be a filamentous fungus which has the capacity to use one or more plant cell wall constituents as carbon source. Examples of useful fungi are given in Evans and Hedge (Evans, C. S. and Hedger J. N. in Gadd, G M ed.: in Fungi in Bioremediation; Cambridge University Press, (2001) p 1-24; ISBN 0-521-781191). In one embodiment, the host microorganism is a fungus selected from the group consisting of white-rot, red-rot and soft-rot fungi. The host cell may also in a preferred embodiment be selected from Ascomycetes. Thus, for example, the host microorganism may be a fungus selected from the group consisting of fungi of the genus Trichoderma, Trametes, Aspergillus, Fusarium and Penicillium. 
In a very preferred embodiment of the invention the host microorganism is a fungus capable of degrading at least one, preferably at least two, more preferably at least three, yet more preferably at least four, more preferably all of the plant cell wall constituents selected from cellulose, hemicellulose, cellobiose, cellodextrin and pectin. Thus, it is preferred that the host microorganism is a fungus which is capable of degrading at least cellobiose, preferably at least cellobiose and cellodextrin, more preferably all of cellulose, hemicellulose, cellobiose, cellodextrin and pectin.
Therefore, in one embodiment of the present invention the host microorganism is a fungus of the Phanerochaetaceae family, more preferably a fungus belonging to the Phanerochaete genus, even more preferably, a fungus selected from the group consisting of Phanerochaete alfantospora, Phanerochaete arizonica, Phanerochaete chrysosporium, Phanerochaete aveilanea, Phanerochaete burtii, Phanerochaete carnosa, Phanerochaete chrysorhizon, Phanerochaete radicata, Phanerochaete salmonicolor, Phanerochaete tuberculata, Phanerochaete velutina and Phanerochaete chrysosporium. In one preferred embodiment the host microorganism is a white rot fungus. The advantage of using for example white-rot fungi is i.a. the ability of these fungi to degrade lignin, which supports the betaglucosidase activity of the polypeptides of the present invention.
More preferably, the host microorganism is, for example of the strain RP 78. This fungus has the enzymatic capacity to degrade cellulose, hemi-cellulose, lignin, and pectin.
P. chrysosporium is in general capable of achieving high conversion rates in biomass degradation and therefore P. chrysosporium is particularly useful as a host microorganism for industrial scale application of the methods according to the present invention. For example, cultivating P. chrysosporium in industrial scale may be performed by solid state fermentation, for example essentially as described by Kumar, A. G. et al. (2006) Bioresource Technology p. 1521-1528). Using this process P. chrysosporium was capable of degrading 65% of lignin content of Achra zapota leaves in 28 days.
In another highly preferred embodiment, the host cell is selected from Ascomycetes. In a most preferred embodiment, the host cell is selected from Trichoderma and Aspergillus 
In one embodiment, the microorganism or host cell/organism is a fungus, such as Aspergillus, and in a specific embodiment, the host of Aspergillus AP/Aspergillus saccharolyticus, which is the natural host for the beta-glucosidases identified by SEQ ID NO: 3, 7, 10, and 13.
The host cell may be any fungal cell. “Fungi” as used herein includes the phyla Ascomycota, Basidiomycota, Chytridiomycota, and Zygomycota (as defined by Hawksworth et al., In, Ainsworth and Bisby's Dictionary of The Fungi, 8th edition, 1995, CAB International, University Press, Cambridge. UK) as well as the Oomycota (as cited in Hawksworth et al., 1995, supra, page 171) and all mitosporic fungi (Hawksworth et al., 1995, supra).
In a preferred embodiment, the fungal host cell is a yeast cell. “Yeast” as used herein includes ascosporogenous yeast (Endomycetales), basidiosporogenous yeast, and yeast belonging to the Fungi Imperfecti (NCBI Blast of omycetes). Since the classification of yeast may change in the future, for the purposes of this invention, yeast shall be defined as described in Biology and Activities of Yeast (Skinner, F. A., Passmore, S. M., and Davenport, R. R., eds, Soc. App. Bacterial. Symposium Series No. 9, 1980).
In a more preferred embodiment, the yeast host cell is a Candida, Hansenula, Kluyveromyces, Pichia, Saccharomyces. Schizosaccharomyces, or Yarrowia cell.
In a most preferred embodiment, the yeast host cell is a Saccharomyces carlsbergensis, Saccharomyces cerevisiae, Saccharomyces diastaticus, Saccharomyces douglasii, Saccharomyces kluyveri, Saccharomyces norbensis or Saccharomyces oviformis cell. In another most preferred embodiment, the yeast host cell is a Kluyveromyces lactis cell. In another most preferred embodiment, the yeast host cell is a Yarrowia lipolytica cell.
In another preferred embodiment, the fungal host cell is a filamentous fungal cell. “Filamentous fungi” include all filamentous forms of the subdivision Eumycota and Oomycota (as defined by Hawksworth et al., 1995, supra). The filamentous fungi are generally characterized by a mycelial wall composed of chitin, cellulose, glucan, chitosan, mannan, and other complex polysaccharides. Vegetative growth is by hyphal elongation and carbon catabolism is obligately aerobic. In contrast, vegetative growth by yeasts such as Saccharomyces cerevisiae is by budding of a unicellular thallus and carbon catabolism may be fermentative.
In a more preferred embodiment, the filamentous fungal host cell is, but not limited to, an Acremonium, Aspergillus, Fusarium, Humicola, Mucor, Mycellophthora, Neurospora, Penicillium, Thielavia, Tolypocladium, or Trichoderma cell.
In a most preferred embodiment, the filamentous fungal host cell is an Aspergillus awamori, Aspergillus foetidus, Aspergillus japonicus, Aspergillus nidulans, Aspergillus niger, Aspergillus aculeatus, Aspergillus uvarum, Aspergillus aculeatinus, Aspergillus carbonarius or Aspergillus oryzae cell. In another most preferred embodiment, the filamentous fungal host cell is a Fusarium bactridioides, Fusarium cerealis, Fusarium crookwellense, Fusarium culmorum, Fusarium graminearum, Fusarium graminum, Fusarium heterosporum, Fusarium negundi, Fusarium oxysporum, Fusarium reticulatum, Fusarium roseum, Fusarium sambucinum, Fusarium sarcochroum, Fusafuim sporotrichiodes, Fusarium sulphureum, Fusarium torulosum, Fusarium trichothecioides, or Fusarium venentum cell. In an even more preferred embodiment, the filamentous fungal host cell is a Fusarium venentum (Nirenberg sp. nov.) cell. In another most preferred embodiment, the filamentous fungal host cell is a Humicola insolens, Humicola lanuginosa, Mucor miehei, Myceliophthora thermophila, Neurospora crassa, Penicillium purpurogenum, Thielavia terrestris, Trichoderma harzianum. Trichoderma koningii, Trichoderma longibrachiatum, Trichoderma reesei, or Trichoderma viride cell. In another even most preferred embodiment, the filamentous fungal host cell is Trichoderma reesei RutC3O.
It is understood that also the Aspergillus saccharolyticus of the present invention may serve as a host cell.
The fungal cell, into which the mixture of plasmid/fragment polynucleotide is to be introduced, may be any fungal cell useful in the present invention. A “recombination fungal cell” is defined herein as a cell capable of mediating shuffling of a number of homologous nucleotide sequences.
In a preferred embodiment, the fungal recombination cell is a yeast cell. In a more preferred embodiment, the yeast recombination cell is a Candida, Hansenula, Kluyveromyces, Pichia, Saccharomyces, Schizosaccharomyces, or Yarrowia cell.
In a most preferred embodiment, the yeast recombination cell is a Kluyveromyces lactis, Saccharomyces carlsbergensis, Saccharomyces cerevisiae, Saccharomyces diastaticus, Saccharomyces douglasi, Saccharomyces kluyveri Saccharomyces norbensis, Saccharomyces oviformis, or Yarrowia lipolytica cell.
In another preferred embodiment, the fungal recombination cell is a filamentous fungal cell. In a more preferred embodiment, the filamentous fungal recombination cell is an Acremonium, Aspergillus, Fusarium, Humicola, Mucor, Mycellophthora, Neurospora, Penicillium, Thielavia, Tolypocladium, or Trichoderma cell.
In a most preferred embodiment, the filamentous fungal recombination cell is an Aspergillus awamori, Aspergillus foetidus, Aspergillus japonicus, Aspergillus nidulans, Aspergillus niger, Aspergillus aculeatus, Aspergillus uvarum, Aspergillus aculeatinus, Aspergillus carbonarius or Aspergillus oryzae cell. In another most preferred embodiment, the filamentous fungal recombination cell is a Fusarium bactridioides, Fusarium cerealis. Fusarium crookwellense. Fusarium culmorum, Fusarium graminearum, Fusarium graminum, Fusarium heterosporum, Fusarium negundi, Fusarium oxysporum, Fusarium reticulatum, Fusarium roseum, Fusarium sambucinum, Fusarium sarcochroum, Fusarium sporotrichioides, Fusarium sulphureum, Fusarium torulosum, Fusarium trichothecioides, or Fusarium venenatum cell. In another most preferred embodiment, the filamentous fungal recombination cell is a Humicola Insolens, Humicola lanuginosa, Mucor miehei, Mycellophthora thermophila, Neurospora crassa, Penicillum purpurogenum, Thielavia terrestris, Trichoderma harzianum, Trichoderma koningli, Trichoderma longibrachiatum, Trichoderma reesei, or Trichoderma viride cell.
Fungal cells may be transformed by a process involving protoplast formation, transformation of the protoplasts, and regeneration of the cell wall in a manner known perse. Suitable procedures for transformation of Aspergillus and Trichoderma host cells are described in EP 238 023.
Method for Producing Polypeptide
The present invention also relates to methods of producing a polypeptide of the present invention. In one aspect, the invention relates to a method of producing a polypeptide, said method comprising cultivating a host cell or a microorganism of the present invention. Thus, the invention relates to a method of producing a polypeptide, said method comprising cultivating
a) a host cell of the present invention, such as a host cell comprising


    
    
        i) a polypeptide of the present invention, such as a polypeptide comprising
        
            an amino acid sequence selected from SEQ NO: 3, 4, 7, 10, and 13,
            a biologically active sequence variant of any of SEQ NO: 3, 4, 7, 10, and 13, wherein said variant has at least 92% sequence identity to said SEQ NO: 3, 4, 7, 10, and 13, or
            a biologically active fragment of at least 30 consecutive amino acids of any of the amino acid sequences of above;
        
        
        ii) a polynucleotide of the present invention, such as a polynucleotide comprising
        
            a polynucleotide sequence encoding a polypeptide consisting of an amino acid sequence SEQ ID NO: 3, 4, 7, 10, and 13, or
            a polynucleotide sequence encoding a biologically active sequence variant of the amino acid sequence, wherein the variant has at least 92% sequence identity to said SEQ ID NO: 3, 4, 7, 10, and 13, or
            a polynucleotide sequence encoding a biologically active fragment of at least 30 consecutive amino acids of any of the amino acid sequences of above, or
            SEQ ID NO.: 1, 2, 5, 6, 8, 9, 11, 12, 14, 15, 16 or 17, 29, or
            a polynucleotide comprising a nucleic acid sequence having at least 70% identity to SEQ ID NO: 1, 2, 5, 6, 8, 9, 11, 12, 14, 15, 16 or 17, or
            a polynucleotide hybridising to SEQ ID NO.: 1, 2, 5, 6, 8, 9, 11, 12, 14, 15, 16 or 17, 29, or
            a polynucleotide complementary to any of the above; or
        
        
        iii) a nucleic acid vector comprising a polynucleotide sequence of the present invention, such as a polynucleotide mentioned under ii); or

b) a microorganism of the present invention, such as a microorganism of the species Aspergillus saccharolyticus, such as the microorganism as deposited in the Centraalbereau voor Schimmelcultures (CBS) and having accession number CBS 127449, or a descendant or a functional mutant thereof

    
    


The produced polypeptide is then preferably recovered from the microorganism and/or host cell, and/or recovered from the incubation broth of the host cell and/or microorganism.
The method of the invention is suitable both for producing a polypeptide of the present invention, such as a BGL polypeptide, for example BGL1, BGL2, BGL3, and/or BGL 4, identified as SEQ ID NO: 3, 7, 10, and 13, respectively, as well as functional variants thereof. However, the method may also be used for producing other polypeptides. The microorganism of the present invention, such as Aspergillus saccharolyticus, is suitable for the expression of transgenes, and thus, a gene encoding any gene of interest may be introduced into the genome of Aspergillus saccharolyticus, and expressed by that microorganism, and recovered from the incubation broth and/or from an extract of the microorganism cells.
In one embodiment, a bgl gene of the microorganism of the invention has been replaced with a heterologous polynucleotide sequence encoding polypeptide to be produced according to the present method, wherein said polypeptide may be recovered. In a preferred embodiment, the bgl1 gene of a microorganism of the invention has been replaced with a heterologous polynucleotide sequence encoding said polypeptide to be recovered.
For facilitating the production of polypeptides, the host cell and/or microorganism may be genetically modified, as explained elsewhere herein. Such modification includes selection markers, polyadenylation signals etc.
However, the polypeptides of the present invention (e.g. those identified by SEQ ID NO: 3, 4, 7, 10, and/or 13 or variant thereof) may also in one embodiment be produced chemically by liquid-phase or solid-phase synthesis. In a preferred embodiment, however, the polypeptides are produced by biosynthesis, wherein the polypeptide is produced in a host organism, such as a microorganism comprising a nucleic acid sequence or vector encoding a polypeptide of the present invention.
Similarly, the polypeptide of the present invention may be extracted from Aspergillus saccharolyticus for example as described herein in the examples.
Method for Degrading a Lignocellulosic Material
In one aspect, the present invention relates to methods for degradation, conversion or hydrolysis of a lignocellulosic material. Thus, one aspect of the present invention relates to a method for degrading or converting a lignocellulosic material, said method comprising incubating said lignocellulosic material with at least one polypeptide as described herein, at least one microorganism as defined herein, at least on recombinant host cell as described herein, at least one composition as defined herein and/or at least one kit-of parts as defined elsewhere herein. After incubation, the degraded lignocellolosic material may be recovered.
In one embodiment, the invention relates to a method for degrading or converting a lignocellulosic material, said method comprising i) incubating said lignocellulosic material with at least one polypeptide as described herein, ii) recovering the degraded lignocellulosic material. The polypeptide is for example BGL1 (SEQ ID NO: 3), BGL2 (SEQ ID NO: 7), BGL3 (SEQ ID NO: 10), or BGL4 (SEQ ID NO: 13), or functional variants thereof.
Another embodiment of the invention relates to a method for degrading or converting a lignocellulosic material, said method comprising i) incubating said lignocellulosic material with at least one microorganism as defined herein and ii) recovering the degraded lignocellulosic material.
Yet another embodiment of the present invention relates to a method for degrading or converting a lignocellulosic material, said method comprising i) incubating said lignocellulosic material with at least one recombinant host cell as described herein and ii) recovering the degraded lignocellulosic material.
A further embodiment of the present invention relates to a method for degrading or converting a lignocellulosic material, said method comprising i) incubating said lignocellulosic material with at least one composition as defined herein and ii) recovering the degraded lignocellulosic material.
Yet a further embodiment of the present invention relates to a method for degrading or converting a lignocellulosic material, said method comprising i) incubating said lignocellulosic material with at least one kit-of parts as defined elsewhere herein and ii) recovering the degraded lignocellulosic material.
In one embodiment the lignocellulosic material is as defined elsewhere herein and obtained from straw, maize stems, forestry waste, sawdust and/or wood-chips.
The lignocellulosic material and at least one polypeptide, at least one microorganism, at least one recombinant host cell, at least one composition and/or kit-of parts is incubated at a temperature in the range from 40 degrees C. to 70 degrees C., preferably in the range from 40 degrees C. to 60 degrees C., more preferably in the range from 40 degrees C. to 50 degrees C. In preferred embodiment the incubation temperature is 50 degrees C. which is the most applied temperature for incubation. However, in one preferred embodiment the lignocellulosic material is incubated at temperatures above 50 degrees C., where the polypeptide of the present invention is still active in contrast to a number of known beta-glucosidases.
In one embodiment the method comprises treating said lignocellulosic material with at least one additional component. The at least one additional component is for example selected from the group consisting of cellulase, endogluconase, cellobiohydrolase, beta-glucosidase, hemicellulase, esterase, laccase, protease and peroxidise. It is appreciated that the at least one component in separate embodiments is cellulase, endogluconase, cellobiohydrolase, beta-glucosidase, hemicellulase, esterase, laccase, protease or peroxidise.
In one embodiment of the method of the present invention, said lignocellulosic material is at least partly converted or degraded to monosaccharide glucose units. In one embodiment at least 50% of said lignocellulosic material is converted or degraded to monosaccharide glucose units, more preferably at least 60%, preferably at least 70%, more preferably at least 80%, preferably at least 90%, more preferably 95%. Preferably 97% said lignocellulosic material is converted or degraded to monosaccharide glucose units
Moreover, the invention relates to a method of producing monosaccharides from a lignocellulosic material, said method comprising a) incubating the cellulosic material with at least one beta-glucosidase polypeptide of the invention, at least one recombinant host cell, at least one composition of the invention, at least one kit-of-parts, and/or at least one microorganism of the invention.
Given that the microorganism and/or host cell of the present invention are able to produce BGL polypeptide of high activity, the microorganism and/or hoist cell is suitable for on-site enzyme production, where the enzyme, such as BGL enzyme (e.g. BGL 1, BGL2, BGL3 and/or BGL4 or functional variants thereof) are produced on location as opposed to being delivered as a prepared enzyme solution. This is particularly useful because at least a part of the beta-glucosidase activity remains in the incubation broth of the microorganism. When the microorganism or host cell is used for on-site enzyme production, the degradation and/or conversion of a lignocellulosic material may be further facilitated by introducing an additional polynucleotide encoding a cellulase, an endogluconase, a cellobiohydrolase, a beta-glucosidase, a hemicellulase, an esterase, a laccase, a protease and/or a peroxidase.
Pretreatment of Solid Lignocellulosic Material
The first step in the process for converting solid lignocellulosic biomass material into lower saccharides, such as monosaccharides, involves preferably a pretreatment of the biomass, wherein the rigid structure of biomass are broken and the accessibility of the sugar polymers for the enzyme hydrolysis is increased. In one embodiment the pretreatment is subjecting the biomass to extreme temperatures, pressure and acid/base conditions or the milder biological approaches as described in Alvira et al 2010 Bioresour Technol 101, 4851-4861), Mosier el at 2005 Bioresour Technol 96, 673-686; Sun & Cheng 2002 Bioresour Technol 83, 1-11, hereby incorporated by reference.
Accordingly, the methods of the present invention for the degration and/or conversion of a lignocellulosic material preferably involve a step of pretreating the lignocellulosic material. The pretreatment include any treatment suitable for disrupting the rigid structure of the lignocellulosic raw material, and making sugar polymers accessible for enzymatic attack. For example, the pretreatment may include biological pretreatments physical pretreatments and chemical pretreatments, and combination thereof, including physico-chemical pretreatments.
In one embodiment, the method of the invention comprises pretreating the lignocellulosic material with an agent capable of converting said lignocellulosic material into cellobiose and/or cellodextrins. The agent is for example an acid, an endoglucanase and/or a cellobiohydrolase.
Biological pretreatments may involve fungal pretreatment, for example with lignin-degrading fungi, such as white-rot fungi such as Phanerochaete chrysosporium, Ceriporia lacerata, Cyathus stercolerus, Ceriporiopsis subvermispora, Pycnoporus cinnarbarinus and/or Pleurotus ostreaus. 
Physical pretreatments may involve mechanical comminution, where the average particle size and cristallinity of the lignocellulosic material is reduced in order to increase the specific surface and reduce the degree of polymerization. This can be achieved by combination of chipping, grinding or milling depending on the final particle size of the material (e.g. 10-30 mm after chipping and 0.2-2 mm after milling or grinding). Another physical pretreatment form is extrusion, where the lignocellulosic material is subjected to heating, mixing and shearing, resulting in physical and chemical modifications during the passage through the extruder. Screw speed and barrel temperature disrupt the lignocellulose structure causing defibrillation, fibrillation and shortening of the fibers, which increases the accessibility of carbohydrates to enzymatic attack.
Chemical pretreatments may involve alkali pretreatments, where the lignocellulosic material is treated with for example sodium, potassium, calcium and ammonium hydroxides. Another alternative is acid pretreatment, which serves to solubilize the hemicellulosic fraction of the biomass and to make the cellulose more accessible to enzymes. Acid pretreatment can be performed with concentrated or diluted acid but utilization of concentrated acid is less attractive for ethanol production due to the formation of inhibiting compounds. Furthermore, equipment corrosion problems and acid recovery are important drawbacks when using concentrated acid pretreatments. Other examples of chemical pretreatments are Ozonolysis (lysis with ozone), Organosolvation (treatment with organic or aqueous solvent mixtures), and Ionic liquids (ILs) (i.e. salts) pretreatment.
Various combinations of biological, physical and chemical pretreatments are also within the scope of the present invention. In one example the lignocellulosic material is subject to physico-chemical pretreatments, such as SO2-steam explosion, in which the biomass is subjected to pressurised steam for a period of time ranging from seconds to several minutes, and then suddenly depressurised. This pretreatment combines mechanical forces and chemical effects due to the hydrolysis (autohydrolysis) of acetyl groups present in hemicellulose.
In one embodiment, the pretreatment involves alkali treatment, in another preferred embodiment the pretreatment involves acid treatment. In yet another embodiment the pretreatment comprises a step of organosolv treatment. In a further embodiment the pretreatment involves steam-, ammonia fiber- or CO2 explosion, and/or wetoxidation. It is appreciated that any of the listed pretreatments can be used in separate embodiments or using one or more types of pretreatment in combination. A person skilled in the art knows how to pretreat biomass material prior to hydrolysis of cellulose, hemicelluse, cellobiose, cuclodextrin and/or pectin.
Further Processing of Degraded and/or Converted Lignocellulosic Material
By the method of the present invention, a lignocellulosic material is at least partly degraded to monosaccharide glucose units, and preferably, at least 50% of said lignocellulosic material is degraded to monosaccharide glucose units. Those monosaccharide glucose units may then be used for further chemical modification or processing, for chemical anabolism, and/or for generation of other chemical products.
So, in one embodiment, the monosaccharide glucose units are incubated with one or more fermenting microorganisms thereby producing a fermentation product. The fermenting microorganism is selected from any suitable microorganism, for example yeast, fungi or bacteria. The method may comprise obtaining at least one fermentation product from the fermentation. The at least one fermentation product is for example an alcohol, inorganic acid, organic acid, hydrocarbon, ketone, amino acid, and/or gas. The fermentation product is preferably recovered from the fermentation.
The monosaccharide glucose units may however, also be used for production of any chemical product, which normally requires glucose. In this way, the method of the present invention may be used for processes, which involved glucose, which is normally obtained from sources other than lignocellulosic material.
In one embodiment, the monosaccharide glucose units are used for the production of a chemical product selected from the group consisting of Formic Acid, Methanol, Carbon Monoxide (+H2 gives syngas), Carbon dioxide, Acetaldehyde, Acetic acid & anhydride, Ethanol, Glycine, Oxalic acid, Ethylene glycol, Ethylene oxide, Alanine, Glycerol, 3-Hydroxypropionic acid, Lactic acid, Malonic acid, Serine, Propionic acid, Acetone, Acetoin, Aspartic acid, Butanol, Fumaric acid, 3-Hydroxybutryolactone, Malic acid, Succinic acid, Threonine, Arabinitol, Furfural, Glutamic acid, Glutaric acid, Itaconic acid, Levulinic acid, Proline, Xylitol, Xylonic acid, Aconitic acid, Adipic acid, Citric acid, Fructose, 2,5 Furan dicarboxylic acid, Glucaric acid, Gluconic acid, Kojic & Comeric acid, Lysine, and/or Sorbitol. However, it is understood that the monosaccharide glucose units obtained from degradation/conversion of lignocellulosic material by a method of the present invention, may be used for any chemical process, and for the generation of any chemical product, wherein glucose is normally employed. In a preferred embodiment, the chemical product is isolated from the reaction.
Composition
The present invention also relates to compositions comprising one or more of the components of the present invention.
In one aspect, the present invention relates to a composition comprising
a) a polypeptide of the present invention, such as a polypeptide comprising


    
    
        an amino acid sequence selected from SEQ NO: 3, 4, 7, 10, and 13,
        a biologically active sequence variant of any of SEQ NO: 3, 4, 7, 10, and 13, wherein said variant has at least 92% sequence identity to said SEQ NO: 3, 4, 7, 10, and 13, or
        a biologically active fragment of at least 30 consecutive amino acids of any of the amino acid sequences of a) through b;

b) a polynucleotide of the present invention, such as a polynucleotide comprising

        a polynucleotide sequence encoding a polypeptide consisting of an amino acid sequence SEQ ID NO: 3, 4, 7, 10, and 13,
        a polynucleotide sequence encoding a biologically active sequence variant of the amino acid sequence, wherein the variant has at least 92% sequence identity to said SEQ ID NO: 3, 4, 7, 10, and 13, and
        a polynucleotide sequence encoding a biologically active fragment of at least 30 consecutive amino acids of any of the amino acid sequences of a) through b), or
        SEQ ID NO.: 1, 2, 5, 6, 8, 9, 11, 12, 14, 15, 16, 17, or 29, or
        a polynucleotide comprising a nucleic acid sequence having at least 70% identity to SEQ ID NO: 1, 2, 5, 6, 8, 9, 11, 12, 14, 15, 16, 17, or 29, or
        a polynucleotide hybridising to SEQ ID NO.: 1, 2, 5, 6, 8, 9, 11, 12, 14, 15, 16, 17, or 29, and
        a polynucleotide complementary to any of the above;

c) a nucleic acid vector comprising a polynucleotide sequence of the present invention, such as a polynucleotide mentioned under b)

d) a host cell of the present invention, such as a host cell comprising a polypeptide mentioned under a), a polynucleotide of the present invention, such as mentioned under b) and/or a recombinant nucleic acid vector of the present invention, such as mentioned under c),

e) a microorganism of the species Aspergillus saccharolyticus, such as the microorganism as deposited in the Centraalbereau voor Schimmeicultures (CBS) and having accession number CBS 127449, or a descendant or a functional mutant thereof

    
    


In another aspect, the invention relates to a composition comprising a beta-glucosidase polypeptide of the present invention, or a biologically active variant or fragment thereof.
Thus, one aspect of the present invention, relates to a composition comprising a beta-glucosidase polypeptide of the present invention as defined previously herein. The composition preferably comprises a carrier/buffer. A non-limiting example of a suitable buffer is a citrate-phosphate buffer with pH in the range of 4 to 5.
Kit of Parts
The present invention in one aspect relates to a kit-of parts comprising at least one polypeptide of the present invention, at least one recombinant nucleic acid vector of the present invention, at least one recombinant host cell of the present invention, at least one isolated microorganism of the present invention, and/or at least one composition of the present invention, and at least one additional component.
In one embodiment the additional component is selected from the group consisting of cellulase, endogluconase, cellobiohydrolase, beta-glucosidase, hemicellulase, esterase, laccase, protease and peroxidise.
In one embodiment the kit-of-parts comprises at least one additional component. Such additional component is for example selected from enzymes degrading cellulose, such as endoglucanase, endo 1-4 β-glucanase, cellobiohydrolase, exo-1-4 β-glucanase, β-glucosidase, enzymes degrading hemicellulose of both the O-acetyl-4-O-methylglucoronoxylan-type e.g endoxylanase, acetylxylane-esterase, α-glucuronidase, β-xylosidase, α-arabinosidase or the O-acetylgalactoglucomannan-type such as endomannan, α-galactosidase, acetylglucomannan-esterase, β-mannosidase, β-glucosidase, enzymes degrading lignin e.g. lignin peroxidase, manganese peroxidase, laccase), enzymes degrading pectin e.g. endo-polygalacturonidases, exo-polygalacturonidase, rhamno-galacuronidase, pectinlyase, rhamnogalacturonan-lyase, pectin-methylesterase, rhamnogalacturonanacetylesterase, oligo-galacturonan-lyase, enzymes degrading starch such as α-amylase, β-amylase, isoamylase, pullulanase, α-1-6-glucanhydrolase) or any other reserve hydrocarbon such as, for example but not exclusively, fructans, inulin, chitin, chitosan, planteose, legumin, xyloglucan, mannan or laminaran.
In a preferred embodiment, the additional component is endoglucanase (EC 3.2.1.4). Another preferred embodiment, the additional component is cellobiohydrolase (EC 3.2.1.91).
It is appreciated that at least one, such as at least two, for example at least 3, such as at least 4, for example at least 5, such as at least 6, for example at least 7, such as at least 8, for example at least 9 additional components and that different groups of additional components may be used in combination such as at least one endoglucanase and at least one cellobiohydrolase.
In one embodiment, the at least one additional component is selected from cellulases, such as Accellerase®, Celluclast®, Cellic CTec2®, and/or AcelleraseDUET®.
The components of the kit-of parts of the present invention are packaged or marked for use together.
In one embodiment, the kit-of-parts can contains two components in one container, and a third component and any additional components in one or more separate containers. Optionally, a kit-of-parts further contains instructions for combining the components so as to formulate composition suitable for degradation or conversion of a cellulosic material, for hydrolyzing a polysaccharide and/or for fermenting a cellulosic material.
The components of the kit-of-parts are preferably comprised in individual compositions, it is however within the scope of the present invention that the components of the kit-of-parts all are comprised within the same composition.
In one embodiment, the kit-of-parts preferably comprises an adjuvant and/or a carrier. The choice of carrier depends on the specific use of the kit-of parts and will be obvious for those of skill in the art.
A carrier may be present independently of an adjuvant. The function of a carrier can for example be to increase the molecular weight of in particular peptide fragments in order to confer stability, to increase the biological activity, or to increase half-life.
The compositions provided by the kits-of-parts of the present invention may be used simultaneously or sequentially.
Additional Component
In the methods of the present invention for degrading a lignocellulosic material, the lignocellulosic material may also be treated with at least one additional component, Such additional component is for example selected from enzymes degrading cellulose, such as (endoglucanase, endo 1-4 β-glucanase, cellobiohydrolase, exo-1-4 β-glucanase, β-glucosidase), hemicellulose of both the O-acetyl-4-O-methylglucoronoxylan-type (endoxylanase, acetylxylane-esterase, α-glucuronidase, β-xylosidase, α-arabinosidase) or the O-acetylgalactoglucomannan-type (endomannan, α-galactosidase, acetylglucomannan-esterase, β-mannosidase, β-glucosidase), lignin (lignin peroxidase, manganese peroxidase, laccase), pectin (endo-polygalacturonidases, exo-polygalacturonidase, rhamno-galacuronidase, pectinlyase, rhamnogalacturonan-lyase, pectin-methylesterase, rhamnogalacturonanacetylesterase, oligo-galacturonan-lyase), starch (α-amylase, β-amylase, isoamylase, pullulanase, α-1-6-glucanhydrolase) or any other reserve hydrocarbon such as, for example but not exclusively, fructans, inulin, chitin, chitosan, planteose, legumin, xyloglucan, mannan or laminaran.
In a preferred embodiment, the additional component is endoglucanase (EC 3.2.1.4). Another preferred embodiment, the additional component is cellobiohydrolase (EC 3.2.1.91). It is appreciated that at least one, such as at least two, for example at least 3, such as at least 4, for example at least 5, such as at least 6, for example at least 7, such as at least 8, for example at least 9 additional components and that different groups of additional components may be used in combination such as at least one endoglucanase and at least one cellobiohydrolase.
The products of the cellulosic material degradation or conversion methods of the present invention may be used for a number of subsequent purposes.
In one aspect of the invention, the glucose monosaccharide products are used in a method for fermenting a cellulosic material, said method comprising

    
    
        a. treating the cellulosic material with at least one polypeptide of the present invention, at least one recombinant host cell of the present invention, at least one microorganism of the present invention, at least one composition of the present invention, at least one kit-of parts of the present invention, and
        b. incubating the treated cellulosic material with one or more fermenting microorganisms.
        c. obtaining at least one fermentation product
    
    


In one embodiment the fermentation product is at least one alcohol, inorganic acid, ketone, amino acid, organic acids, hydrocarbons and/or gas.
EXAMPLES
The following examples are provided by way of illustration only and not by way of limitation. Those of skill in the art will readily recognize a variety of noncritical parameters that could be changed or modified to yield essentially similar results. The examples are offered for illustrative purposes only, and are not intended to limit the scope of the present invention in any way. Efforts have been made to ensure accuracy with respect to numbers used (e.g., amounts, temperatures, etc.), but some experimental error and deviation should, of course, be allowed for.
All publications and patent applications cited in this specification are herein incorporated by reference as if each individual publication or patent application were specifically and individually indicated to be incorporated by reference.
Although the foregoing invention has been described in some detail by way of illustration and example for purposes of clarity of understanding, it will be readily apparent to one of ordinary skill in the art in light of the teachings of this invention that certain changes and modifications may be made thereto without departing from the spirit or scope of the invention as defined in the appended claims.
Example 1
Discovery of a New Prominent Beta-Glucosidase Producing Aspergillus sp
Fungal Samples
This example comprises fungal samples from many different sources, including new isolations and “previously isolated fungi. Table 1 specifies strain numbers, identity, identification method, origin, and reference of each sample. New fungal isolates were from soil and decaying wood samples, isolated by multiple transfers on potato broth agar (PDA) plates supplemented with 50 ppm chloramphenicol and 50 ppm kanamycin, incubated at room temperature. Samples isolated in this work were all identified by ITS sequencing, using the method described below. All fungi were grown on potato dextrose agar (PDA, Sigma) at room temperature and maintained in 10% glycerol at −80° C.
The following Aspergilli reference strains were kindly donated by Professor Jens C. Frisvad, Technical University of Denmark: A. niger CBS 554.65T, A. homomorphus CBS 101889T. A. aculeatinus CBS 121060T, A. aculeatus CBS 172.66T, A. uvarum CBS 121591T, and A. japonuicus CBS 114.51T.







TABLE 1







Fungi included in the beta-glucosidase screening










Identity (strain number)
ID method1
Origin
Reference2





Alternaria radicina (R27)
M
Poland
K. Tylkowska


A. radicina (R28)
M
Poland
K. Tylkowska


Alternaria sp. (AS1-2)
ITS
Jamaica
This work


Amorphothea resinae (Anja)
ITS
Denmark
This work


Aspergillus sp (AP)
ITS
Denmark
This work. (Sorensen et al.,)


Aspergillus sp. (1259)
M
Costa Rica
(Danielsen, 1997)


A. fumigates (AS3-1)
ITS
Jamaica
This work


A. fumigatus (AS11-2)
ITS
Jamaica
This work


A. fumigatus (AS11-3)
ITS
Jamaica
This work


A. fumigatus (AS12)
ITS
Jamaica
This work


A. fumigatus (AS2-3)
ITS
Jamaica
This work


A. fumigatus (AS2-3)
ITS
Jamaica
This work


A. fumigatus (AS9-7)
ITS
Jamaica
This work


A. fumigatus (AS11-4)
ITS
Jamaica
This work


A. niger (Hj1)
ITS
Denmark
This work. (Sorensen et al.,)


A. niger (IBT25747)
ITS
Not known
This work. (Sorensen et al.,)


A. terreus (AS4-1)
ITS
Jamaica
This work


A. terreus (AS9-2)
ITS
Jamaica
This work


Chaetomium aureum (1165)
M
Costa Rica
(Danielsen, 1997)


C. globosum (11.4 kont)
ITS
Denmark
This work. (Sorensen et al.,)


Cladosporium sp. (1160)
M
Costa Rica
(Danielsen, 1997)


Cladosporium sp. (1209)
M
Costa Rica
(Danielsen, 1997)


Cladosporium sp. (1195)
M
Costa Rica
(Danielsen, 1997)


Cladosporium sp. (1208)
M
Costa Rica
(Danielsen, 1997)


C. cladosporiades (2.1)
ITS
Denmark
This work. (Sorensen et al.,)


Clanostachys rosea (IBT9371)
M, UP-PCR
Denmark
(Bulat et al., 1998)


C. rosea (Gr3)
M, UP-PCR
Denmark
(Bulat et al., 1998)


C. rosea (Gr5)
M, UP-PCR
Denmark
(Bulat et al., 1998)


Colletotrichum acutatum (9955)
ITS
Denmark
T. Sundelin


C. acutatum (F5-3)
ITS
Costa Rica
(Schiller et al., 2006)


C. acutatum (F7-1)
ITS
Costa Rica
(Schiller et al., 2006)


C. acutatum (Lupin1A)
ITS
Not known
T. Sundelin


C. acutatum (SA2-2)
ITS
Denmark
(Sundelin et al., 2006)


C. gloeosporioides (2133A)
ITS
Denmark
T. Sundelin


Coprinopsis cinerea (AS2-2)
ITS
Jamaica
This work


Drechslera sp. (1178)
M
Costa Rica
(Danielsen, 1997)


Fusarium sp. (3.012)
M
Denmark
I. Weiergang


Fusarium sp. (3.015)
M
Denmark
I. Weiergang


F. avenaceum/trincinctum (1.8.1)
ITS
Denmark
This work. (Sorensen et al.,)


F. culmorum (IBT9615)
M
Norway
(Tobiasen at al., 2007)


F. equiseti (1236)
M
Costa Rica
(Danielsen, 1997)


F. graminearum (1237)
M
Costa Rica
(Danielsen, 1997)


F. graminearum (NRRL31084)
M
USA
(Tobiasen at al., 2007)


F. graminearum (IBT9203)
M
Costa Rica
(Tobiasen at al., 2007)


F. moniliforme (1247)
M
Costa Rica
(Danielsen, 1997)


F. moniliforme (1258)
M
Costa Rica
(Danielsen, 1997)


F. oxysporum (1244)
M
Costa Rica
(Danielsen, 1997)


F. oxysporum f.s.p. pisi (88.001)
M
Denmark
I. Weiergang


F. semitectum (1232)
M
Costa Rica
(Danielsen, 1997)


F. semitectum (1242)
M
Costa Rica
(Danielsen, 1997)


Nigrospora sp. (1168)
M
Costa Rica
(Danielsen, 1997)


Penicillium sp. (1219)
M
Costa Rica
(Danielsen, 1997)


P. chrysogenum or P. commune (11.5)
ITS
Denmark
This work, (Sorensen et al.,)


P. chrysogenum or P. commune (2.3A)
ITS
Denmark
This work, (Sorensen et al.,)


P. paneum (14)
ITS
Denmark
This work, (Sorensen et al.,)


P. paneum (2.8)
ITS
Denmark
This work, (Sorensen et al.,)


P. spinolosum (1.6)
itS
Denmark
This work, (Sorensen et al.,)


P. spinolosum (2.38)
ITS
Denmark
This work, (Sorensen et al.,)


P. spinolosum (9.3.2)
ITS
Denmark
This work, (Sorensen et al.,)


P. spinolosum (9.4.2)
ITS
Denmark
This work, (Sorensen et al.,)


P. swiecickii or P. raistrickii (11.4)
ITS
Denmark
This work, (Sorensen et al.,)


Pestalotiopsis sp. (1220)
M
Costa Rica
(Danielsen, 1997)


Pestalotiopsis sp. (1226)
M
Costa Rica
(Danielsen, 1997)


Rhizoctonia solani (C596)
M, UP-PCR
Japan
(Lubeck & Poulsen, 2001)


R. solani (ST-11-6)
M, UP-PCR
Japan
(Lubeck & Poulsen, 2001)


R. solani (AH-1)
M, UP-PCR
Japan
(Lubeck & Poulsen, 2001)


R. solani (RH165)
M
Japan
(Lubeck & Poulsen, 2001)


R. solani (GM10)
M, UP-PCR
Japan
(Lubeck & Poulsen, 2001)


Binuclear Rhizoctonia (S21)
M
USA
(Lubeck & Poulsen, 2001)


Binuclear Rhizoctonia (SN-1-2)
M
Japan
(Lubeck & Poulsen, 2001)


Rhizopus microsporum (A51-1A)
ITS
Jamaica
This work


R. microsporum (A51-1B)
ITS
Jamaica
This work


R. microsporum (A52-4)
ITS
Jamaica
This work


Spaeropsidales (1190)
M
Costa Rica
(Danielsen, 1997)


Stenocarpella sp. (1198)
M
Costa Rica
(Danielsen, 1997)


Stenocarpella sp. (1214)
M
Costa Rica
(Danielsen, 1997)


Stenocarpella sp. (1239)
M
Costa Rica
(Danielsen, 1997)


Thielavia sp. (AS11-1)
ITS
Jamaica
This work


Trichoderma harzianum (5.1)
ITS
Denmark
This work, (Sorensen et al.,)


T. harzianum (O7)
M
Costa Rica
(Danielsen, 1997)


T. harzianum (IBT9385)
M, UP-PCR
Sweden
(Bulat et al., 1998)


T. koningii (1211)
M
Costa Rica
(Danielsen, 1997)


T. koningii (CB5850.68)
M, UP-PCR
Germany
(Bulat et al., 1998)


T. virens (I10)
ITS
Italy
(Sarrocco et al., 2006)


T. viride (IBT8186)
M, UP-PCR
Denmark
(Bulat et al., 1998)


T. viridescens (7.1)
ITS
Denmark
This work, (Sorensen et al.,)





1Identification method: M = morphology, ITS = ITS and NCBI NCBI Blast of search, UP-PCR = PCR finger printing


2Where names are found instead of reference numbers, the fungal strains have not previously been published, but identified by the person specified. Prof. Krystyna Tylkowska, August Cheszkowski Agricultural University of Poznan, Poland, Thomas Sundelin, University of Copenhagen, DK, Inge Weiergang, Maribo Seed, Nordzucker AG.






Beta-Glucosidase Screening

For beta-glucosidase activity screening, three 0.5×0.5 cm squares were cut from PDA plates with 7 days old single fungal strains and incubated in liquid culture of 20 g/l wheat bran (Finax), 20 g/l corn steep liquor (Sigma), 3 g/l NaNO3, 1 g/l K2HPO4, 0.5 g/l KCl, 0.5 g/l MgSO47H2O, 0.01 g/l FeSO47H2O in a Falcon tube set-up with 10 ml of media shaking (180 rpm) at room temperature for another 7 days. The samples were centrifuged at 10,000 rpm for 10 min and the supernatants were subsequently assayed for beta-glucosidase activity and protein content.
Beta-glucosidase assay was carried out using 5 mM p-nitrophenyl-beta-D-glucopyranoside (pNPG) in 50 mM Na-Citrate buffer pH 4.8 as substrate for measuring beta-glucosidase activity. 15 μl sample and 150 μl substrate was incubated at 50° C. for 10 min in 200 μl PCR tubes in a thermocycler (Biorad); 30 μl of the reaction was transferred to a microtiter plate already containing 50 μl 1M Na2CO3 for termination of the reaction. Absorbance was read at 405 nm in a plate reader (Dynex Technologies Inc.). pNP was used to prepare a standard curve. One unit (U) of enzyme activity was defined as the amount of enzyme needed to hydrolyze 1 μmol pNPG in 1 minute. Protein quantification was done using the Pierce BCA protein assay kit microplate procedure according to manufacturer's instructions (Pierce Biotechnology).
Identification of Fungi Using Sequencing of ITS1 Region
DNA extraction was carried out by the method of Dellaporta et al. 1983, using bead beating (2×20 sec) of fungal biomass in extraction buffer (500 mM NaCl, 100 mM Tris pH8, 50 mM EDTA, 1 mM DTT) and 1×20 sec with SDS added to final concentration of 2%. Protein and cell debris was precipitated with potassium acetate at a final concentration of 1.4 M. DNA was precipitated with equal volumes of sample and 2-propanol, followed by washing with 70% ethanol, and finally resuspended in water. Two fungal primers ITS1 (5′ TCCGTAGGTGAACCTGCGG 3′) and ITS2 (5′ GCTGCGTTCTTCATCGATGC 3′) that match the conserved 18S and 5.8S rRNA genes, respectively, were used for the amplification of the non-coding IST1 region (White et al., 1990, Kumar et al., 2008). Approx 100 ng genomic DNA was used as template in a polymerase chain reaction with 1 U proof reading WALK polymerase (A&A Biotechnology), PCR buffer (50 mM Tris pH8, 0.23 mg/ml BSA, 0.5% Ficoll, 0.1 mM cresol red, 2.5 mM MgCl2), 0.2 mM of dNTP, 0.4 μM of each primer ITS1 and ITS2. Using a thermocycler (BioRad), an initial denaturation step (94° C., 2 min) was followed by 35 cycles of denaturation (94° C., 30 sec), annealing (60° C., 30 sec), and elongation (72° C. 1 min), and a final elongation step (72° C., 2 min) following the last cycle. All products were checked by gel electrophoresis for a band size of approx. 600 bp. Depending on the purity of the sample, either GelOut or CleanUp was performed (EZNA kits from Promega) according to the manufacturer's instructions. DNA sequencing was performed by either MWG Eurofins, Germany or Starseq, Germany, directly sequencing the PCR products with the ITS1 or ITS4 primer. The sequence data was submitted to the GenBank NCBI nucleotide NCBI Blast of search database for fungal identification.
Molecular Phylogeny
Phylogenetic analysis of the ITS1 region of the fungus AP/Aspergillus saccharolyticus and different Aspergilli was carried out as described by Varga et al. (2007) and Samson et al. (2007). ClustalW multiple alignment was used for sequence alignment and manual improvement of the alignment was performed using BioEdit (http://www.mbio.ncsu.edu/BioEdit/bioedit.html). The PHYLIP program package version 3.69 was used for preparation of phylogenetic trees (Felsenstein, 2004). The distance matrix of the data set was calculated based on the Kimura method (Kimura, 1983) using the program “Dnadist”. The phylogenetic tree was prepared by running the program “Neighbor” using the neighbor-joining method (Saitou & Nei, 1987) to obtain an unrooted trees. A. flavus was defined as the outgroup in the program “Retree”, and finally the tree was visualized using the program TreeView (win32) (Page, 1996). Bootstrap values (Felsenstein, 1985) were calculated by running the program “Seqboot” to produce 1000 bootstrapped data sets from the original data set. Again, “dnadist” with the Kimura method was used to prepare distance matrices of the multiple data sets, and “neighbor” with the neighbor-joining method to obtain unrooted trees of the multiple data sets. Finally, the bootstrap values were obtained from the consensus tree which was identified by the majority-rule consensus method by running the program “Consense”.
Strain AP/Aspergillus saccharolyticus, Culture Conditions and Enzyme Extract Preparation
The fungal strain AP/Aspergillus saccharolyticus was grown on potato dextrose agar (Sigma) for sporulation. Spores were harvested after 7 days of growth by adding sterile water to the plate and scrape on the surface of the culture. The heavy spore suspension was filtered through Myra cloth. Two ml of the spore solution was inoculated into 200 ml seed medium (2.0 g/l wheat bran, 5 g/l corn steep powder, 0.25 g/l yeast extract, 0.75 g/l peptone, 1.4 g/l (NH4)2SO4, 2.0 g/l KH2PO4, 0.4 g/l CaCl2 2H2O, 0.3 g/l MgSO4 H2O, 5.0 mg/l FeSO4, 1.6 mg/l MnSO4 7H2O, 1.4 mg/l ZnSO4 7H2O, 2.0 CoCl2 6H2O) in an 500 ml Erlenmeyer flask, and incubated at 30° C. for 2 days, shaking at 160 rpm. Solid state fermentation at approximately 30% TS was carried out adding 100 ml of the cultivated seed medium to 1 l of a solid state fermentation medium comprising of 343 g wheat bran (TS of 87.4%), 9 g corn steep powder, 557 ml Czapek liquid (3 g/l NaNOa, 1 g/l K2HPO4, 0.5 g/l KCl, 0.5 g/l MgSO4 7H2O, 0.01 g/l FeSO4 7H2O) (Samson et al., 2004a). Incubation was carried out in large flat boxes (20 cm×20 cm×5 cm) in order to allow a large surface area where the fermentation media had a height of approx. 2 cm. The samples were incubated at 30° C. without shaking. After 7 days incubation, liquid was extracted from the medium by pressing the medium by hand using gloves. The extract was centrifuged at 10000 g, and the supernatant filtered through Whatman filter paper.
Beta-Glucosidase Activity Assays
In this work specific activity (U/mg) is defined as units per amount of total protein. Specific beta-glucosidase activity was measured using two different substrates: pNPG and cellobiose. The assay using 5 mM pNPG in NaCitrate buffer pH 4.8 was performed as previously described; enzyme samples were assayed at different concentrations in triple determination to ensure substrate saturation in the assay. The assay using 6 mM cellobiose in 50 mM NaCitrate buffer pH 4.8 was performed as follows: 15 μl sample and 150 μl substrate was incubated at 50° C. for 10 min in PCR tubes in a thermocycler; 50 μl of the reaction was transferred to a HPLC vial already containing 1 ml 100 mM NaOH for termination of the reaction. The glucose concentration was measured at Dionex ICS3000 using gradient elution: 0-20% eluent B (0.5M NaAcetate in 100 mM NaOH) in 13 min followed by 2 min washing with 50% eluent B and 5 min re-equilibrating with 100% eluent A (100 mM NaOH). Samples were assayed at different concentrations in triple determination to ensure substrate saturation in the assay.
Kinetic Studies
For performing Michaelis-Menten kinetics beta-glucosidase activity was measured as described above, but using different substrate concentrations (pNPG 0.1-10 mM, cellobiose 0.2-18 mM), and with an enzyme dilution that ensured substrate saturation was reached within this range. Triple determinations were performed. A substrate saturation curve was prepared by plotting substrate concentration [S] vs reaction rate, v. The Michealis Menten constants Km and Vmax were determined from Hanes-Wolf plots where substrate concentration [S] is plotted against substrate concentration over reaction rate [S]/v, and the linear relationship of the data gives a slope of 1/Vmax, a y-intercept of Km/Vmax, and an x-intercept of −Km.
Glucose Tolerance
For testing glucose tolerance, 5 mM pNPG in NaCitrate buffer pH 4.8 was used as substrate with different glucose amounts added, ranging final glucose concentrations of 0-280 mM. The remaining activity (glucose tolerance) was measured spectrophotometrically by release of pNP at 50° C. reaction conditions, as described earlier. Triple determinations were performed. Using 20 mM cellobiose in NaCitrate buffer pH 4.8 as substrate and glucose concentrations ranging from 0-120 mM, 15 μl sample and 150 μl substrate with the different glucose concentrations was incubated at 50° C. for 10 min in PCR tubes in a thermocycler; 100 μl of the reaction was transferred to a tube already containing 100 μl 200 mM NaOH for termination of the reaction. The reactions were further diluted 512 times and final cellobiose concentration was measured at Dionex ICS3000 using gradient elution: 0-20% eluent B in 13 min followed by 2 min washing with 50% eluent 8 (0.5 M NaAcetate in 100 mM NaOH) and 5 min re-equilibrating with 100% eluent A (100 mM NaOH). The activity was calculated by the amount of cellobiose being hydrolyzed. Triple determinations were performed.
pH and Temperature Profile
For testing the thermostability of the enzyme extract, aliquots of the extracts were incubated in PCR tubes in a thermocycler with temperature gradient option at 12 different temperatures from 48.5 to 67.0° C. for different time periods (0-4 hours) followed by assaying the activity at 50° C. with 5 mM pNPG in NaCitrate buffer pH 4.8 as substrate. The rate of denaturation, kD, was calculated as the slope of a semi-logarithmic plot of remaining activity vs incubation time. The half life was calculated as: T1/2=ln(2)/kD.
For testing the pH optimum of the enzyme extracts, they were assayed at 50° C. with 5 mM pNPG in Citrate Phosphate buffer at different pH ranging from 2.65 to 7.25. Endoglucanase activity of Celluclast 1.5 L was assayed with AZO-CMC as described by the manufacturer (Megazyme), but testing the same pH range 2.65-7.25 as for the pNPG assay.
Hydrolysis of Cellodextrins
Hydrolysis of cellohexaose was carried out by mixing, in the ratio 1:1, 0.2 mM cellohexaose in 50 mM NaCitrate buffer pH 4.8 and enzyme diluted in 50 mM NaCitrate buffer pH 4.8 to a concentration of 3.7 μg/ml. The reaction was incubated at 50° C. and for a period of 30 min, 100 μl sample was placed on ice every 5 min. 100 μl 200 mM NaOH was added to terminate the reaction, and after another 1 fold dilution with 100 mM NaOH, the samples were analyzed at Dionex ICS3000 using gradient elution: 0-30% eluent B in 26 min followed by 2 min washing with 50% eluent B (0.5 M NaAcetate in 100 mM NaOH) and 5 min re-equilibrating with 100% eluent A (100 mM NaOH).
Hydrolysis of Pretreated Bagasse
Pretreated bagasse was kindly provided by BioGasol, Denmark. The bagasse had been pretreated using wet explosion (personal communication with BioGasol). Bagasse hydrolysis was carried out in 2 ml Eppendorf tubes in thermoshaker heating blocks. The pretreated bagasse was hydrolyzed at 5% dry matter (DM) with a total enzyme load of 10 mg protein per g DM. The ratio amount of Celluclast 1.5 L vs extract from strain AP/Aspergillus saccharolyticus or Novozym 188 was varied, ranging 0-100% of one compared to the other. The hydrolysis was carried out at 50° C. for 24 hours, using triple determinations. The samples were centrifuged and supernatants filtered through 0.45 μm filters before sugar analysis using the Ultimate 3000 HPLC (see below).
Analytical Equipment
DionexICS-3000 equipped with an amperometric detector using a gold working electrode and an Ag/AgCl pH reference electrode was used for measuring glucose, cellobiose, and cellooligomers by ionexchange chromatography, acquiring and interpreting data with the Chromeleon software (Dionex). 10 μl samples were run on a CarboPac PA1 column with 100 mM NaOH as eluent A and 0.5 M NaAcetate in 100 mM NaOH as eluent B. Gradient runs were performed as described in the different assays, all at a flow rate of 1 ml/min. Standards of glucose, cellobiose, -triose, -tetraose, -pentaose, and -hexaose were run at concentrations 3.125 μM-0.1 mM. Ultimate 3000 HPLC equipped with RI-101 detector (shodex) was used for measuring glucose and cellobiose by high pressure liquid chromatography, acquiring and interpreting data with the Chromeleon software (Dionex). 10 μl samples were run on a BIORAD aminex HPX-87H ion exclusion column, heated to 60° C., run with 4 mM H2SO4 as eluent at flow rate 0.6 ml/min. Standards of glucose and cellobiose were run at concentration 0.5-20 g/l.
Results
Beta-Glucosidase Activities in Broad Screening
Eighty six filamentous fungal strains, spanning 19 different fungal genera, were screened for extracellular beta-glucosidase activity using pNPG as substrate; most of the screened fungi belonging to the ascomycota phylum (Table 1). The screening showed a great variety in activity levels, with a few strains being remarkably better than the others (FIG. 1). All produced extracellular beta-glucosidase, though for about 35% of the assayed fungi the activity was negligible (<0.1 U/ml). Some genus tendencies are seen, with Aspergillus, a few Fusarium, Penicillium, and Trichoderma viridescens showing greatest beta-glucosidase activity at the assayed conditions. Where several strains belonging to same species were assayed, the variation at species level was in most cases insignificant, except for A. niger where a great variation was observed within the two strains, the stain Hj1 showing approximately two times the activity of strain F1.
Strain number AP (identified as an Aspergillus sp or Aspergillus saccharolyticus) and strain number Hj1 (identified as an Aspergillus niger) showed significantly greater activity than all other strains assayed at these conditions, with strain AP/Aspergillus saccharolyticus reaching more than ten times greater activity than the average of all the stains assayed.
Identity of the Prominent Beta-Glucosidase Producing Aspergillus sp.
Primers matching the conserved 18S and 5.8S rRNA genes were used for the amplification of the non-coding ITS1 region. A GenBank NCBI NCBI Blast of of the ITS1 sequence of strain AP/Aspergillus saccharolyticus resulted in the closest hit being the black aspergilli, A. kanagawaensis, A. pervulus, A. cervinus, A. eculeatus, A. violaceofucus, A. japonicus, and A. bahamensis, but only with an identity of 81-79%.
Strain AP/Aspergillus saccharolyticus was phylogenetically studied by preparing a phylogenetic tree of the ITS1 region of strain AP/Aspergillus saccharolyticus, some of the aspergilli mentioned above as well as other selected aspergilli in the section Nigri based on the work by Samson et al (2007) (FIG. 2). This placed AP/Aspergillus saccharolyticus on its own branch far from the other aspergilli. This low percentage identity of the strain AP/Aspergillus saccharolyticus compared to the data in the NCBI database and its location on a separate branch in the phylogenetic tree, clearly indicates that the strain AP/Aspergillus saccharolyticus is an unknown species.
Aspergillus Screening
The beta-glucosidase activity of the prominent Aspergillus sp (strain AP/Aspergillus saccharolyticus) was compared to neighbor Aspergilli in the submerged fermentation set up using wheat bran as growth medium as described in the screening. A. niger was specifically included as this fungus is a known and industrially used beta-glucosidase producer (Dekker, 1986). Based on the phylogenetic tree, the data is arranged so the column furthest from strain AP/Aspergillus saccharolyticus is the most distantly related strain in this Aspergillus screening. At the conditions tested, AP/Aspergillus saccharolyticus produces significantly greater amount of beta-glucosidase activity (FIG. 3). The protein levels (data not shown) in the assayed extracts did not vary much compared to the difference seen in enzyme activity. Relative to the other Aspergilli tested, strain AP/Aspergillus saccharolyticus is therefore more specialized towards beta-glucosidase productions at the tested conditions.
Potential of Strain AP/Aspergillus saccharolyticus Enzyme Extract Compared with Commercial Enzymes
A solid state fermentation extract of the strain AP/Aspergillus saccharolyticus was compared to the commercially available Novozym 188, Celluclast 1.5 L, and Cellic CTec (Novozymes AS, Denmark). Solid state fermentation was chosen to obtain as concentrated an extract as possible. In the previous screening, pNPG activity of 6.6 U/ml (FIG. 3) and specific activity or 3.1 U/mg total protein (data not shown) were obtained for the submerged fermentation of strain AP/Aspergillus saccharolyticus. With the solid state fermentation, a pNPG activity of 105 U/ml and a specific activity of 5.7 U/mg total protein were obtained. The volume based activity is naturally increased as the water content of solid state is severely reduced compared to submerged fermentation. However, there is no definite conclusion whether the difference in specific activity (U/mg protein) is due to the solid state fermentation favoring the expression of specifically beta-glucosidase proteins or whether the wheat bran proteins in the extracts originating from the medium make up a larger percentage of the total proteins measured in one case compared to the other and thereby cause the difference observed in specific activity.
As the enzyme extract of strain AP/Aspergillus saccharolyticus is intended for use in combination with Celluclast 1.5 L for complete hydrolysis of cellulosic biomasses, the working pH must match the pH profile of Celluclast 1.5 L cellulose activity. Within pH 4.5-6 Celluclast activity stays above 90% of maximum activity measured (FIG. 4). The pH span of strain AP/Aspergillus saccharolyticus beta-glucosidase was examined using pNPG as substrate. Its profile is very similar to Novozym 188, with an optimum around pH 4.2 (FIG. 4). Within the pH range 3.8-4.8 the activity stays above 85% of maximum. pH 4.8 generally used in hydrolysis experiments with Celluclast 1.5 L and Novozym 188 is therefore also valid for the AP/Aspergillus saccharolyticus extract with beta-glucosidases.
Enzyme kinetics are preferably carried out on pure enzyme preparations, but are in this study used for the comparison of the beta-glucosidases of the crude enzyme extract of strain AP/Aspergillus saccharolyticus and the commercial enzyme preparation Novozym 188 and Cellic CTec. Any parameter expressed per amount of protein is always total protein content in the extract or commercial enzyme preparation, with no specific knowledge of how large a fraction that is beta-glucosidase proteins. Kinetic analysis was performed on both pNPG and cellobiose, measuring the specific activity at different substrate concentrations. By plotting reaction rate vs. substrate concentration, it was found that for all three samples, strain AP/Aspergillus saccharolyticus, Novozym 188 and Cellic CTec, the hydrolysis of pNPG only follows MM kinetics at low substrate concentrations, while evidence of substrate inhibition or transglycosylation is found at higher concentrations, seen by a decrease in reaction rate with increased substrate concentration (data no shown). With regards to cellobiose, no substrate inhibition was observed within the substrate concentrations tested. The MM kinetics parameters, Vmax and Km, were therefore only determined for cellobiose. The enzyme extract from strain AP/Aspergillus saccharolyticus and the commercial preparation Novozym 188 have similar affinity for cellobiose; and values being slightly better than Cellic CTec (Table 2), the lower the Km values the better the affinity. The maximum activity is, however, highest for Cellic CTec, but with strain AP/Aspergillus saccharolyticus being better than Novozym 188.







TABLE 2







Kinetic properties of strain AP/Aspergillus saccharolyticus,


Novozym 188, and Cellic CTec with cellobiose as substrate


for MM kinetics study










Vmax
Km



U/mg
mM














Strain AP
11.3
1.09



Novozym
7.5
1.06



188





Cellic CTec
22.9
1.69









Product inhibition was found to be substrate dependent, especially for strain AP/Aspergillus saccharolyticus beta-glucosidases (FIG. 5). Using pNPG as substrate, strain AP/Aspergillus saccharolyticus beta-glucosidases remain an activity of >80% at product concentrations 12 times higher than the substrate concentration. Cellic CTec is slightly lower (approx 75%), while the activity of Novozym 188 at this product-substrate ratio has dropped to just below 40%. The activities of strainAP, Cellic CTec, and Novozym 188 is calculated to reach half the maximum activity at concentrations 180, 115, and 60 mM glucose (equal to 36×, 23×, and 12× the substrate concentration), respectively. With regards to cellobiose, an activity drop to around 80% is found for both Strain AP/Aspergillus saccharolyticus and Novozym 188 when the product and substrate occur in equal concentrations. Over all, the profile of substrate inhibition is identical for strain AP/Aspergillus saccharolyticus and Novozym 188 when using cellobiose as substrate, while with pNPG, strain AP/Aspergillus saccharolyticus beta-glucosidases perform much better at high inhibitor concentrations than Novozym 188. This glucose inhibition study demonstrates the importance of testing the true substrate, cellobiose, and not just rely on pNPG data.
The thermostability of the enzymes was examined at temperatures ranging from 48.5 to 67.0° C. using pNPG as substrate. At temperatures up to 58° C. there was no significant difference between strain AP/Aspergillus saccharolyticus and Novozym 188 in terms of stability; both were fairly stable throughout the four hours of Incubation (data not shown). Meanwhile, the beta-glucosidases of Cellic CTec were much more sensitive to temperature increases. At temperatures ≧60° C., strain AP/Aspergillus saccharolyticus beta-glucosidases are dearly more stable than Novozym 188, and Cellic CTec is uncompetitive with any of them as it is severely inactivated even within the first half hour (FIG. 6). At 60.7° C., 65% of the activity remains for strain AP/Aspergillus saccharolyticus beta-glucosidases after 4 hours of incubation, while only 33% activity remains for Novozym 188. The inactivation roughly followed first order kinetics, with the rate constants of denaturation, kD, defined by the slopes of the lines in a semi-logarithmic plot of the remaining activity vs. time for the different temperatures, and the half-life calculated as T1/2=ln(2)/kD. The calculated half-life of strain AP/Aspergillus saccharolyticus at 60.7° C. was 440 min vs 180 min for Novozym 188. To reach a half-life of 180 min for Cellic CTec, the temperature should be lowered to around the tested 55.8° C., while for strain AP/Aspergillus saccharolyticus the temperature could be raised to around the tested 62.9° C.
Cellooligomers were used to make a hydrolytic time course study of strain AP/Aspergillus saccharolyticus extract, Novozym 188, Celluclast 1.5 L, and Cellic CTec (FIG. 7). Strain AP/Aspergillus saccharolyticus enzyme extract show clear exo-activity, with a cellopentaose and glucose concentration increase as the cellohexaose concentration decreased. Less rapidly, the cellotetraose and cellotriose concentrations increase too. Evidence of endo-activity or cellobiohydrolase activity is found, as the cellobiose concentration goes up relatively fast compared to the cellotetraose and cellotriose. On the contrary, Novozym 188 only shows beta-glucosidase exo-activity, with the only significant change over time being glucose and cellopentaose increase as cellohexaose decrease. The results suggest that the beta-glucosidases act by capturing the substrate, cleave the glycosidic bond, and release the products. They do not continuously cleave one bond after another upon capturing the substrate. Celluclast 1.5 L mainly possess cellobiohydrolase and endoglucanase activity, seen by the immediate increase in cellobiose and cellotriose, and lacking sufficient beta-glucosidase activity as the glucose concentration does not increase but the cellobiose concentration increases continually. As the only sample, Cellic CTec showed continuously increase in both cellobiose and glucose, indicating a combination of cellobiohydrolase and beta-glucosidase activity. Endoglucanase activity is most likely present too, identified by the formation of cellotriose.
Pretreated bagasse was hydrolyzed by strain AP/Aspergillus saccharolyticus beta-glucosidases combined with Celluclast 1.5 L to investigate its capabilities on a lignocellulosic substrate. This is compared with hydrolysis data of Novozym 188 and Celluclast 1.5 L. Strain AP/Aspergillus saccharolyticus beta-glucosidases and Novozym 188 beta-glucosidases are compared on total protein amount basis. A dosage-response plot of hydrolysis of 5% DM pretreated bagasse showed a leveling off in glucose yields at total enzyme dosages greater than 10 mg/gDM (data not shown). This total enzyme dosage was used for optimal enzyme ratio determination; the ratio of Celluclast 1.5 L and Strain AP/Aspergillus saccharolyticus extract or Novozym 188. The greatest yields were found with approximately 20% Novozym 188 (80% Celluclast 1.5 L) and 15% strain AP/Aspergillus saccharolyticus extract (85% Celluclast 1.5 L) (FIG. 8). Generally, the glucose yields were higher when using strain AP/Aspergillus saccharolyticus extract compared with Novozym 188, illustrating the possibility of substituting the commercial enzyme preparation with an extract from our newly isolated Aspergillus strain AP/Aspergillus saccharolyticus. These results for bagasse hydrolysis correlate well with the fact that the beta-glucosidases of strain AP/Aspergillus saccharolyticus extract has a higher reaction rate on cellobiose (Vmax, Table 2) compared to Novozym 188.
Discussion
Traditionally, two commonly used enzyme preparations that supplement each other in the hydrolysis of cellulosic biomasses are Novozym 188 and Celluclast 1.5 L (Novozymes AS, Denmark), contributing with beta-glucosidase activity, and endoglucanase and cellobiohydrolase activity, respectively (Berlin et al., 2005). Recently, an enzyme preparation containing all three components has been released into the market, Cellic CTec (Novozymes AS, Denmark). Costs related to enzymatic hydrolysis make this step a bottle neck in the process of creating a sugar plat form for biofuels, chemicals, and pharmaceuticals; therefore there is a need for more efficient enzymes, both in terms of reaction rates and stability (Berlin et al., 2005). Beta-glucosidases are widely distributed in nature, with especially fungi known to be industrial producers of these enzymes for cellulose hydrolysis. In this study, we present a prominent fungal beta-glucosidase producer naturally producing an enzyme cocktail with better beta-glucosidases compared to the commercial preparation Novozym 188 and markedly better thermostabily than both Novozym 188 and Cellic CTec. The work builds on a broad screening of 86 fungal strains collected by the authors as well as an in house collection of fungi kindly donated by various scientists. To our knowledge, broad screenings of fungal extracts for beta-glucosidase activity are not frequently published. In publication by Sternberg et al. (1977), 200 fungal strains were searched amongst for a strain producing large quantities of beta-glucosidases that could supplement the Trichoderma viride cellulases for cellulose saccharification. Generally, black Aspergilli were found to be superior in terms of beta-glucosidase production (Sternberg et al., 1977). Later, a study focusing on identification of acid- and thermotolerant extracellular beta-glucosidase activities in zygomycetes fungi was published were Rhizomucor miehei performed best (Tako et al., 2010). Screening for general cellulase activities in few cases include beta-glucosidase activities (Djarwanto & Tachibana, 2009, Jahangeer et al., 2005, Krogh et al., 2004, Pedersen et al., 2009), and other strategies for obtaining beta-glucosidases have been employed such as screening environmental DNA for beta-glucosidase activity rather than collecting microbial samples (Kim et al., 2007b), and a proteomics strategy to discover beta-glucosidases from Aspergillus fumigatus has been reported (Kim et al., 2007a). In this work, wheat bran was used as substrate in a submerged fermentation, as it is generally known as a good substrate for cellulases and beta-glucosidase production (Jager et al., 2001, Leite et al., 2008), being rich in carbohydrates and protein (Kent & Evers, 1994), and submerged fermentation allows for easy assaying of the extracellular enzymes of the fungi. The supernatants were tested for beta-glucosidase activity using pNPG at 50° C. pH4.8; which are optimal conditions for Celluclast 1.5 L, thus aiming at finding enzyme activities supplementing this enzyme preparation.
It was found that especially strains from the genera Aspergillus, Fusarium, Penicillium, and Trichoderma had the highest beta-glucosidase activity, with strains of Aspergillus being the best. These fungal genera have also been found in other screening programs for discovery of cellulolytic enzymes (Jahangeer et al., 2005, Sohail et al., 2009). Aspergilli in general have a high capacity for producing and secreting extracellular enzymes (Ward et al., 2006, de Vries & Visser, 2001), especially A. niger, with all classes of enzymes essential for cellulose degradation having been found amongst Aspergilli (de Vries & Visser, 2001). Within the A. fumigati strains, the expression level of beta-glucosidases at the tested conditions were very consistent, while great strain variation was found in A. niger (FIG. 1). This variation was not surprising as it correlates well with publications on citric acid, antioxidant, and urease production in A. niger, which is also very strain dependent (Ali, 2004, Kawai et al., 1994, Ghasemi et al., 2004).
Several studies have been published on the kinetics of Novozym 188 and A. niger beta-glucosidases, and it is apparent that substrate affinity, Km, does vary amongst strains within this species (Jager et al., 2001, Eyzaguirre et al., 2005, Krogh et al., 2010, Seidle of al., 2004). However, most common amongst the A. niger beta-glucosidases is that they have greater affinity for pNPG than for cellobiose; Jäger et al. (2001) report similar findings for other Aspergillus strain beta-glucosidases (Jager et al., 2001). We have, however, chosen to only calculate MM kinetics parameters related to hydrolysis of cellobiose as hydrolysis data of pNPG did not fit the MM equation. It is speculated that pNPG actually is a poor substitute in terms of assaying for beta-glucosidase activity, which was also concluded by e.g. Khan et al. 1985, and especially in this study it was additionally evident in relation to product inhibition. To compare activities, it is always desired to perform measurements at substrate saturation; however, with pNPG the saturation point could not be determined as substrate inhibition was the dominating factor at high substrate concentrations which correlates with studies carried out by Dekker (1986) and Eyzaguirre et al. (2005). As transglycosylation activity has been reported in several cases for different beta-glucosidases (Bhatia et al., 2002) it was speculated if the proposed substrate inhibition was rather a transglycosylation reaction at high product concentrations. However, the option of the enzyme carrying out transglycosylation by coupling the glucose product to a new pNPG at high pNPG concentrations was not investigated which could potentially mimic substrate inhibition in data evaluation. The effect of pNPG substrate inhibition or transglycosylation reaction on the measured reaction rates in the beta-glucosidase screening strategy was a factor that was not taken into account. However, the significance of the elevated activity of stain AP/Aspergillus saccharolyticus beta-glucosidase compared to all other assayed fungi would most likely be evident even had this been taken into account.
Product inhibition is a common phenomenon with beta-glucosidases; glucose being the main inhibitor, which can have a significant influence for process reaction in industrial applications (Berlin et al., 2005). The importance of testing such inhibitory effects on the true substrate, cellobiose, rather than the substitute, pNPG, was demonstrated in this study, as the beta-glucosidases of strain AP/Aspergillus saccharolyticus compared to Novozym 188 only showed low inhibition by glucose using pNPG as substrate, but when using cellobiose, the inhibition patterns of the two enzyme preparations were similar, with the activities only reaching 50% when twice the concentration of glucose is present compared to cellobiose concentration (FIG. 5). pNPG is an easy-to-use substrate, but can be misguiding in terms of beta-glucosidase performance in true “real life” hydrolysis conditions.
The extract of strain AP/Aspergillus saccharolyticus showed greater specific beta-glucosidase activity than Novozym 188, while that of Cellic CTec was found to be even greater (Table 2). The enzyme preparations were evaluated on basis of total extracellular proteins, which, however, also comprise proteins originating from the growth medium. It is therefore unknown how much of the measured protein is actually fungal proteins. Furthermore Aspergilli strains are known to possess several beta-glucosidases that can have different relative activities and specificities. e.g. three beta-glucosidases from A. aculeatus have been assayed with the findings that one has very weak and the two other very high activities towards cellobiose relative to pNPG (Sakamoto et al., 1985). The beta-glucosidase activity of the screened extract is therefore very likely the combined activity of several beta-glucosidases of the strain AP/Aspergillus saccharolyticus. Without further optimization, the specific activity of the solid state fermentation extract of strain AP/Aspergillus saccharolyticus was able to compete with Novozym 188 in hydrolysis of cellobiose, and in the case of cellohexaose the rate by which the cellohexaose concentration decreased and the glucose and cellopentaose increase was greatest for strain AP/Aspergillus saccharolyticus than Novozym 188. Increasing the degree of complexity and potential amount of inhibitors, etc, bagasse is one of many cellulose containing biomasses of interest for bioethanol purposes. Bagasse is a lignocellulosic waste product from the sugar cane industry produced in great quantities in countries such as Brazil and other tropical places (Soccol et al., 2010). Its utilization for fuel production is value contributing to the current processes (Leite et al., 2009). Hydrolysis of bagasse was here used to show that our stain AP/Aspergillus saccharolyticus enzyme extract supplemented with Celluclast (FIG. 8), did work on actual lignocellulosic material and was competitive with Novozym 188.
Thermostability and temperature optima presented in different publications are difficult to compare as the incubation time, reaction time, and temperatures tested vary. Generally, the dependence of temperature resembles a bell-shaped curve, with a maximum where the enzyme is actually not at its optimum as the maximum indicates the beginning of the irreversible denaturation process (Bisswanger, 2008). This method of directly assaying at different temperatures to determine the temperature profile is of no real use in terms of industrial hydrolysis as hydrolysis reactions are usually run for several hours and time dependent enzyme degradation will play a role. By pre-incubating the enzymes at distinct temperatures and assaying after different time intervals at normal assay temperatures, the beta-glucosidases of strain AP/Aspergillus saccharolyticus were found to have excellent temperature stability compared to Novozym 188 (FIG. 6). Novozym 188 has previously been reported to only maintain stability at temperatures at or below 50° C. (Krogh et al., 2010). Cellic CTec was found to be very unstable at elevated temperatures observed by the poor performance when assaying for activity after incubation above 50° C., which relates to the manufactures instructions of best performance at temperatures 40-50° C. (Novozymes A/S, 2010). The time course of the inactivation of all enzymes approximately followed a first order reaction from which the denaturation rates and half-lives at the different temperatures could be calculated, confirming the dominating status of strain AP/Aspergillus saccharolyticus beta-glucosidases in terms of thermostability.
In this work, a potential yet unidentified species has been identified: strain AP/Aspergillus saccharolyticus, belonging to the Aspergillus nigri group. This stain had significantly greater beta-glucosidase potential than all other fungi screened and was shown to be a valid substitute for Novozym 188, even performed better than Novozym 188 in some aspects, and definitely out-competed Cellic CTec in terms of thermostability.
Example 2
Aspergillus saccharolyticus sp. nov., a New Black Aspergillus Species Isolated on Treated Oak Wood in Denmark
During a broad screening of different fungal strains collected in Denmark for prominent beta-glucosidase producing fungi (EXAMPLE 1), we discovered a uniseriate Aspergillus, morphologically similar to A. japonicus. However, both molecular data and an extrolite profile showed that this fungus differed significantly from known aspergilli from section Nigri. In this example we describe the relationship of this strain to other black aspergilli using the polyphasic approach with studies of ITS, calmodulin, and beta-tubulin sequence phylogeny, UP-PCR finger printing, macro- and micro-morphology, temperature tolerance, and extrolite production.
Materials and Methods
A strain of a novel species, Aspergillus saccharolyticus, was isolated in door from treated oak wood in Denmark. The isolate was maintained on potato dextrose agar at room temperature. All reference strains and accession numbers used for comparison are listed in Table 3.







TABLE 3







GenBank accession numbers of sequence data used to prepare the


phylogenetic trees











ITS
Beta-tubulin
Calmodulin





A. niger CBS 554.65T
AJ223852
AY585536
AJ964872


A. tubingensis CBS 134.48T
AJ223853
AY820007
AJ964876


A. japonicus CBS 114.51T
AJ279985
AY585542
AJ964875


A. aculeatus CBS 172.66T
AJ279988
AY585540
AJ964877


A. foetidus CBS 565.65
AJ280999
AY585533
FN594547


A. brasiliensis CBS 101740T
AJ280010
AY820006
AM295175


A. heteromorphous
AJ280013
AY585529
AM421461


CBS 117.55T





A. ellipticus CBS 707.79T
AJ280014
AY585530
AM117809


A. vadensis CBS 113363T
AY585549
AY588531
EU163269


A. ibericus CBS 121593T
AY656625
AM419748
AJ971805


A. castaricaensis
DQ900602
AY820014
EU163268


CBS 115574T





A. piperis CBS 112811T
DQ900603
AY820013
EU163267


A. lacticoffeatus
DQ900604
AY819998
EU163270


CBS 101883T





A. carbonarius CBS 111.26T
DQ900605
AY585532
AJ964873


A. sclerotioniger
DQ900606
AY819996
EU163271


CBS 115572T





A. homomorphus
EF166063
AY820O15
AM887865


CBS 101889T





A. aculeatinus CBS 121060T
EU159211
EU159220
EU159241


A. sclerotiicarbonarius
EU159216
EU159229
EU159235


CBS 121057T





A. uvarum CBS 121591T
AM745757
AM745751
AM745755


A. aculeatus CBS 114.80
AJ280005
AY585539
AM419750


A. saccharolyticus
HM853552
HM853553
HM853554


CBS 127449T





A. flavus CBS 100927T
AF027863
AY819992
AY974341









Molecular Analysis

Fungal biomass for DNA extraction was obtained by scraping the surface of a PDA plate with a seven day old colony. DNA extraction was carried out as described by (Yu & Mohn, 1999), using bead beating for cell disruption. The two fungal primers Bt2a (5′ GGTAACCAAATCGGTGCTGCTTTC) and Bt2b (5′ ACCCTCAGTGTAGTGACCCTTGGC) were used to amplify a fragment of the beta-tubulin gene (Glass & Donaldson, 1995), while the primers Cmd5 (5′ CCGAGTACAAGGAGGCCTTC) and Cmd6 (5′ CCGATAGAGGTCATAACGTGG) were used to amplify a segment of the calmodulin gene (Hong et al., 2006), and the primers ITS1 (5′ TCCGTAGGTGAACCTGCGG) and ITS4 (5′ TCCTCCGCTTATTGATATG) were used to amplify the ribosomal rDNA spacers, ITS1 and ITS2 (White et al., 1990). Phylogenetic analysis of the beta-tubulin, calmodulin, and internal transcribed spacer region of rRNA (ITS1 and ITS2) sequences of the novel isolate was carried out as described by Varga et al. (2007), using the beta-tubulin, calmodulin, and ITS region sequences of the aspergilli presented in the article by Samson et al (Samson et al., 2007). ClustalW multiple alignment was used for sequence alignment and manual improvement of the alignment was performed using BioEdit (http://www.mbio.ncsu.edu/BioEdit/bioedit.html). The PHYLIP program package version 3.69 was used for preparation of phylogenetic trees (Felsenstein, 2004). The distance matrix of the data set was calculated based on the Kimura method (Kimura, 1983) using the program “Dnadist”. The phylogenetic tree was prepared by running the program “Neighbor” using the neighbor-joining method (Saitou & Nei, 1987) to obtain unrooted trees. A. flavus was defined as the outgroup in the program “Retree”, and finally the tree was visualized using the program TreeView (win32) (Page, 1996). Bootstrap values (Felsenstein, 1985) were calculated by running the program “Seqboot” to produce 1000 bootstrapped data sets from the original data set. Again, “dnadist” with the Kimura method was used to prepare distance matrices of the multiple data sets, and “neighbor” with the neighbor-joining method to obtain unrooted trees of the multiple data sets. Finally, the bootstrap values were obtained from the consensus tree which was identified by the majority-rule consensus method by running the program “Consense”.
UP-PCR fingerprinting was carried out using two different UP primers, L45 (5′ GTAAAACGACGGCCAGT) and L15/AS19 (5′ GAGGGTGGCGGCTAG) (Lubeck et al., 1999) for DNA amplification in separate reactions. The amplification was performed as described in Lübeck et al. (1999) except that the reactions were carried out in a 25 μl volume containing 50 mM Tris pH8, 0.23 mg/ml BSA, 0.5% Ficoll, 2.5 mM MgCl2, 0.2 mM of dNTP, 0.4 μM of primer and 1 U RUN polymerase (A&A Biotechnology, Poland).
Morphological Analysis
For microscopic analysis, microscopic mounts were made in lactophenol from colonies grown on MEA (malt extract autolysate) and OA (oat meal agar).
For investigation of morphological characteristics, a dense spore suspension of A. saccharolyticus was three-point inoculated on the following media: CREA (creatine sucrose), CYA (Czapek yeast autolysate), CY20S (CYA with 20% sucrose), CY40S (CYA with 40% sucrose), CYAS (CYA with 50 g/l NaCl), MEA (malt extract autolysate), OA (oat meal agar) and YES (yeast extract sucrose) agar (Samson et al., 2004a), and incubated 7 days in the dark at 25° C. For temperature tolerance analysis, three-point inoculating was performed on CYA and incubated 7 days in the dark at different temperatures: room temp, 30° C., 33° C., 36° C., and 40° C.
Extrolite Analysis
Three 6 mm diameter plugs were taken from each strain grown as three-point inoculations in the dark at 25° C. for 7 and 14 days on YES, CYA20, CYA40, PDA, CYA media (Samson et al., 2004a, Nielsen et al., 2009). The plugs were transferred to a 2-mL vial and 1.4 mL of ethyl acetate containing 1% formic acid was added. The plugs were placed in an ultra sonication bath for 60 min. The ethyl acetate was transferred to a new vial in which the organic phase was evaporated to dryness by applying nitrogen airflow at 30° C. The residues were re-dissolved by ultrasonication for 10 min in 150 μL ACN/H2O (1:1, v/v) mixture.
HPLC-UV/VIS-high resolution mass spectrometry (LC-HRMS) analysis was performed with an Agilent 1100 system (Waldbronn, Germany) equipped with a diode array detector and coupled to a Micromass LCT (Micromass, Manchester, U.K.) equipped with an electrospray (ESI) (Nielsen et al, 2009, Nielsen & Smedsgaard, 2003). Separations of 2 μL samples was performed on a 50×2 mm inner diameter, 3 μm Luna C18 II column (Phenomenex. Torrance, Calif.) using a linear water-ACN gradient at a flow of 0.300 ml/min with 15-100% ACN in 20 min followed by a plateau at 100% ACN for 3 min (Nielsen et al., 2009). Both solvents contained 20 mM formic acid. Samples were analyzed both in ESI− and ESI+ mode.
For compound identification, each peak was matched against an internal reference standard database ( ̃800 compounds) (Nielsen et al., 2009, Nielsen & Smedsgaard, 2003). Other peaks were tentatively identified by matching data from previous studies in our lab and searching the accurate mass in the  ̃13 500 fungal metabolites reported in Antibase 2010 (Laatsch, 2010).
Results and Discussion
In a screening program, fungal strains were obtained from different environmental habitats, Danish as well as international, and tested for beta-glucosidase activity (EXAMPLE 1). Some of the strains were found in door in Denmark on treated oak wood, and one of these strains showed an extraordinary good beta-glucosidase activity. In this example, a thorough characterization was carried out in order to identify the strain.
Morphological data showed that the strain was related to A. japonicus or A. aculeatus, but extrolite profiles and DNA sequencing data showed that the strain clearly was different from all known species. The genetic relatedness of this novel species, A. saccharolyticus, to other black aspergilli was investigated by comparing sequence data of parts of the beta-tubulin and calmodulin genes as well as the ITS region, using A. flavus as the out group. The black aspergilli chosen for comparison are the same as the ones presented by Samson et al. (2007). Phylogetic trees were prepared for A. saccharolyticus based on these sequence data and data obtained in this work, with especially the ITS and calmodulin sequence trees showing similar topology (FIGS. 9, 10, and 11). Based on the phylogenetic analysis of the ITS and calmodulin gene sequence data, A. saccharolyticus was with high bootstrap values found to belong to the clade with A. homomorphus, A. aculeatinus, A. uvarum, A. japonicus, and both A. aculeatus strains, while for the beta-tubulin gene sequence data A. saccharolyticus clustered with A. homomorphus. A. aculeatinus, A. uvarum, and A. aculeatus CBS 114.80. The separate grouping in the beta-tubulin tree of A. japonicus and A. aculeatus CBS 172.66T has consistently been shown in other publications (Varga et al., 2007, Samson et al., 2007. Noonim et al., 2008, de Vries et al., 2005, Samson et al., 2004b). For all three loci, A. saccharolyticus is placed on its own branch far from the other species in the clade supported by the majority-rule consensus analysis for all three loci and high bootstrap values for the beta-tubulin and calmodulin loci, but low bootstrap value (51%) for the ITS locus. Sequence alignment revealed that amongst the species from section Aculeati that are in clade with A. saccharolyticus, interspecific sequence divergences are ≦0.7%, 7.1%, and 5.7% for the ITS, calmodulin, and beta-tubulin regions, respectively. Meanwhile, the interspecific sequence divergences in the ITS, calmodulin, and beta-tubulin region between A. saccharolyticus and the other species in the clade are on average 12.9±0.6%, 20±0.5%, and 15.4±1.2%, respectively. The variation in sequence data observed between A. saccharolyticus and A. homomorphus is the same as the variation between A. homomorphus and the smaller clade(s) of A. aculeatinus, A. uvarum, A. japonicus, and both A. aculeatus strains. Searching the NCBI database does not give any closer genetic match. Based on this, there is a clear genetic foundation for proposing the new species, A. saccharolyticus. 
Furthermore, this strain could readily be distinguished from other black aspergilli by Universally Primed-PCR analysis using each of the two UP primers, L45 and L15/AS19 (Supplementary Figure S3). UP-PCR is a PCR fingerprinting method that has demonstrated its applicability in different aspects of mycology. These applications constitute analysis of genome structures, identification of species, analysis of population and species diversity, revealing of genetic relatedness at infra- and inter-species level, and identification of UP-PCR markers at different taxonomic levels (strain, group and/or species) (Lübeck & Lübeck, 2005). Each of the analyzed aspergilli, A. saccharolyticus, A. aculeatinus, A. ellipticus, A. homomorphus, A. niger, A. uvarum, A. aculeatus and A. japonicus, produced a unique banding profile, and did not share any bands (FIG. 12). This is an illustration of clearly separated species, as strains within a species should at least have some similarities in their banding profiles (Lübeck & Lübeck, 2005).
The extrolite profiles further showed that A. saccharolyticus produced the largest chemical diversity on YES agar (25° C.), whereas CYA (25 and 30° C.), and CYAS, CY20S, CY20, CY40S, and PDA (all at 25° C.) yielded fewer peaks. The results further showed that it is a new species since it does not share any metabolites with other species in the Nigri section where e.g. the naphto-γ-pyrones are consistently produced (Nielsen et al., 2009) and only two compounds, ACU-1 and ACU-2, with series Aculeati (Table 4 and FIG. 13) whereas the well known compounds from the series: neooxaline, secalonic acids, cycloclavine and aculeasins were not detected (Parenicova et al., 2001). In addition, none of the 12 detected peaks matched with the approx. 13500 fungal extrolites in Antibase 2010 (Laatsch, 2010) thus providing that the species had not been investigated by natural products chemists.







TABLE 4







Physiological features and extrolite production by the strains of uniseriate


species in Aspergillus section Nigri












Growth at




Growth on CYAS
37° C. on CYA



Species
(diam, mm)
(diam, mm)
Extrolites





A saccharalyticus sp. nov
11-44
 7-14
12 compounds not described in the literature*


(CBS127449*)


including ACU-1* and ACU-2**


A aculeatinus
37-54
18-52
Aculeasins, neoxaline, secalonic acid D & P


(CBS121060CD5





121875, IBT 29275)





A aculeatus
0-4
15-26
Secalonic acid D & P, ACU-1* and ACU-2**


(CBS 172.66*)





A japonicus
0
 8-25
Cycloclavine, festuclavine


(CBS 114510, IBT 29220





IBT 26338, ITEM 4497)





A uvarum
54-73
11-14
Asterric acid, dihydrogeodin, erdin, geodin


(CBS 121591T, ITEM 4634;


secalonic acid D & P


ITEM 4856; ITEM 5024





*No matches found among the 13 500 fungal metabolites listed in Antibase2010.


**ACU-1 and ACU-2 unidentified compounds with UV max 242 nm (100%) and 346 (88%) with mono isotopic messes of 315.1799 and 218.1268 Da respectively.






Morphologically, A. saccharolyticus is most closely related to A. japonicus (FIG. 14), but with larger conidia of 5-6 μm and vesicle size in the high margin of A. japonicus. Based on physiological features, differences between A. saccharolyticus and other uniseriate species in the Nigri section were found. Growth on CREA resembled that of A. aculeatinus, as moderate growth and medium acid production was observed, while growth on CYA mostly resembled that of A. aculeatus, however, the reverse side of A. saccharolyticus is olive-green/brownish with sulcate structure, while that os A. aculeatus is curry-yellowish/brown (FIG. 14 compared with (Samson et al., 2007)). MEA was a medium where colony size was clearly different, with A. saccharolyticus being smaller than the other uniseriate aspergilli. A. saccharolyticus grew better on CYA than A. aculeatus and A. japonicus, but groth was limited compared to A. aculeatinus and A. uvarum. Growth diameter of A. saccharolyticus on CYA at 37° C. was approximately the same as for A. uvarum, while A. aculeatus and A. japonicus were less inhibited, and A. aculeatinus even less inhibited measuring the larger diameter of all uniseriate at this elevated temperature (Table 4).
With regards to temperature tolerance, growth was examined on CYA at 30° C., 33° C., 36° C., and 40° C. The maximum temperature A. saccharolyticus was able to grow at was 36° C., but growth at this temperature was restricted compared to the lower temperatures, which is generally the case for the other uniseriate aspergilli as well (Samson et al., 2007). A. saccharolyticus showed a distinct change in morphology on CYA from 30° C. to 33° C., but maintaining good growth at both temperatures (FIG. 15). The same tendency has been observed for A. aculeatinus grown on MEA, while A. japonicus, and A. aculeatus showed no change in morphology at these temperatures, while growth of A. uvarum was inhibited at 33° C. (Samson et al., 2007).
The conclusion that Aspergillus saccharolyticus is a novel species is based on a polyphasic approach combining phylogenetic analysis of three genes and UP-PCR data for characterizing the genotype, and morphological, physiological, and chemotaxonomical characteristics for phenotype analysis. Because the strain was unique in its genetic phylogeny, UP-PCR profile, extrolite profile, morphological, and physiological characteristics, Aspergillus saccharolyticus is a novel species. Aspergillus saccharolyticus is an efficient producer of beta-glucosidases (EXAMPLE 1) and the name refers to its great ability to hydrolyze cellobiose and cellodextrins.
Latin Diagnosis of Aspergillus Saccharolyticus Sørensen, Lübeck et Frisvad sp. nov.
Coloniae post 7 dies 58-62 mm diam in agaro CYA, in CYA, 37° C.: 7-14 mm; in MEA 35-37, in YES 75-80 mm, in agaro farina avenacea confecto 39-42 mm, in CREA 30-34 mm. Coloniae primum albae, deinde obscure brunneae vel atrae, reversum cremeum vel dilute brunneum. Condiorum capitula primum globosa, stipes 200-850×5-7 μm, crassitunicatus, levis, vesiculae 25-40 μm diam, fere globosae; capitula uniseriata; phialides lageniformes, collulis brevis, 5.5-7 μm; conidia globosa vel subglobosa, 5-6.2 μm, echinulata. Sclerotia haud visa.
Typus CBS 127449T (=IBT 28509T), isolatus e lignore Quercetorum in Gentofte, Dania.
Description of Aspergillus saccharolyticus Sørensen, Lübeck et Frisvad sp. nov.
Aspergillus saccharolyticus (sac.ca'ro.ly'ti.cus. N.L. masc. adj. saccharolyticus, being able to degrade cellobiose and cellodextins).
Colony diameter at 7 days: CYA at 25° C.: 58-62 mm, at 37° C.: 7-14 mm; CYAS: 11-14 mm; YES: 75-80 mm; OA: 39-42 mm; CY20S: 42-54 mm; CY40S: 43-54 mm; MEA: 35-37 mm; CREA 30-34 mm, poor growth, good acid production, colony first white then dark brown to black (FIG. 14). Exudates absent, reverse cream-coloured to light greyish olive brown on CYA and light brown on YES. Conidial heads globose; stipes 200-850×5-7 μm, walls thick, smooth; vesicles 25-40 μm diam, globose; uniseriate, phialides flask shaped with a short broad collulum, 5.5-7 μm; conidia mostly globose, but some are subglobose, 5-6.2 μm, distinctly echinulate, with long sharp discrete spines, the spines being 0.6-0.8 μm long. Sclerotia have not been observed. The type strain CBS 127449T (=IBT 28509T) was isolated from under a toilet seat made of treated oak wood, Gentofte, Denmark
Example 3
Cloning, Expression, and Characterization of a Novel Highly Efficient Beta-Glucosidase from Aspergillus saccharolyticus 
As shown in the previous example 1, Aspergillus saccharolyticus produce beta-glucosidases with more efficient hydrolytic activity compared to commercial beta-glucosidase containing preparations, especially with regard to thermostability (EXAMPLE 1). In the present example, the most prominent beta-glucosidase from A. saccharolyticus are identified, isolated and characterized. The molecular cloning of the novel beta-glucosidase gene, bgl1 is reported, and a model prediction of its structure is presented. The novel beta-glucosidase was expressed in T. reesei for purification and the enzyme was then characterized by Michaelis-Menten kinetic studies, thermostability, pH optimum, glucose tolerance, and ability to hydrolyze cellodextrins.
Fungal Strain and Enzyme Extract Preparation
A. saccharolyticus CBS 127449T was initially isolated from treated hard wood (EXAMPLE 2) and routinely maintained on potato dextrose agar. A solid state fermentation enzyme extract of A. saccharolyticus was prepared as described in EXAMPLE 1.
Fractionation by Ion Exchange Chromatography
The enzyme extract of A. saccharolyticus was fractionated by ion exchange chromatography using an ÄKTApurfier system with UNICORN software. HiTrap Q XL 1 ml anion column (GE Healthcare) was run at a flow rate of 1 ml/min, 5 CV of buffer A (Tris buffer pH 8) was used to equilibrate the column, 5 CV sample (approx 0.5 mg protein/ml) was loaded onto the column, followed by a 2 CV wash with buffer A. Gradient elution was carried out over 30 CV with buffer B (Tris buffer pH 8+1M NaCl) reaching 70% of the total volume. The column was finally washed with 5 CV buffer B and reequilibrated for the next run with buffer A. Aliquots of 1 ml were collected and assayed for beta-glucosidase activity as well as quantified in terms of protein content, as described below.
Assays for Beta-Glucosidase Activity and Protein Quantification
Beta-glucosidase activity was assayed using using 5 mM p-nitrophenyl-beta-D-glucopyranoside (pNPG) (Sigma) in 50 mM Na-Citrate buffer pH 4.8 as described in EXAMPLE 1.
Protein quantification was done using the Pierce BCA protein assay kit microplate procedure according to manufacturer's instructions (Pierce Biotechnology), using bovine serum albumin as standard.
Electrophoresis
Sample preparation and electrophoresis was performed using ClearPAGE precast gels and accessories (C.B.S. Scientific Company, Inc). Samples were prepared by mixing 65 vol % protein, 25% 4×LDS sample buffer (40% glycerol, 4% Ficoll-400, 0.8M Triethano amine pH 7.6, 6N HCl, 4% Lithium dodecyl sulphate, 2 mM EDTA di-sodium, 0.025% Brilliant blue G250, 0.025% Phenol red), and 10% 10× reducing agent (20 mM DTT) and heating for 10 min at 70° C. 25 μl of each sample were loaded on a ClearPAGE 4-12% SDS-gel, using ClearPAGE two-color SDS marker for band size approximation. The gel was stained with ClearPAGE Instant Blue stain by placing the gel in a small container, adding the Instant Blue stain till the gel was covered, followed by shaking the gel gently for 10-30 minutes till desired band intensity was achieved. No destaining was performed, but the gels were washed a few times in ultrapure water, with gently shaking.
Mass Spectrometry and Protein Identification
Bands of interest were excised from the gel, and in-gel digestion was performed as described by Kinter and Sherman (2000) (Kinter & Sherman, 2000). The trypsin digestion, and sample analysis was carried out by The Laboratory for Biotechnology and Bioanalysis 2 (LBB2). Washington State University, Pullman. Wash., USA, where analysis was performed by LC-MS/MS using LC Packings Ultimate Nano high-performance liquid chromatography system (with LC Packings monolithic column PS-DVB) and Esquire HCT electrospray ion trap (Bruker Daltonics, Billerica, Mass.) as described in their former publication (Noh et al., 2008). The Mascot search engine (www.matrixscience.com) was used to search the peptide finger prints against predicted peptides in the NCBI database with the significance threshold p<0.05.
Isolation and Cloning of Beta-Glucosidase Gene
Based on the Aspergillus aculeatus peptide match found in the LC-MS/MS analysis, the corresponding full length beta-glucosidase protein (GenBank: BAA10968) was submitted to a NCBI NCBI Blast of search in the protein entries of GenBank (http://NCBI Blast of .ncbi.nlm.nih.gov/NCBI Blast of .cgi) to identify similar beta-glucosidases. An alignment of these sequences was made with BioEdit (http://www.mbio.ncsu.edu/BioEdit/bioedit.html) to identify conserved regions. Degenerate primers were designed using the CODEHOP strategy (Rose et al., 2003): forward primer: 5′CACGAAATGTACCTCtggcccttygc and reverse primer 5′CCTTGATCACGTTGTCGccrttcykcca. Genomic DNA of A. saccharolyticus was isolated as described in EXAMPLE 1. The primers were used in polymerase chain reaction (PCR) with genomic DNA and RUN polymerase (A&A Biotechnology), obtaining a fragment of approximately 950 bp. The band was excised from the gel and sequenced using the sequencing service at MWG (MWG, Germany), and was by NCBI NCBI Blast of found to be related to other aspergilli beta-glucosidase fragments. From several rounds of genome walking (Guo & Xiong, 2006), the flanking regions were characterized, thereby obtaining the full genomic sequence of the gene. The start and stop codon was predicted by NCBI NCBI Blast of comparison and the GenScan Web server (http://genes.mit.edu/GENSCAN.html).
RNA was prepared from 4 day old fungal spores and mycelium grown on plates containing 20 g/l wheat bran, 20 g/l corn steep liquor, 3 g/l NaNO3, 1 g/l K2HPO4, 0.5 g/l KCl, 0.5 g/l MgSO47H2O, 0.01 g/l FeSO47H2O, 15 g/l agar. The cells were disrupted by bead beating (2×20 sec) in Fenozol supplied with the Total RNA kit (A&A Biotechnology) and RNA purified following the kit protocol, cDNA was prepared from total RNA using First strand cDNA synthesis kit and random hexamer primers (Fermentas).
A cassette comprising Magnaporthe grisea Ribosomal promoter RP27, the beta-glucosidase genomic DNA gene, six histidine residues, and Neurospora crassa beta-tubulin terminator was constructed using PCR cloning techniques and cloned into the PciI site of pAN7-1. The plasmid pAN7-1 containing the E. coli hygB resistance gene was donated by Peter Punt (University of Leiden, The Netherlands) (Punt eof al., 1987). The promoter and terminator were from plasmid pSM565 (Bourett et al., 2002) and the beta-glucosidase gene was from A. saccharolyticus genomic DNA. PCR was performed using proofreading WALK polymerase (A&A Biotechnology), while restriction enzymes (fast digest PciI), alkaline phosphatase (fastAP), and ligase (T4 DNA ligase) were from Fermentas. The construct pAS3-gBGL was transformed into E. coli Top 10 competent cells (prepared using CaCl2 (Sambrook & Russel, 2001)) and plated on LB plates (10 g/l bacto tryptone, 5 g/l yeast extract, 10 g/l NaCl, 15 g/l agar, pH 7.5) with ampicillin selection (100 ppm). Correct transformants were checked for by colony PCR using several different promoter, beta-glucosidase, and terminator specific primers. An overnight culture with a correct transformant was prepared and the constructed cloning vector purified the following day (E.Z.N.A. Plasmid Midi Kit, Omega Biotech). The final cloning vector, pAS3-gBGL, is sketched in FIG. 16.
Transformation and identification of active recombinant beta-glucosidase in T. reesei Protoplast preparation of T. reesei QM6a was carried out similarly to the procedure described by Pentillä et al. (1987) (Pentilla et al., 1987) 100 ml complete medium (10 g/l glucose, 2 g/l peptone, 1 g/l yeast extract, 1 g/l casamino acids, 6 g/l NaNO3, 0.52 g/l KCl, 0.52 g/l MgSO4.7H2O, 1.52 g/l KH2PO4, 22 mg/l ZnSO4.7H2O, 11 mg/l H3BO3, 5 mg/l MnCl2.4H2O, 5 mg/l FeSO4.7H2O, 1.7 mg/l CoCl2.6H2O, 1.6 mg/l CuSO4.5H2O, 1.5 mg/l Na2MoO4.2H2O, and 50 mg/l Na2EDTA) in a 500 ml baffled flask was inoculated with fresh T. reesei conidia reaching a concentration of 106 spores per ml and incubated for 16-22 hours at 30° C., 120 rpm. The mycelium was collected on double folded Miracloth (Andwin scientific) and washed with sterile water. The mycelium was suspended in 20 ml protoplasting solution (1.2 M MgSO4, 50 mM NaPO4 pH 5.8) with 60 mg VinoTaste Pro (Novozymes A/S) enzyme per ml, incubated for 2-4 hours at 30° C., 65 rpm, then filtered through double folded Miracloth, and washed with a few ml protoplasting solution. The protoplasts were overlaid with ST buffer (0.6 M sorbitol, 0.1M Tris-HCL pH 7.0) (approx. 20% the volume of protoplasting solution) and centrifuged at 1000 g for 10 min. Protoplasts were collected from the interphase and washed twice with STC buffer (1.0 M sorbitol, 10 mM CaCl2 2H2O, 10 mM Tris-HCl pH 7.5), finally resuspending in STC buffer at a concentration of approximately 5×102 for immediate use in transformation.
For transformation, 200 μl protoplasts, 10 μl plasmid DNA (>1 μg), and 50 μl PEG1 (25% PEG 6000 in STC buffer) were mixed gently and incubated on ice for 20 min. 2 ml PEG2 (25% PEG 6000, 50 mM CaCl2, 10 mM Tris-HCl pH7.5) was added and incubated 5 min at room temperature, followed by addition of 4 ml STC buffer. Aliquots of 1 ml were plates in recovery agar (1 g/l MgSO47H2O, 10 g/l KH2PO4, 6 g/l (NH4)2SO4, 3 g/l NaCitrate 2H2O, 10 g/l Glucose, 182 g/l sorbitol (final 1M), 5 mg/l FeSO47H2O, 1.6 mg/l MnSO4H2O, 1.4 mg/l ZnSO4H2O, 2 mg/l CaCl22H2O, 15 g/l agar) with 100 ppm hygromycin as selection, and incubated at 28° C. over night. The following day, a top layer of the above described agar, again with 100 ppm hygromycin, but without sorbitol, was added, and the plates were incubated for another 2-4 days before colonies that had surfaced were picked and carried through multiple retransfers and streaking on selective medium to obtain pure colonies.
Identification of positive transformants was done by a simple pNPG activity screen, where three 0.5×0.5 cm agar plugs of the transformants were added to 10 ml growth medium (20 g/l wheat bran, 20 g/l corn steep liquor, 3 g/l NaNO3, 1 g/l K2HPO4, 0.5 g/l KCl, 0.5 g/l MgSO47H2O, 0.01 g/l FeSO47H2O) in 50 ml Falcon tubes and incubated at 30° C., 180 rpm for five days. The supernatant was collected, centrifuged at 10,000 rpm for 10 min and assayed for beta-glucosidase activity using the pNPG assay described earlier. At these conditions, the wild type QM6a showed no significant activity, so positive transformants were identified by the presence of beta-glucosidase activity.
Purification of Expressed Beta-Glucosidases
Using the HisSpin Trap kit (GE Healthcare), following the protocol supplied with the kit, the optimal imidazole concentration for purification of the histidine tagged beta-glucosidases was found to be 0 mM imidazole.
The transformant having shown the greatest beta-glucosidase activity was cultured in 150 ml growth medium (specified above) in a 500 ml baffled flask, incubated at 30° C., 160 rpm for 6 days. The supernatant was centrifuged at 10,000 rpm for 10 min, filtered through a 0.22 μm filter (Millipore) and pH adjusted to 7.4.
The his-tagged beta-glucosidases were purified on the ÄKTApurifier system with UNICORN software, using a HisTrap HP 5 ml anion column (GE Healthcare), run at a flow rate of 5 ml/min. The column was equilibrated with 5 CV of binding buffer (20 mM sodium phosphate, 0.5M NaCl, pH 7.4), 100 ml sample was loaded onto the column, followed by washing with binding buffer till the absorbance reached the baseline. The his-tagged beta-glucosidases were eluted with 3 CV elution buffer (20 mM sodium phosphate, 0.5M NaCl, 500 mM imidazole, pH 7.4) and the peak (1 CV) collected by monitoring the absorbance.
Assays for Characterization of Purified Beta-Glucosidases
Michaelis Menten kinetics, glucose tolerance, thermostability, pH optimum, and cellodextrin hydrolysis were carried out as described in EXAMPLE 1.
Sequence Comparisons and Homology Modeling
Similar sequences were located by NCBI BLAST OF (Altschul et al., 1997) in the protein entries of GenBank (Benson et al., 2004) and aligned using hidden Markov models (Karplus et al., 2005) and CLUSTAL W (Thompson et al., 1994). Similar beta-glucosidase catalytic domain structures were obtained from the Protein Data Bank (PDB; (Berman et al., 2000)), then superimposed and compared with the program O (Jones et al., 1991). Multiple sequence alignments were used to generate the best pair-wise alignment of the A. saccharolyticus beta-glucosidase with that of the T. neapolitana beta-glucosidase 3B. This pair-wise alignment was the basis of creating a homology model, with PDB entry 2X40 (Pozzo et al., 2010) as the template in the program SOD (Kleywegt et al., 2001). The model was adjusted in O, using rotamers that would improve packing in the interior of the protein. The model is available upon request from the authors. The figure was prepared using O, MOLSCRIPT (Kraulis, 1991) and Molray (Harris & Jones, 2001).
Results
Identification of Beta-Glucosidase in A. saccharolyticus Extract
The enzyme extract of A. saccharolyticus produced by solid state fermentation on wheat bran, was fractionated by ion exchange chromatography, investigating the beta-glucosidase activity and protein content of each fraction (FIG. 17). Protein content could be measured in all fractions. Approximately 25% of the proteins did not bind to the column, but passed through prior to the start of the gradient elution, No beta-glucosidase activity was found in this initial flow-through. The fractions displaying the greatest beta-glucosidase activity were the fractions #15-17. These fractions with eluted beta-glucosidase were calculated to have a NaCl concentration of approximately 0.14-0.23M. From SDS-page, one dominating band of approximately 130 kDa was discovered in these fractions (FIG. 17). The intensity of this band in the different fractions followed the measured beta-glucosidase activity. The proteins in this band were found to be highly expressed relative to other proteins in the raw A. saccharolyticus extract (FIG. 18). The band of fraction 16 was excised from the gel, trypsin digested, analyzed by LC-MS/MS, and searched against the NCBI database for peptide matches using the Mascot program. The sample was identified as a beta-glucosidase, having peptides identical to several Aspergilli species, including A. aculeatus (Swiss-Prot: P48825), A. terreus (NCBI ref seq XP_001212225), A. niger (GenBank CAB75696), and A. fumigatus (NCBI ref seq XP_750327). The best match was the beta-glucosidase of A. aculeatus, with five peptide matches. Besides of beta-glucosidase peptides, also peptide matches of beta-galactosidase from different Aspergillus species were found suggesting that the analyzed band contained more than one protein. Only the results for the beta-glucosidase peptides were used for degenerate primer design to obtain the homologous beta-glucosidase of A. saccharolyticus. 
Characterization of Beta-Glucosidase Gene, Bgl1, and Predicted Protein, BGL1
By the use of degenerate primers and genome walking, the genomic coding sequence of bgl1 of 2919 base pairs (incl stop coden) was obtained (GenBank HM853555). The sequence comprised seven exons, intercepted by six introns located at 58-119, 263-313, 359-414, 468-523, 1716-1776, 2636-2685 bp, which all followed the GT-AG rule at the intronlexon junctions. The gene encodes a 680 amino acid polypeptide, BGL1, predicted by NetAspGene 1.0 (Wang et al., 2009) and confirmed by mRNA isolation and sequencing of the derived cDNA. A signal peptide with a cleavage site between amino acid 19 and 20 was predicted by SignalP server (Bendtsen et al., 2004. Nielsen et al., 1997). A TATA-like sequence at position −138 bp, a CCAAT box at position −695 bp, and several CreI sites at positions −145, −619, −1186, −1294, and −1313 were identified upstream of the start codon. Analysis of the predicted cDNA gene sequence revealed 85% identity with bgl1 from A. aculeatus (GenBank 064088.1) (Kawaguchi et al., 1996) and 75% identity with bgl1 A. (NCBI ref seq XM_001398779) (Pel et al., 2007).
The pI of BGL was calculated to 4.96 and the molecular mass was calculated to 91 kDa using the ExPASy Proteomics server (Gasteiger et al., 2005). This prediction does not relate to the size of the band in fraction 16 (FIG. 18), but from the NetNGlyc 1.0 server (Blom et al., 2004) BGL has 12 asparagines that are potential N-linked glycosylation sites. The molecular weight of 130 kDa observed by SDSpage therefore probably reflects extensive glycosylation.
The previous MS/MS data of the band in faction 16 was by use of Mascot searched against possible trypsin fragments and expected MS/MS patterns of the BGL sequence. The observed MS/MS data matched the expected data, thus confirming that the cloned bgl gene codes for the protein present in fraction 16.
Analysis of the amino acid sequence of BGL resulted in 91% identity with beta-glucosidase BGL1 from A. aculeatus (GenBank BAA10968) (Kawaguchi et al., 1996) and 82% identity with beta-glucosidase GBL1 from A. niger (NCBI ref seq XP_001398816) (Pel et al., 2007). Alignment of the amino acid sequence of BGL from A. saccharolyticus with several aspergilli glycosyl hydrolase (GH) family 3 beta-glucosidases revealed a high degree of homology in highly conserved regions including the catalytic sites (FIG. 19), and PROSITE scan (Sigrist of al., 2010) confirmed the presence of a GH family 3 active site in BGL1, predicting the signature sequence to be between amino acids 248-264 (LLKSELGFQGFVMSDWGA) in the mature protein. The putative nucleophile, Asp261, of the mature BGL1 of A. saccharolyticus is located in this region (Henrissat, 1991).
Homology modeling studies show that A. saccharolyticus beta-glucosidase 1 catalytic module possesses a fold similar to that of beta-glucosidase 3B from T. neapolitana with 5 deletions and 8 insertions compared to it (FIG. 20). Although the sequence identity is relatively low (35%) it is obvious that the residues important for substrate binding and catalysis are conserved (FIG. 20A).
These results imply that BGL1 is a novel beta-glucosidase belonging to GH family 3.
Heterologous Expression of Bgl by T. reesei 
The bgl gene was heterologously expressed in T. reesei from the constitutive RP27 ribosomal promoter. Positive transformants were selected by simple pNPG assay, where the negative control, wild type QM6a, showed no beta-glucosidase activity at the culture and assay conditions used. The transformant identified from the screening to have the highest beta-glucosidase activity was confirmed by PCR to have the expression cassette incorporated into its genomic DNA. Using a Ni sepharose column, the his-tagged proteins were purified from an extract of the transformant. An SDS-page gel of the eluent showed two bands (FIG. 18), one correlating in size with the band found in fractions 15-17 in the initial fractionation of the A. saccharolyticus extract (approximately 130 kDa) and another that was smaller (approximately 90 kDa) correlating with the predicted size of the protein. 3.8 mg purified protein was obtained from 100 ml filtered culture extract, which corresponded to about 2.7% of the total amount of protein in the culture extract.
Characterization of the Purified BGL1
The purified BGL1 was characterized by its activity on pNPG and cellobiose.
A substrate saturation plot of BGL1 revealed inhibition of the enzyme reaction, when pNPG in high concentrations was used as substrate. This was observed by a decrease in reaction rate with increasing substrate concentration rather than a leveling off toward a maximum velocity (FIG. 21A). Meanwhile, a MM kinetics relationship was found for cellobiose, where the reaction rate tends towards the maximum velocity (FIG. 21A). A Hanes plot of the cellobiose data gave a good distribution of the data points for preparation of a straight trendline from which Vmax and KM were determined to be 45 U/mg and 1.9 mM, respectively. Glucose inhibition was investigated with pNPG as substrate, showing a reduction in activity to 50% at a product concentration 30 times greater than the substrate concentration (FIG. 21B).
BGL1 was incubated at different temperatures for different time periods to investigate the thermostability and half-life of the enzyme. At regularly used hydrolysis temperature of 50° C., the enzyme was stable throughout the incubation period (data not shown). The enzyme is fairly stable at temperatures up to 58° C. at 4 hour incubation (FIG. 22A), but with temperatures above 60° C. the calculated half-life is approximately 6 hours (FIG. 22A). From 62° C. and up to 65° C. there is a gradually decrease in the half-life to less than 2.5 hours. The pH span of BGL was examined at 50° C. using pNPG as substrate. Its profile gives the typical bell-shape curve with an optimum around pH 4.2, and within the pH range 3.8-4.8 the activity stayed above 90% of maximum. At basic conditions, activity was below 10%, showing that acidic pH values are better suited for enzyme activity (FIG. 22B).
The ability of BGL1 to hydrolyze short chains of glucose units was studied with cellohexaose, -pentaose, -tetraose, and -triose, where only data for cellohexaose hydrolysis is shown here (FIG. 23). Initially, as the level of cellohexaose decreases, the concentration of primarily cellopentaose and glucose increase. Later, as the concentration of cellopentaose has increased, an increase in cellotetraose is observed, indicating that the enzyme hydrolyzes the different cellodextrins depending on the concentration in which they occur. Similar results were obtained using cellopentaose, -tetraose and -triose as initial substrates. These observations of the different cellodextrins increasing in concentration over time related to their length suggests that the enzyme hydrolyzes the different cellodextrins through exohydrolase action, removing one glucose unit at the time releasing glucose and the one unit shorter product before it associates with another substrate, rather than processively cleaving off glucose units.
Discussion
We have cloned a beta-glucosidase, BGL, from the novel species A. saccharolyticus (EXAMPLE 2) and expressed it in T. reesei in order to purify the enzyme for a specific characterization.
Initially, we used ionexchange fractionation of the raw enzyme extract of A. saccharolyticus followed by LC-MS/MS analysis of the dominating protein band in the fractions with high beta-glucosidase activity. This was applied for the identification of active beta-glucosidases from A. saccharolyticus. Aspergilli are known to possess several beta-glucosidases in their genomes, e.g. A. niger has 11 GH3 beta-glucosidases predicted (Pel et al., 2007) of which 6 were identified as extracellular proteins by the SignalP 1.0 server (Bendtsen et al., 2004, Nielsen et al., 1997). With this approach we intended to identify the key beta-glucosidase player amongst the potential several expressed beta-glucosidases of A. saccharolyticus. 
Ion exchange separates molecules on the basis of differences in their net surface charge. The net surface charge of proteins will change gradually as pH of the environment changes (Amersham Biosciences, 2004). The isoelectric point (pI) of the 6 predicted A. niger secreted beta-glucosidases (Pel et al., 2007) were, using ExPASY proteomics server (Gasteiger et al., 2005), calculated to around pH 5. Assuming the pI of the secreted A. saccharolyticus beta-glucosidases are in the same range, an anion column was chosen for ion exchange using Tris buffer pH 8, as proteins will bind to an anion exchanger at pH above its isoelectric point (Amersham Biosciences, 2004). The beta-glucosidases of A. saccharolyticus did bind to the column at these conditions, with no activity found in the initial flow through fractions, and analysis of the later deducted amino acid sequence of BGL was calculated to have a pI of 4.96, correlating well with the above.
Proteomics is useful for the identification of secreted proteins and have been used for the identification of beta-glucosidases of A. fumigatus (Kim et al., 2007a). MS/MS peptide analysis followed by molecular techniques were here employed for the identification and cloning of beta-glucosidases from A. saccharolyticus. From LC-MS/MS analysis, peptides of a beta-glucosidase and a beta-galactosidase were identified in the protein band that was dominating in the protein fractions with high beta-glucosidase activity, Indicating that it had not been a pure band, but rather had it contained both a beta-glucosidase and a beta-galactosidase of A. saccharolyticus. Only the identification of the beta-glucosidase was further pursued.
By genome walking, the beta-glucosidase was successfully cloned, and the size of its cDNA corresponded well with the beta-glucosidases of A. aculeatus (GenBank: BAA10968) and A. niger (GenBank: XP_001398816) to which it is most closely related. However, the predicted polypeptide size of the cloned beta-glucosidase was only 91 kDa compared to the approximately 130 kDa band seen in the SDS page gel. Glycosylation of beta-glucosidases is common (Krogh et al., 2010, Murray et al., 2004, Dan et al., 2000, Jeya et al., 2010. Decker et al., 2000) and it was therefore assumed that the SDS page gel size estimation of the protein was mislead by glycosylation that makes the protein run slower in the gel, which has also been seen with beta-glucosidases from Talaromyces emersonii expressed in T. reesei (Murray et al., 2004). Several potential N-glycosylation sites were identified for BGL, supporting this assumption. Based on interest in obtaining knowledge of regulation of bgl expression in A. saccharolyticus, putative binding sites for the cellulose regulatory protein, CREI, were searched for upstream of the bgl gene. Five putative CreI sites were found within the 1350 pb sequence from genome walking have obtained upstream of the gene. CREI is known to be involved in carbon catabolite repression of many fungal cellulase genes.
BGL1 was based on its amino acid sequence characterized as belonging to the GH family 3, matching the active site signature (Henrissat, 1991, Cantarel et al., 2009). Several GH3 beta-glucosidases have been cloned and characterized, but few studies have been published on heterologous expression by T. reesei, while several have been expressed by E. coli, and some by Yeast (Bhatia et al., 2002). One example of expression by T. reesei is the beta-glucosidase, cel3a cDNA, of T. emersonli where the chb1 promoter and terminator of T. reesei were used (Murray et al., 2004). Another example is the T. reesei production strain by Novozymes A/S expressing A. oryzae beta-glucosidase for improved cellulose conversion (Merino & Cherry, 2007). We here present heterologous expression of bgl from A, saccharolyticus by T. reesei QM6a using the constitutive M. grisea ribosomal promoter RP27 and the N. crassa beta-tubulin terminator to control expression of the gDNA clone of bgl1, thereby successfully combining host, promoter, gene, and terminator from different eukaryotes. The host strain was transformed with the non-linearized plasmid for random insertion, giving recombinant protein yields of 3.8 mg/100 ml from 6 days cultivation of the best transformant. This is significantly greater than the expression levels reached with T. emersonii (Murray et al., 2004), but still low compared to the secretion capacity of T. reesei (Merino & Cherry, 2007).
Interestingly, it appeared that T. reesei secreted the heterologously expressed BGL1 in two different forms represented by the two bands on the SDSpage gel of the histidine-tag purified proteins. It is speculated that these two different bands represent different degrees of glycolysation, the large one being glycosylated to the same extent as found in the A. saccharolyticus secreted BGL, and the smaller one correlating with the predicted molecular mass thus not being glycosylated. Postsecretional modification of glycosylated proteins expressed by T. reesei is medium dependent, with the effect on extracellular hydrolases being most dominating in enriched medium (Stals et al., 2004), possibly explaining the different forms of the recombinant BGL beta-glucosidases. BGL1 is classified as a broad specificity beta-glucosidase as it can hydrolyze both aryl-beta-glycosides, cellobiose, and cellooligo-saccharides (Bhatia et al., 2002). Comparing the properties of A. saccharolyticus BGL to other Aspergillus beta-glucosidases, the observed inhibition at high pNPG substrate concentrations has also been reported for A. niger (Krogh et al., 2010, Seidle et al., 2004, Yan et al., 1998), A. aculeatus and A. japonicus (Decker et al., 2000). Whether the inhibition of A. saccharolyticus BGL is due to regular substrate inhibition kinetics with an additional pNPG binding to the substrate-enzyme complex hindering release of product, or if transglycosylation occurs with pNPG playing the role of the nucleophile competing with a water molecule in breaking the enzyme-product complex, is not known. BGL1 has KM value of cellobiose comparable with other reported values for Aspergillus beta-glucosidases, with KM values of 2-3 mM for A. phoenicis, A. niger, and A. carbonarius beta-glucosidases (Jager et al., 2001), 1 mM for A. japonicus (Korotkova et al., 2009), and a general literature search by Jäger et al. (2001) showing KM varying from 1.5-5.6 mM for A. niger (Jager et al., 2001). Meanwhile, the specific activity, Vmax, of A. saccharolyticus BGL1 was significantly higher than values reported for other purified Aspergillus beta-glucosidases, with cellobiose as substrate in hydrolysis (Table 5) (Jager et al., 2001, Rajoka et al., 2006, Yan & Lin, 1997).







TABLE 5







Comparison of Vmax values reported in the literature for hydrolysis


of cellobiose by purified beta-glucosidases, either heterologously


expressed or directly purified from extract of origin












Assay




Vmax
conditions



Organism ID, enzyme ID
(U/mg)
(° C., pH)
Reference













A. cellulolyticus CBS 127449
49
50, 4.8
This work


A. niger NIAB280
36.5
50, 5.0
Rajoka et al. (2006)


A. niger CCRC31494
5.27
40, 4.0
Yan and Lin (1997)


A. niger BKMF-1305
38.8
50, 4.0
Jager et al. (2001)


A. carbonarius KLU-93
15.4
50, 4.0
Jager et al. (2001)


A. phoenicis QM329
27.3
50, 4.0
Jager et al. (2001)









Hydrolysis of cellodextrins was facilitated by BGL1, as has also been found with A. niger beta-glucosidase, that similarly in exo-fashion removes one glucose unit at the time from the end of the cellodextrins, so that products released are subsequently used as substrates to be shortened by another glucose (Seidle et al., 2004).
Acidic pH being best suited for beta-glucosidase activity was also found for beta-glucosidases from A. oryzae, A. phoenicis, A. carbonarius, A. aculeatus, A. foetidus. A. japonicus, A. niger, and A. tubingensis with optima ranging pH 4-5, and close to no activity at alkaline conditions (Jager et al., 2001, Decker et al., 2000, Korotkova et al., 2009, Riou et al., 1998). Thermal stability, however, is more difficult to compare as different researches use different incubation conditions, times and temperatures. We found A. saccharolyticus BGL to be more thermostable compared with Novozym 188 from A. niger, as it retained more than 90% activity at 60° C. and still had approx. 10% activity at 67° C. after 2 hours of incubation, while Novozym 188 had 75% activity at 60° C. but no activity at 67° C. after 2 hours of incubation (EXAMPLE 1). After 4 hours of incubation these differences is much more pronounced as our BGL still had more than 70% activity while Novozym 188 drop to 40% activity at 60° C. Jäger et at (2001) studied beta-glucosidases from A. phoenicis, A. niger, A. carbonarius, finding them all to be stable at 2 hours incubation at 50° C. while activities of 87%, 64%, and 53%, respectively, remained after 2 hours incubation at 60° C. and total inactivation was observed after 2 hours at 70° C. (Jager et al., 2001). Compared to this, A. saccharolyticus BGL showed approximately the same stability as A. phoenicis. Rojaka et al. (2006) similarly find half-life of A. niger beta-glucosidase to be 8 hours at 50° C. and 4 hours at 60° C. (Rajoka et al., 2006), which is similar to our results (EXAMPLE 1), whereas Krogh et al. indicate a half-life for A. niger BG of 24 hours at 60° C. This is six times longer than measured by us and Rojaka et al. (2006). Decker et al. (2000) demonstrates that an A. japonicus and A. tubingensis beta-glucosidase were remarkably stable, maintaining 85% and 90% activity, respectively, after 20 hours incubation at 60° C. (Decker et al., 2000). However, Korotkova et al. (2009) found A. japonicus beta-glucosidase to only retain 57% of its activity after incubation for 1 hour at 50° C. (Korotkova et al., 2009), contradicting the findings of Dekker et al. (2000). The crude extract of A. saccharolyticus, from which BGL was identified, has previously been characterized by its beta-glucosidase activity and evaluated against two commercial enzyme preparations (EXAMPLE 1). Comparing the enzyme kinetics, temperature and pH profiles, glucose tolerance, and cellodextrin hydrolysis, a striking similarity was found for the crude extract and the purified BGL. Substrate inhibition (or transglycosylation activity) with pNPG was found in both cases, while none was observed for cellobiose within the tested concentrations. There was therefore no foundation for the calculation of Vmax for pNPG as no tendency of the activity approaching a maximum was seen rather the activity decreased with higher substrate concentrations. Therefore Vmax and KM were only calculated for cellobiose where the data correlated well with MM kinetics and a straight Hanes plot could be obtained for determination of the kinetic parameters. Calculated KM values for cellobiose were similar, 1.9 mM for the purified BGL vs. 1.09 mM for the crude extract, while the Vmax value expectedly increased for the purified BGL compared to the crude extract. The pure enzyme was inhibited by glucose to the same extent as the crude extract, the pH and temperature profiles were very similar, and the mode of hydrolysis of cellodextrins was consistent. This all together indicate that BGL is the main contributor to the beta-glucosidase activity observed in the crude extract of A. saccharolyticus. 
The crystal structure of a beta-glucosidase from barley has recently been used as template to construct a homology model of a beta-glucosidase from Penicillium purpurogenum where superimposition of the modeled structure on the true structure from barley showed similar orientation and location of the conserved catalytic residues (Jeya et al., 2010). We chose to use the recently resolved crystal structure of a T. neopolitana beta-glucosidase to construct a homology model of the A. saccharolyticus BGL and found that the conserved catalytically important residues show that the enzyme possesses beta-glucosidase activity (FIG. 20A). The deletion of loop X (FIG. 20B), having Ser370 described to have weak H-bonds with glucose in −1 subsite in T. neapolitana structure, makes the catalytic pocket wider where this may be important for substrate accessibility as well as to remove the product fast from the enzyme. The insertions and deletions lining the catalytic pocket (FIG. 20B) may play a major role in the dynamics of the enzyme. The motif KHFV, Lys163, His164, Phe165, Val166, in the T. neapolitana structure is considered to be important for substrate recognition (Pozzo et al., 2010). However, this motif in the A. saccharolyticus enzyme is slightly different, KHYI, Lys170, His171. Tyr172 and Ile173. The homology modeling revealed that the catalytic pocket of A. saccharolyticus beta-glucosidase is open compared to those of barley (PDB entry 1 LQ2) (Hrmova et al., 2004). Pseudoalteromonas sp. BB1 (PDB entry 3F94) and T. neapolitana (Pozzo et al., 2010) indicating possible high activity. The distance between the putative nucleophile (D261) and the acid/base (E490) is approximately 5.8 Å displaying the general characteristic of a retaining enzyme.
In conclusion, a novel highly efficient beta-glucosidase from the newly discovered species A. saccharolyticus has been identified and expressed. The enzyme has a great potential for use in industrial bioconversion processes due to its high degree of thermostability compared to the commercial beta-glucosidase from A. niger (Novozym 188) as well as a high specific activity.
Sequences
SEQ ID NO: 1: BGL1 gDNA
Aspergillus saccharolyticus BGL1 gDNA sequence
>Gene#BGL gDNA 2919 bp
SEQ ID NO: 2: BGL1 actual cDNA
Aspergillus saccharolyticus BGL1 cDNA sequence
>Gene#BGL actual cDNA 2582 bp
SEQ ID NO: 3: BGL1 protein
Aspergillus saccharolyticus BGL1 protein sequence
>Gene#BGL1 protein 861aa
signal peptide is underlined
amino acid residues shown in bold are involved in substrate binding
Residues shown in italics are D (catalytic nucleophil) and E catalytic acid residue





















APTFGEIGNASDYLYPEGLDRITAFIYPWLNSTDLKESSGDPDYGVDTAKYIPAGATNS


 


SAQPVLPAGGGFGGNPRLYDELIRVSVTVKNTGRVTGDAVPQLYVSLGGPNEPKVVL


 


RQFDRITLRPSEETVWTTTLTRRDLSNWDVAAQDWVITSYPKKVHVGSSSRQLPLHA


 


ALPKVQ






SEQ ID NO: 4: BGL1 protein without signal peptide

Aspergillus saccharolyticus BGL1 protein sequence without signal peptide

BGL1 protein without signal peptide




















TFGEIGNASDYLYPEGLDRITAFIYPWLNSTDLKESSGDPDYGVDTAKY


 


IPAGATNSSAQPVLPAGGGFGGNPRLYDELIRVSVTVKNTGRVTGDAVP


 


QLYVSLGGPNEPKVVLRQFDRITLRPSEETVWTTTLTRRDLSNWDVAAQ


 


DWVITSYPKKVHVGSSSRQLPLHAALPKVQ






SEQ ID NO: 5; BGL2 gDNA

Aspergillus saccharolyticus BGL2 gDNA sequence

ATG start site and signal sequence as well as stop codon are highlighted bold

Introns are underlined








gccttaaggccnaagagccgcccagatcgttattcatccaacaatgattg


 


actgcctcgttgacattgactgtggtgctctggacactgattggttttct


 


tctatcatatgtcatggtgtgtgcagactgcatatgtgattcgaggccgc


 


gtgatccaagatccctgtttggactggggtaggaagacaggtagctatat


 


cttcagcagcctgtcgggtcataaacggtgatggtaaggttttcctgagt


 


ctgaccgtgtcctttcttccgttcaggggcattgacaatgactcctgtct


 


ggcattatctcatttatctgaccctgcttcttccaggataccttgcagcc


 


gatcaccgccgccgcgacgatgacgctgaagccttctcgcctccctacta


 


tccggcccctccgggaggttggatatccgattggagtgctgcatacgcca


 


aagctcaggctgtggtgagcaatatgaccctagctgagaaagtcaacctc


 


actaccggtaccggaatgttcatgggcccttgcgtcggtcaaacaggtag


 


cgcacttcgattcgggataccaaacctctgtatgcaggactcccctctgg


 


gaatccgcaactcggaccataataccgcgttccctcctggggtaactgtt


 


ggagctacctgggacaaggatctgatgtaccagcgtggtgtcgaacttgg


 


ggaagaagctcgcgggaaaggtgtgaacgttctgcttggtccagtggtcg


 


gacccatgttcaggaagccactcggcggacgcgggtgggaaggcttcggc


 


gccgatccgaccctgcaggcagttggaggcgcattgacgatccagggcat


 


gcaaagcactggtgcgatagcttgtttgaaacatttcattgggaatgagc


 


aagagatgtatcgcgagacctcggttctaactcaaggttattcatcgaac


 


atcgatgaccgtaccctgcatgaactgtacttgtggccatttgcggaggg


 


agtccgggctggcgtgggctctgtgatgatggcgtacaacgatgtgagtt


 


cctcagacagtaggccagacggatttactgatcaggataggtgaatcgct


 


cggcctgtagccagaatagcatgctcatcagcggcatccttaaggacgag


 


ttaggcttccaggggtttgtcatgaccgactggctggctcagcagggcgg


 


cgtctcgtctgccctcgccggacttgacatggctatgcctggcgatgggg


 


ccatccctttgctcggggatgcttactggggatccgagctatcaaccgcc


 


atcctcaacggaacagtgccgctggatcgactcaatgacatggtatgaga


 


tcgtcaacctcctgctcctttcatactaagttttcaaggtcactcggatc


 


gttgcgacttggtatcaaatgggtcaggatgaggattatcctctgcccaa


 


cttttcgagcaacacgctcgacaaaacaggccctctctatcccggtgccc


 


tgttctccccgacgggcgttgtcaaccaatatgtcgacgtgcaaggcaac


 


cataacatcactgcgcacgctgttgcccgagatgcgatcactctcctcaa


 


gaacgagaataacacattgcccctcaagcgcagtgccgctctcaaggtgt


 


ttggtaccgatgctgggcccaacacttccggcctcaactcctgtagtgac


 


atgggctgcgaccagggcgtccttacgatgggctggggaagtggtacctc


 


gcacctcccttcactcgtcacgccgcaagaagccattgccaatcttacta


 


cgtcgaattcgactaccttttacttgtcggatacgttccctgccaatctc


 


gccaccccatccacttccgacatcgctgtggtcttcatcaacgctgactc


 


tggcgagaactacatcactgtcgagtccaatccaggagaccgcaccagcg


 


caggcttcgatgcgtggcacaacggcaacgcgctcgttcaagctgctgcg


 


gccgagttctcgactgtggttgtagtgatccatactgttggccctatact


 


gcttgaatcgtttattgacctccctagcgtcaaggctgtgcttattgctc


 


acctccccggccagactgccggctattcgctcacggatgtcctgtatggc


 


gaggtcagccctagcggccatctgccctacactatccctacatcggcgtc


 


aaactacccatcctccatggacatcatcacctcacagccacttttgtccc


 


agatccaggactggtttgatgaggggatttacatcgactatcgttacttt


 


ctacaagccaacatcaccccccgctaccctttcggctacggattgtcgta


 


cacgacgttccagtactcggcaccagttctgaccactgtgaccgaactga


 


gcaccgaatatcccgctgcgagagcaagcaaggcttcggtcccaacttat


 


cccacagatattcccgatcctcaagaagtcgcatggccgagcacgcttga


 


tcggatctggcgctacctgtacccgtatctggatgatcccgagagcgtta


 


ccaacacaagcacctactcgtacccggccggctactccaccacggcgcat


 


gcggccccgcgtgccgggggaggacagggtggcaaccctgcccttttcga


 


aaccgcttttgaggtagcggtgaccatcaccaacaccggcacacgaagtg


 


gacgagccgtggcacaactgtatgtgcaaatgccggatgaggcagttctt


 


ggagtagacaccccgaagagacagttgcgggcgtttgcgaagaccgggac


 


cctggcgtccggggagagcgaagtcgtgactatgaatgtgaccaggaaag


 


atttgagtgtgtgggatgtcacggtgcaggattggcgagcgccagttggt


 


ggagcgggtgtgactttctgggtaggggacagtgttgcagaagaggacct


 


gacggtgaaatgtgctgttgggagtgactagggggctcataggccttaag


 


gc






SEQ ID NO: 6: BGL2 cDNA

Aspergillus saccharolyticus BGL2 cDNA sequence

SEQ ID NO: 7: BGL2 protein

Aspergillus saccharolyticus BGL2 protein sequence

Signal sequence is highlighted bold








mtpvwhyliyltlllpgylaadhrrrdddaeafsppyypappggwisdws


 


aayakaqavvsnmtlaekvnlttgtgmfmgpcvgqtgsalrfgipnlcmq


 


dsplgirnsdhntafppgvtvgatwdkdlmyqrgvelgeeargkgvnvll


 


gpvvgpmfrkplggrgwegfgadptlqavggaltiqgmqstgalaclkhf


 


igneqemyretsvltqgyssniddrtlhelylwpfaegvragvgsvmmay


 


ndvnrsacsqnsmlisgilkdelgfqgfvmtdwlaqqggvssalagldma


 


mpgdgaipllgdaywgselstailngtvpldrlndmvtrivatwyqmgqd


 


edyplpnfssntldktgplypgalfsptgvvnqyvdvqgnhnitahavar


 


daitllknenntlplkrsaalkvfgtdagpntsglnscsdmgcdqgvltm


 


gwgsgtshlpslvtpqeaianlttsnsttfylsdtfpanlatpstsdiav


 


vfinadsgenyitvesnpgdrtsagfdawhngnalvqaaaaefstvvvvi


 


htvgpillesfidlpsvkavliahlpgqtagysltdvlygevspsghlpy


 


tiptsasnypssmdiitsqpllsqiqdwfdegiyidyryflqanitpryp


 


fgyglsyttfqysapvlttvtelsteypaaraskasvptyptdipdpqev


 


awpstldriwrylypylddpesvtntstysypagysttahaapragggqg


 


gnpalfetafevavtltntgtrsgravaqlyvqmpdeavlgvdtpkrqlr


 


afaktgtlasgesevvtmnvtrkdlsvwdvtvqdwrapvggagvtfwvgd


 


svaeedltvkcavgsd*






SEQ ID NO: 8: BGL3 gDNA

Aspergillus saccharolyticus BGL3 genomic DNA sequence

ATG start site and signal sequence as well as stop codon are highlighted bold

Introns are underlined








gccttaaggcctaggaacgtcccagaacgttgatcccaggactggccaat


 


ttttcccttttcttttgtctgcagcgtgagaatagattgagcgtcggctt


 


gtcaagtcagccagctcctctttccctcaccttttcacaatgggtgtcag


 


tctgctagccaaggggcttgcgcttcttcacctctgcgccggtgtcactg


 


ccagtagcaatgactcaacaccgctgtacaagaaccccaatgcgccggtg


 


gaggatcgtgtcagtgaccttctgggccgcatgaccatccacgacaagac


 


gggacaactgatgcaaggtatgagtcttcctcgcgggtgatccgttaaat


 


gtcttggataatctgtgctgactgctactgcaggggatctcgcgaactgg


 


atgaacaccacaactggagcgttcaactacacgggtctggtcgcgaacat


 


ggaaatgaaggcgggaggattctacggtacgagtccttgatcatgctgat


 


tatcgcgatgggaaagctgactagcgggcagttggatatgcggtcccgtg


 


ggactggatggtgaccaacatcaagcatgcgcaggactacctgatccata


 


acaccacgcttggtattcctgcacttgttcagtcagaaggtaggcttgat


 


gcaaaagttttggggaggatgttgctcacggctgcaggtattcatgggtt


 


cctggttcagaacgccactattttcaattcccctattgcatatggttgct


 


ccttcaaccgtgaggtgagtggtggacaccaactccagtgagccctgcag


 


gctaatgatcgataacagctggtctccaaaatggccaaaatcatcagtca


 


agaatctctcactctgggcgtcaaccagctatttgcccctgtggttgacc


 


tggcccgtgagctgcggtatgggcgggtaagctcatgacttggacatagg


 


ctaggctaggctttttagctaattgattaacaggccgaagagacgttctc


 


ggaggacccataccttgctggcgagattggctacaactatgtgcaaggcc


 


tgcagagtctcaacgtttcggccactgtcaagcattttgcgggcttcagt


 


gcccctgaacaggggttgaacactgcgccagttcagggaggagagcgata


 


tcttcgtactacgtaagtacagctaacaatcttaagatttatgctgacat


 


gatgcagctggctgcactcattcaagcgtgcgatcatcgatgcaggtgca


 


tggagtgtcatgagcgcataccactcgtgagtttgatgcttttgggaaca


 


agattccttgcttacatgcatctagctacgatggcattcccgctgttgcc


 


gactggtttaccctgacaaaggttctgcgagaagagtggggtttcaagca


 


ctgggttttcagcgattcgggcgctactgatcgactgtgcaccgctttca


 


agctctgtcaagcctctccaatcgacatggaagcagtcaccctgcaggca


 


ctccctgctggtaacgacgttgagatgggtggtggctccttgtaagtatc


 


ctaggttggtaacctgcgagagactaaccctgtctagcaacttccagaag


 


atcccggagcttgtagagtccggaaggctggacatcgagactgttgacac


 


tgctgtctcgcgcattctgagggccaagttcgaaatgggtctctttgaga


 


accccttccctgctgctcctgagtcggagtggcacaagttgatccacagc


 


tcagaggcggtcgagctcgctagaaccttggacaaggagtctatcgtctt


 


gctggagaaccacaacaagacccttcctttggacaagagcggcagcatcg


 


ccgttattgggcccatggcccatggcttcatgaacgtgagtgattggcct


 


atctcggcccagagcatctactaacttatatacagtatggagactacgtc


 


gtttacaagagccagtaccgcggtgtaacccctctggacggcatcaaagc


 


tgctgttggcgacaacgccacgatcaactacgcccagggctgcgagcggt


 


ggagcaacgaccagtccggcttcgatgaagccattgcagcggccaagaag


 


tcggacgtggctgttgtcgtcgtaggcacctggtctcgcgaccagaccga


 


gctgtggtccggttacaacgcgacgtgagttgcctattgcttgcatgtaa


 


tcccgagacgtcgccgctaaccaccaacagaaccggcgagcacattgatc


 


tggataacctcgccctcgtcggtgcccaaggcccgctcgtcaaggctatt


 


atcgacaccggcgtccccaccatcgtggtcctctccagcggcaagcccat


 


cacggacgtgacctggctcgcgaactcgaccgcggcgctcgtccagcaat


 


tctatccgtcggagcaaggcggcaatgcgctggccgacgtgctgttcggc


 


gactacaacccctctggcaagctgtccgtcagcttcccgcgcttcgtcgg


 


cgacctcccgatctactacgacttcctcaattcggcgcgcaacatcggcc


 


cggccggccacgccttccccaacggcaccctggaattcgagagccagtac


 


gtcctgggcgaccccaccgcgatctacgagttcgggtacggcaagagcta


 


cgtcgactttgactacggcgccgtcacgctgagccagaccaacgtgaccg


 


cctcggacacggtgacggtccgcgtggacgtgaccaacactgacgccacc


 


cgcgacggcaccgaggtcgtgcaggtgtatgtgtcggatgtgatcgcgct


 


ggtggtggtgccgaaccgggcgctcaagggcttcgagaaagtggtcatcc


 


cggctggcacgaccaagacggtggagattgatttgcaggtggaggacctg


 


gggctctggaaccgctcgatgcagtatgtcgttgagccgggagcgtttgc


 


ggtgttggtgggcagcagttcggcggatatccgggggaatgcgacgtttt


 


atgttgagtaggtctgatgcggatgggtgagtggtacagtgggtggcggc


 


aatcaccgggtcaattgcttcgatacctaccctgcttattgattgttcgc


 


tcaatcactttctttgaatacttctattaaagctcttgtgatgagtggct


 


ctagttggttgggatggtggttagttgaaggtagaagtgtagtctactgt


 


ctgtcatcaataaatagcgcgaaacagatgttattttgcagtcggggtga


 


caggtttttaaaactttatttgacgaaacgagaaaatatcagagagtaaa


 


tgattcgaaccgggatgactttgatctgagatctagacagtggtagcccc


 


ggcataagtgaagataaagagagatgcaacgggtgctgttcgatcgatcc


 


gattgcccattacgtggacctggaaagaaaccctaaatgctcgtctagcc


 


gtcctgcagccattctcccctggtttaacgagctctccaccctccgctcg


 


ccgttggtttgaccccataccgcggggtcatagctcaaagacacagccaa


 


taagaacatatccgcatccccgaagtaggcctaaccg






SEQ ID NO: 9: BGL3 cDNA

Aspergillus saccharolyticus BGL3 cDNA sequence

ATG start site and signal sequence as well as stop codon are highlighted bold








atgggtgtcagtctgctagccaaggggcttgcgcttcttcacctctgcgc


 


cggtgtcactgccagtagcaatgactcaacaccgctgtacaagaacccca


 


atgcgccggtggaggatcgtgtcagtgaccttctgggccgcatgaccatc


 


cacgacaagacgggacaactgatgcaaggggatctcgcgaactggatgaa


 


caccacaactggagcgttcaactacacgggtctggtcgcgaacatggaaa


 


tgaaggcgggaggattctacgttggatatgcggtcccgtgggactggatg


 


gtgaccaacatcaagcatgcgcaggactacctgatccataacaccacgct


 


tggtattcctgcacttgttcagtcagaaggtattcatgggttcctggttc


 


agaacgccactattttcaattcccctattgcatatggttgctccttcaac


 


cgtgaggccgaagagacgttctcggaggacccataccttgctggcgagat


 


tggctacaactatgtgcaaggcctgcagagtctcaacgtttcggccactg


 


tcaagcattttgcgggcttcagtgcccctgaacaggggttgaacactgcg


 


ccagttcagggaggagagcgatatcttcgtactacctacgatggcattcc


 


cgctgttgccgactggtttaccctgacaaaggttctgcgagaagagtggg


 


gtttcaagcactgggttttcagcgattcgggcgctactgatcgactgtgc


 


accgctttcaagctctgtcaagcctctccaatcgacatggaagcagtcac


 


cctgcaggcactccctgctggtaacgacgttgagatgggtggtggctcct


 


tcaacttccagaagatcccggagcttgtagagtccggaaggctggacatc


 


gagactgttgacactgctgtctcgcgcattctgagggccaagttcgaaat


 


gggtctctttgagaaccccttccctgctgctcctgagtcggagtggcaca


 


agttgatccacagctcagaggcggtcgagctcgctagaaccttggacaag


 


gagtctatcgtcttgctggagaaccacaacaagacccttcctttggacaa


 


gagcggcagcatcgccgttattgggcccatggcccatggcttcatgaact


 


atggagactacgtcgtttacaagagccagtaccgcggtgtaacccctctg


 


gacggcatcaaagctgctgttggcgacaacgccacgatcaactacgccca


 


gggctgcgagcggtggagcaacgaccagtccggcttcgatgaagccattg


 


cagcggccaagaagtcggacgtggctgttgtcgtcgtaggcacctggtct


 


cgcgaccagaccgagctgtggtccggttacaacgcgacaaccggcgagca


 


cattgatctggataacctcgccctcgtcggtgcccaaggcccgctcgtca


 


aggctattatcgacaccggcgtccccaccatcgtggtcctctccagcggc


 


aagcccatcacggacgtgacctggctcgcgaactcgaccgcggcgctcgt


 


ccagcaattctatccgtcggagcaaggcggcaatgcgctggccgacgtgc


 


tgttcggcgactacaacccctctggcaagctgtccgtcagcttcccgcgc


 


ttcgtcggcgacctcccgatctactacgacttcctcaattcggcgcgcaa


 


catcggcccggccggccacgccttccccaacggcaccctggaattcgaga


 


gccagtacgtcctgggcgaccccaccgcgatctacgagttcgggtacggc


 


aagagctacgtcgactttgactacggcgccgtcacgctgagccagaccaa


 


cgtgaccgcctcggacacggtgacggtccgcgtggacgtgaccaacactg


 


acgccacccgcgacggcaccgaggtcgtgcaggtgtatgtgtcggatgtg


 


atcgcgctggtggtggtgccgaaccgggcgctcaagggcttcgagaaagt


 


ggtcatcccggctggcacgaccaagacggtggagattgatttgcaggtgg


 


aggacctggggctctggaaccgctcgatgcagtatgtcgttgagccggga


 


gcgtttgcggtgttggtgggcagcagttcggcggatatccgggggaatgc


 


gacgttttatgttgagtag






SEQ ID NO: 10: BGL3 protein

Aspergillus saccharolyticus BGL3 protein sequence

Signal sequence is highlighted bold








mgvsllakglallhlcagvtassndstplyknpnapvedrvsdllgrmti


 


hdktgqlmqgdlanwmntttgafnytglvanmemkaggfyvgyavpwdwm


 


vtnikhaqdylihnttlgipalvqsegihgfivqnatifnspiaygcsfn


 


reaeetfsedpylageigynyvqglqslnvsatvkhfagfsapeqglnla


 


pvqggerylrttydgipavadwttltkvlreewgfkhwvfsdsgatdric


 


tafklcqaspidmeavtlqalpagndvemgggsfnfqkipelvesgrldi


 


etvdtavsrilrakfemgifenpfpaapesewhklihsseavelartldk


 


esivllenhnktlpldksgsiavigpmahgfmnygdyvvyksqyrgvtpi


 


dgikaavgdnatinyaqgcerwsndqsgfdeaiaaakksdvavvvvgtws


 


rdqtelwsgynattgehididnlalvgaqgplvkaiidtgvptivvlssg


 


kpitdvtwlanstaalvqqfypseqggnaladvlfgdynpsgklsvsfpr


 


fvgdlpiyydflnsarnigpaghafpngtlefesqyvigdptaiyefgyg


 


ksyvdfdygavtlsqtnvtasdtvtvrvdvtntdatrdgtevvqvyvsdv


 


ialvvvpnralkgfekvvipagttktveidlqvedlglwnrsmqyvvepg


 


afavlvgsssadirgnatfyve*






SEQ ID NO: 11: BGL4 gDNA

Aspergillus saccharolyticus BGL4 gDNA sequence

ATG start site and signal sequence as well as stop codon are highlighted bold

Introns are underlined








gccttaaggcctacgaaactcccagccacctacctaaccctcattcttgc


 


cctggatattccactgctgaaacctgcagatggccgtcttagagcctttc


 


agttcttgtttttctgccgatatttacccgggagtcaggcaattctgcgg


 


agtattcggagcattaggtgggattgaccaactcggtcttcttgtacagt


 


ccactcgatgcattggactaaaggtataaatacgtcaggcagtcgcggag


 


gcaaaatatcgagacaggcaagcgagtccagcagaatgtacggtctagca


 


tcttttgcggccttgttgggcggtctttcactttgctccgcggccccgac


 


tgagcaaaatattacaagcgatacttacttttatggcgattctccgcccg


 


tctacccctcccgtacgtgcaacactgtgcttttctaccatgtcctcaat


 


actggcccaaccatctagcggacggtgccggaaccgggtcctgggccgca


 


gcctacgtaaaggcaaagagttttgtcgctcaactcacagacgaggagaa


 


gatcaacttcacagccgggtatactgccagtaatggctgctcaggcaaca


 


ttccagcagtctctcgtctcggcttccccgggctttgtgtttctgatgca


 


ggaaatgggctggtaagtgcacaaggtcgcgctggattgaccatgaccgc


 


taacatttacgcagcgtggaaccgattttgtgaatggctggccaagtggc


 


attcacgtgggagcaaggtaagagatgtcacagccactgcatccgtggca


 


aacgagtaatgattccattctatctagctggaataaaactcttgcacacc


 


aacgcgccctatacatgggacaggagttccatcgaaagggggtaaatctc


 


ctactgggcccagttgttggcccacttggtcgtgtcgtggaaggtggtcg


 


taactgggaaggctttgccaacgatccttacctcagcggtgcgctggtgt


 


atgagactgtgcagggtgtgcaggaagccggtgtcggcgtttcggtcaag


 


gtatgtgcataccatcttactggaaagtcatctgagtcatggctaagggt


 


tgaatcaaagcactacatcggaaacgagcaagagaccaacagaaaccccg


 


agactgagaacggcgtcactgttgcctcagtttcctctaacatcgacgac


 


aaaactatccatgaactgtatctttggccatttcaagacgccgttctggc


 


gggaagtgtctccgtgatgtgctcgtacaaccgagtcaataattcctaca


 


gctgccagaacagtaagacgctgaatggtcttctgaagaccgaactgggc


 


ttccaaggtaagacggcctaatcaatcctccgcatcattgctgatatttg


 


caaggctacgttgtcactgattgggatgcccaacacgccgggatcgctgg


 


tgctaatgccggcctggacatggtcatgccaagtaccaccacatgggggt


 


ccaatctcacgacggccattgccaacggcagcatggaagcatcgagactg


 


gacgatatggtcactaggtaggttagatcaccttccacctttgatactca


 


ttcttactcaatcaggatcgttgcctcctggtaccaattaaaccaagaca


 


ccgactttccctcaccaggcattgggatgcccgtcgacgtctactccgag


 


catgagatcgtcattggaacttctgccgatgagaaggacgctttgctgca


 


aagcgcaatcgagggacacgtcctcgttaaaaaccaaggctccgtcctcc


 


ctctccagtcgccacgcctagtctccgtgttcggctacgacgccaaagcc


 


ccggagtccctggacctagcccccgtctctctaagtgtcgctccgcccac


 


gcaaaacaacacactctgggtgggcggaggttccggtgccaacaatcccg


 


catacgttatcgcccccttggacgccatccagcaacaagcctatgaagac


 


aacaccgccgtcctctgggacgtgacatcgttcgacccagacgtcgaccc


 


cgcctcccacgcctgcctagttttcatcaacagctacgcctccgaaggca


 


gtgaccggacaggtctggtggactccgacagcgacacgctggtaaccaac


 


gtcgccagcaaatgcaacaacacgatcgtcgtgatccacaacgcgggcat


 


ccgtctcgtgtataactggatcgaccacgagaacgttaccgctgtgatct


 


tcgcccatcttccaggccaagacacaggcaaagctctcgtggatttactg


 


tacggccgcgccaacccctcgggccgcctcccctacaccgtcgccaagca


 


ggcctccgactacggcgcagtcttacaccccgtgcagcccgtcgcgcctt


 


acggcctgttcccgcaggacaacttcaccgagggagtatacatcgactac


 


cgcgccttcgacaaggaggacatcactccgcagttcgagttcggcttcgg


 


tctctcgtacaccaccttcgattattccagcctgaacatccaacgcacct


 


cggtcgaggccacacagtaccctcctgcggcggttatccaggaaggaggc


 


aacccgcggctgtgggatgttttggtcaacgtcacggcgcaggtggagaa


 


cgccggctcggtcgacggcgcggaggtcgcacagctgtacgtgggcatcc


 


ccaatggaccgatccgtcagctgcgcgggttcgataaggtgaatatcctg


 


gctggggagacggtgacggtcacgttcgccttgacgagacgtgatttgag


 


tacgtggagtgtggaggcgcaggagtgggagctgcagcagggagaatata


 


aggtgtatgtgggacgatcgagtcgggatctgcctctgacggggagtttg


 


accttgtgaagtgtagtattgccaggagatgacacttggatgataattga


 


aaatcttccactccattctaatgcaatttagtctgcatctattcaactgc


 


tgtaaaacccgtcccaagtgcaaatcaaaccacaaaccacaaaagttaac


 


ataaccgtccatcgcagaccggtctcagaatcctacaacaatcaatataa


 


tcaccacgccccaccgatgcctcatctccaatacccgcgcccacccgccc


 


ccaacatcccagacttaaccgtccccaactcttcaccatcaacatcctcc


 


tccaccaagcctacatcccagacataatattcctcaactcctccgcatcc


 


ccgaactaggccttaaccg






SEQ ID NO: 12: BGL4 cDNA

Aspergillus saccharolyticus BGL4 cDNA sequence

ATG start site and signal sequence as welt as stop codon are highlighted bold








atgtacggtctagcatcttttgcggccttgttgggcggtctttcactttg


 


ctccgcggccccgactgagcaaaatattacaagcgatacttacttttatg


 


gcgattctccgcccgtctacccctccccggacggtgccggaaccgggtcc


 


tgggccgcagcctacgtaaaggcaaagagttttgtcgctcaactcacaga


 


cgaggagaagatcaacttcacagccgggtatactgccagtaatggctgct


 


caggcaacattccagcagtctctcgtctcggcttccccgggctttgtgtt


 


tctgatgcaggaaatgggctgcgtggaaccgattttgtgaatggctggcc


 


aagtggcattcacgtgggagcaagctggaataaaactcttgcacaccaac


 


gcgccctatacatgggacaggagttccatcgaaagggggtaaatctccta


 


ctgggcccagttgttggcccacttggtcgtgtcgtggaaggtggtcgtaa


 


ctgggaaggctttgccaacgatccttacctcagcggtgcgctggtgtatg


 


agactgtgcagggtgtgcaggaagccggtgtcggcgtttcggtcaagcac


 


tacatcggaaacgagcaagagaccaacagaaaccccgagactgagaacgg


 


cgtcactgttgcctcagtttcctctaacatcgacgacaaaactatccatg


 


aactgtatctttggccatttcaagacgccgttctggcgggaagtgtctcc


 


gtgatgtgctcgtacaaccgagtcaataattcctacagctgccagaacag


 


taagacgctgaatggtcttctgaagaccgaactgggcttccaaggctacg


 


ttgtcactgattgggatgcccaacacgccgggatcgctggtgctaatgcc


 


ggcctggacatggtcatgccaagtaccaccacatgggggtccaatctcac


 


gacggccattgccaacggcagcatggaagcatcgagactggacgatatgg


 


tcactaggatcgttgcctcctggtaccaattaaaccaagacaccgacttt


 


ccctcaccaggcattgggatgcccgtcgacgtctactccgagcatgagat


 


cgtcattggaacttctgccgatgagaaggacgctttgctgcaaagcgcaa


 


tcgagggacacgtcctcgttaaaaaccaaggctccgtcctccctctccag


 


tcgccacgcctagtctccgtgttcggctacgacgccaaagccccggagtc


 


cctggacctagcccccgtctctctaagtgtcgctccgcccacgcaaaaca


 


acacactctgggtgggcggaggttccggtgccaacaatcccgcatacgtt


 


atcgcccccttggacgccatccagcaacaagcctatgaagacaacaccgc


 


cgtcctctgggacgtgacatcgttcgacccagacgtcgaccccgcctccc


 


acgcctgcctagttttcatcaacagctacgcctccgaaggcagtgaccgg


 


acaggtctggtggactccgacagcgacacgctggtaaccaacgtcgccag


 


caaatgcaacaacacgatcgtcgtgatccacaacgcgggcatccgtctcg


 


tgtataactggatcgaccacgagaacgttaccgctgtgatcttcgcccat


 


cttccaggccaagacacaggcaaagctctcgtggatttactgtacggccg


 


cgccaacccctcgggccgcctcccctacaccgtcgccaagcaggcctccg


 


actacggcgcagtcttacaccccgtgcagcccgtcgcgccttacggcctg


 


ttcccgcaggacaacttcaccgagggagtatacatcgactaccgcgcctt


 


cgacaaggaggacatcactccgcagttcgagttcggcttcggtctctcgt


 


acaccaccttcgattattccagcctgaacatccaacgcacctcggtcgag


 


gccacacagtaccctcctgcggcggttatccaggaaggaggcaacccgcg


 


gctgtgggatgttttggtcaacgtcacggcgcaggtggagaacgccggct


 


cggtcgacggcgcggaggtcgcacagctgtacgtgggcatccccaatgga


 


ccgatccgtcagctgcgcgggttcgataaggtgaatatcctggctgggga


 


gacggtgacggtcacgttcgccttgacgagacgtgatttgagtacgtgga


 


gtgtggaggcgcaggagtgggagctgcagcagggagaatataaggtgtat


 


gtgggacgatcgagtcgggatctgcctctgacggggagtttgaccttgtg


 


a






SEQ ID NO: 13: BGL4 protein

Aspergillus saccharolyticus bgl4 protein sequence

Signal sequence is highlighted bold








myglasfaallgglslcsaapteqnitsdtyfygdsppvypspdgagtgs


 


waaayvkaksfvaqltdeekinftagytasngcsgnipavsrlgfpglcv


 


sdagnglrgtdfvngwpsgihvgaswnktlahqralymgqefhrkgvnll


 


lgpvvgplgrvveggrnwegfandpylsgalvyetvqgvqeagvgvsvkh


 


yigneqetnrnpetengvtvasvssniddktihelylwpfqdavlagsvs


 


vmcsynrvnnsyscqnsktlngllktelgfqgyvvtdwdaqhagiagana


 


gldmvmpstttwgsnlttaiangsmeasriddmvtrivaswyqlnqdtdf


 


pspgigmpvdvyseheivigtsadekdallqsaieghvlvknqgsvlplq


 


sprlvsvfgydakapesldlapvslsvapptqnntlwvgggsgannpayv


 


iapldaiqqqayedntavlwdvtsfdpdvdpashaclvfinsyasegsdr


 


tglvdsdsdtlvtnvaskcnntivvihnagirlvynwidhenvtavifah


 


lpgqdtgkalvdllygranpsgrlpytvakqasdygavlhpvqpvapygl


 


fpqdnftegvyidyrafdkeditpqfefgfglsyttfdysslniqrtsve


 


atqyppaaviqeggnprfwdvlvnvtaqvenagsvdgaevaqlyvgipng


 


pirqlrgfdkvnilagetvtvtfaltrrdlstwsveaqewelqqgeykvy


 


vgrssrdlpltgsltl*






SEQ ID NO: 14: beta-tubulin gene

>Aspergillus AP, Aspergillus saccharolyticus beta-tubulin, partial coding sequence

SEQ ID NO: 15: calmodulin gene

>Aspergillus AP, Aspergillus saccharolyticus calmodulin, partial coding sequence

SEQ ID NO: 16: ITS gene

>Aspergillus AP, Aspergillus saccharolyticus ITS, partial coding sequence

SEQ ID NO: 17: BGL1 protein signature sequence

BGL1, predicting the signature sequence to be between amino acids 248-264 (LLKSELGFQGFVMSDWGA)

SEQ ID NO: 18-28: gene primers

ITS gene primers











ITS1
(5′ TCCGTAGGTGAACCTGCGG 3′)



 



ITS2
(5′ GCTGCGTTCTTCATCGATGC 3′)



 



ITS4
(5′ TCCTCCGCTTATTGATATG)






beta-tubulin gene primers











Bt2a
(5′ GGTAACCAAATCGGTGCTGCTTTC)



 



Bt2b
(5′ ACCCTCAGTGTAGTGACCCTTGGC)






calmodulin gene primers











Cmd5
(5′ CCGAGTACAAGGAGGCCTTC)



 



Cmd6
(5′ CCGATAGAGGTCATAACGTGG)






Primers for UP-PCR fingerprinting











L45
(5′ GTAAAACGACGGCCAGT)



 



L15/AS19
(5′ GAGGGTGGCGGCTAG)






Degenerate primers










5′ CACGAAATGTACCTCtggcccttygc



 



5′ CCTTGATCACGTTGTCGccrttcykcca,






Where y is A or T.

SEQ ID NO: 29: BGL1 gDNA

Aspergillus saccharolyticus BGL1 gDNA sequence including upstream sequence

ATG start site and signal sequence as well as stop codon are highlighted bold

Introns are underlined








cggttaaggcctaactcggagagggaccaacgggatgcagaggtggagat


 


gcggggaatggctggggaggataataccgtatgtatccgcgtgtcatgac


 


accaggtataccttattctcgtctgccaactatcaccactgcagtgagtg


 


cttgctcgctggcagacctgcggggaacaacacagactggactgatacaa


 


tggataccaccttccatcttcatcttcttgtcagcttctcgggtgtcatt


 


caagtccgatatttgtccgattagcctgtatccgaagcggatcggaatgt


 


aaacgaggaacgggataacttaagtttacggagtattctggttccagtcg


 


agaatgctgggcagctcccggccgatcgtatgctgcttgctgcctgaatg


 


ataataattatctattttattctgagagaaaattcttggattattttctt


 


gtattccttaaatctttataaaacagagtgcagttggagattcatgtccg


 


agagagatgctgagtgttaagactgtaagtaagtagaggaagtggtaagt


 


tgtttggattgaactggaaagcgtcacaggattacatacaggcacctccc


 


ggccccactgcggtcggggaacttcttccagtccacagggcagcagtact


 


caatatccatccaatatccatccttccactacatccaccatcatcattgt


 


ttcccggatggcaggatactggcaccacgctctgacgtggggctcggcca


 


ttccagttatcccagctcaattccctgcaggtctgctgcgaactattgac


 


cgcgaaaatgaaagtttttttgggagttgatgttccacggtgccgtgcgc


 


aggtgaatgcaagcaagagcagcgatccagagatggagagtgaatgaatc


 


acggtaagtagcatcgcttgacttgcctgcgttccggtcgttccatgctt


 


tttctcgactctccctcgctgtctgtctctctctcgatctggattcctcc


 


ctgtcgatccatccccatgcttagagccaaaacaactaagccgatggggc


 


tggctggccttcgactgctggcgggcgagacagcattcaaagagtggact


 


acttgtggtagctccgcagcatcagccaagaaagtctaggttgatgttag


 


ttattcactcgtctgctggtctctgagtctcatagctgtggcgcccccct


 


cctgccgttgctggggttatttatatcccctcccttccccccccctgatc


 


ggatatgtttgtcttcccacaataagttgtgttacctcgccatcttcctc


 


aattgctcgagactagctcgtcccttccgcttccttcagctacctcgacg


 


ccatcatgaggctcagttggctcgaggctgccgccttgacggctgcatcc


 


gtcgtcagcgctgtatgttttgccgcttgtttggatggatgactgggtgt


 


gaaactgacatttgtgctcgctaggatgaacttgccttcgcttccccctt


 


ctatccttccccttgggccaatggccagggcgagtgggcggatgcctaca


 


agcgcgcagtggacattgtttcccagatgactctggacgagaaggtcaat


 


ctgaccaccggaactgggtatgggagcgtaattcatgcggtccgcatcgc


 


ctgctaacatattccaagctgggagctggagaagtgcgtcggtcaaactg


 


gtggtgttccaaggtatgcactgattgaatgggtttctactagaacggtt


 


aattgacaattgtgcctagactcgacatcggtggaatgtgtcttcaggac


 


agtccgctcggagtccgtgattgtaagtctcgttaggagccgacatcaaa


 


cgtgtcttattaacaatgtgtcttccagcggactacaattcgggattccc


 


cgctggcgtcaacgttgctgcgacttgggacaggaagctcgcctatctcc


 


gtgggcaggccatgggtcaagaatttagtgacaagggagttgatgtccag


 


ctggggccggccgccgggcccctgggcagaagtcccgatggaggtcggaa


 


ctgggaagggttttcgcccgacccagcactcactggtgtgctctttgccg


 


agacgatcaagggtatccaagatgccggggtcatcgccacagctaagcac


 


tacattctcaatgagcaggaacatttccgccaagtctcggaggctgcggg


 


ctacggtttcaacatctctgataccatcagctccaacatcgacgacaaaa


 


ccattcatgagatgtacctctggcccttcgcggatgccgtgcgtgccggt


 


gtgggcgccgtcatgtgctcctacaaccagattaacaacagttacgcctg


 


ccagaacagctacacactgaacaagcttctgaagtcggagctcggctttc


 


aaggatttgttatgtcggactggggtgctcaccacagtggtgtcggctct


 


gctttggccgggttggatatgtctatgcccggtgacgtttcttttgattc


 


tgccaccagtttctggggtaccaacctgactgttgccgttctcaatggaa


 


ccgtcccgcagtggcgtgttgacgacatggccgttcgtatcatggctgcc


 


tactacaaggttggccgtgatcgcttgtaccagccgcccaacttcagctc


 


ctggactcgggacgagtacggcttcaagtactactactcccaggaaggcc


 


cctacgagaaggtcaatcaatatgtcaatgtgcagcgcaaccacagcgaa


 


gtcattcgcaaggtgggagccgacagcactgtcctgttgaagaacaacaa


 


tgctcttcctctgactggaaaggagcgcaaggttgctctcatcggcgagg


 


atgctggatctaacgcctacggtgccaacggctgcagtgaccgcggatgc


 


gacaacgggacgctcgccatggcctggggcagtggcaccgcagagttccc


 


atacctggtcactcccgagcaggccattcaagccgaggtgctcaagaaca


 


agggcagcacttacactatcaccgacaactgggcattgagccaggtggag


 


gccctcgctaagacggctaggtgagcccttccattcatgatactggtctg


 


ccgtgacaatccactgacaagtcgctcgcagtgtctccctggtctttgtg


 


aatgccgactcgggcgaaggctacatctcggttgatggcaacgagggtga


 


ccgcaacaacctcaccctgtggaagaacggggacaatctcatcaaggcta


 


ctgccagcaactgcaacaacaccattgttgtcatccactccgttggggct


 


gttctggtggacgaatggtatgaccacccgaacgtcactgcgattctctg


 


ggctggcttgcctggccaggagtctggcaattctcttgccgatgtcctct


 


acggccgcgtcaaccctggcggtaagacgcccttcacctggggcaagacg


 


agagcgtcttacggggactacctggttcgggagcccaacaacggccacgg


 


agccccgcaggataacttctcggagggtgttttcatcgactaccgcggct


 


ttgacaagcgcaatgagaccccgatctacgagttcggacacggtctgagc


 


tacaccaccttcaactattcgggcctgcaggtggaggttctcaacacgtc


 


ttccagcactccggtcgctacccagaccaagcccgcacccactttcggcg


 


agattggcaacgcgtcggactacttgtaccctgagggattggaccgaatt


 


accgcgttcatctacccctggctcaactccacggacctcaaggagtcatc


 


tggtgacccggactatggggtggacaccgccaagtatattcccgccggcg


 


ccaccaacagctcggcccagcctgttctgccggctggcggtggcttcggt


 


ggtaacccgcgtctctacgatgagctgatccgtgtttcggttaccgtcaa


 


gaacactggtcgtgtcactggggacgccgtgcctcaattggtaagttgct


 


cgtccggggagttggtagatcgcgtactaacatgagacagtatgtatcgc


 


ttggcggacctaatgagcccaaggtggtgctgcgccagttcgaccgcatc


 


acgctccggccttcggaggagacggtgtggacgactactctgacccgtcg


 


cgatctgtccaactgggatgttgcggctcaggactgggttattacttcct


 


acccgaagaaggttcacgtgggtagctcttcgcgtcagctgccgcttcat


 


gcggcgctgcctaaggtgcaatgagcggatggggattgggtgcgatgggg


 


atgatgctgtatacttctttccagtcgggagactacgaattgatgactat


 


gttattgtaaagacgagcgatccagggatccaggtacaggaggggtgtag


 


tgtaatgtaagcgtaatgatctggggtcgggtggctgtggcggtggaggt


 


gaagcggcgggcgggcggaagacagcgacgtcatccgacttccaccggca


 


cttcgtctccctttggtaacttccatcatttctccgacctctgcctggtt


 


ttcgtctatccatcctgacgcctcaattcccatcatctttctttgaattt


 


tgctccacgcttgactttgaattgattgcctccaaaacaagccaccacaa


 


gacagcgcagccactcaaaccatcgaagggactctatccggaattggc






Deposit of Microorganisms Under the Budapest Treaty

The following biological material has been deposited under the terms of the Budapest Treaty with the Centraalbereau voor Schimmelcultures (CBS), Uppsalaan 8, 3584 CT Utrecht, The Netherlands; P.O. Box 85167, 3508 AD Utrecht, The Netherlands and given the following accession number














Deposit
Accession Number









CBS
127449
Aspergillus saccharolyticus









Aspergillus AP/Aspergillus saccharolyticus (=IBT 28509)

Date of Deposit: Jun. 30, 2010

The strain has been deposited under conditions that assure that access to the cultures will be available during the pendency of this patent application to one determined by foreign patent laws to be entitled thereto. The deposit represents a substantially pure culture of the deposited strain. The deposit is available as required by foreign patent laws in countries wherein counterparts of the subject application, or its progeny are filed. However it should be understood that the availability of a deposit does not constitute a license to practice the subject invention in derogation of patent rights granted by governmental action
NCBI Blast of NCBI Blast of

## Claims

1. A recombinant host cell of a microorganism, the host cell comprising a recombinant nucleic acid sequence or its complementary sequence, the expression product thereof being capable of hydrolyzing a β1-4 glucose-glucose linkage, the recombinant nucleic acid sequence being selected from the group consisting of:
a. a polynucleotide sequence encoding a polypeptide consisting of an amino acid sequence SEQ ID NO: 4,
b. a polynucleotide sequence encoding a biologically active sequence variant of said amino acid sequence, wherein the variant has at least 96% sequence identity to said SEQ ID NO: 4,
c. SEQ ID NO: 1, SEQ ID NO: 2, or SEQ ID NO: 29,
d. a polynucleotide comprising a nucleic acid sequence having at least 85% identity to SEQ ID NO: 1, SEQ ID NO: 2, or SEQ ID NO: 29, and
e. a polynucleotide complementary to any of a) to d).

2. The host cell according to claim 1, wherein said microorganism or descendant thereof, comprises a beta-glucosidase (BGL) polypeptide and/or a gene encoding said polypeptide.

3. The host cell according to claim 2, wherein said beta-glucosidase (BGL) polypeptide is BGL1 (SEQ ID NO: 4).

4. The host cell according to claim 1, wherein said microorganism or descendant thereof, comprise a nucleic acid sequence, which is at least 90% identical to SEQ ID NO: 16.

5. The host cell according to claim 1, wherein said microorganism or descendant thereof, comprise a nucleic acid sequence, which is at least 90% identical to SEQ ID NO: 15.

6. The host cell according to claim 1, wherein said microorganism or descendant thereof, comprise a nucleic acid sequence, which is at least 88% identical to SEQ ID NO: 14.

7. An isolated polynucleotide comprising a recombinant nucleic acid sequence or its complementary sequence, the expression product thereof being capable of hydrolyzing a β1-4 glucose-glucose linkage, the recombinant nucleic acid sequence being selected from the group consisting of:
a. a polynucleotide sequence encoding a polypeptide consisting of an amino acid sequence SEQ ID NO: 4,
b. a polynucleotide sequence encoding a biologically active sequence variant of said amino acid sequence, wherein the variant has at least 96% sequence identity to said SEQ ID NO: 4,
c. SEQ ID NO: 1, SEQ ID NO: 2, or SEQ ID NO: 29,
d. a polynucleotide comprising a nucleic acid sequence having at least 85% identity to SEQ ID NO: 1, SEQ ID NO: 2, or SEQ ID NO: 29, and
e. a polynucleotide complementary to any of a) to d).

8. The host cell according to claim 1, wherein said microorganism comprises a fungus.

9. The host cell according to claim 8, wherein the fungus comprises a filamentous fungus.

10. The host cell according to claim 8, wherein the fungus is selected from the group consisting of: Trichoderma and Aspergillus.

11. The host cell according to claim 8, wherein the fungus comprises a white rot fungus.

12. The host cell according to claim 1, wherein said microorganism comprises a yeast.

13. The host cell according to claim 1, wherein said microorganism comprises bacteria.